
<html lang="en"     class="pb-page"  data-request-id="9a3c417e-6b1c-4af0-bf67-0d1fd6beb486"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.9b00611;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-14;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy" /></meta><meta name="dc.Creator" content="Hao  Zhang" /></meta><meta name="dc.Creator" content="Lijuan  Xu" /></meta><meta name="dc.Creator" content="Xia  Qin" /></meta><meta name="dc.Creator" content="Xiaofei  Chen" /></meta><meta name="dc.Creator" content="Hui  Cong" /></meta><meta name="dc.Creator" content="Longmiao  Hu" /></meta><meta name="dc.Creator" content="Long  Chen" /></meta><meta name="dc.Creator" content="Zhenyuan  Miao" /></meta><meta name="dc.Creator" content="Wannian  Zhang" /></meta><meta name="dc.Creator" content="Zhenyu  Cai" /></meta><meta name="dc.Creator" content="Chunlin  Zhuang" /></meta><meta name="dc.Description" content="Necroptosis, a form of programmed cell death, plays a critical role in various diseases, including inflammatory, infectious, and degenerative diseases. We previously identified N-(7-cyano-6-(4-fluo..." /></meta><meta name="Description" content="Necroptosis, a form of programmed cell death, plays a critical role in various diseases, including inflammatory, infectious, and degenerative diseases. We previously identified N-(7-cyano-6-(4-fluo..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 16, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00611" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00611" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00611" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00611" /></link>
        
    
    

<title>N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00611" /></meta><meta property="og:title" content="N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0016.jpeg" /></meta><meta property="og:description" content="Necroptosis, a form of programmed cell death, plays a critical role in various diseases, including inflammatory, infectious, and degenerative diseases. We previously identified N-(7-cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) (6) as a potent inhibitor of necroptosis by targeting both receptor-interacting protein kinase 1 (RIPK1) and 3 (RIPK3) kinases. Herein, we performed three rounds of structural optimizations of TAK-632 and elucidated structure–activity relationships to generate more potent inhibitors by targeting RIPK3. The analogues with carbamide groups exhibited great antinecroptotic activities, and compound 42 showed &gt;60-fold selectivity for RIPK3 than RIPK1. It blocked necrosome formation by specifically inhibiting the phosphorylation of RIPK3 in necroptotic cells. In a tumor necrosis factor-induced systemic inflammatory response syndrome model, it significantly protected mice from hypothermia and death at a dose of 5 mg/kg, which was much more effective than TAK-632. Moreover, it showed favorable and druglike pharmacokinetic properties in rats with an oral bioavailability of 25.2%. Thus, these RIPK3-targeting small molecules represent promising lead structures for further development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00611"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00611">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00611&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00611&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00611&amp;href=/doi/10.1021/acs.jmedchem.9b00611" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6665-6681</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00537" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00616" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title"><i>N</i>-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hao Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hao Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hao++Zhang">Hao Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lijuan Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lijuan Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lijuan++Xu">Lijuan Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xia Qin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xia Qin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Center for Liver Cancer, Second Military Medical University, 225 Changhai Road, Shanghai 200438, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xia++Qin">Xia Qin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaofei Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaofei Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaofei++Chen">Xiaofei Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hui Cong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hui Cong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Cong">Hui Cong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Longmiao Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Longmiao Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Center for Liver Cancer, Second Military Medical University, 225 Changhai Road, Shanghai 200438, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Longmiao++Hu">Longmiao Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Long Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Long Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Long++Chen">Long Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhenyuan Miao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhenyuan Miao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhenyuan++Miao">Zhenyuan Miao</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7839-4183" title="Orcid link">http://orcid.org/0000-0001-7839-4183</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wannian Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wannian Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#02786a636c65756c69426a6d766f636b6e2c616d6f"><span class="__cf_email__" data-cfemail="f18b99909f96869f9ab1999e859c90989ddf929e9c">[email protected]</span></a> (W.Z.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wannian++Zhang">Wannian Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhenyu Cai</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhenyu Cai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">National Center for Liver Cancer, Second Military Medical University, 225 Changhai Road, Shanghai 200438, China</div><div class="loa-info-affiliations-info">Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai 200032, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3054425351594a58555e4945700102061e535f5d"><span class="__cf_email__" data-cfemail="0f6b7d6c6e6675676a61767a4f3e3d39216c6062">[email protected]</span></a> (Z.C.)</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhenyu++Cai">Zhenyu Cai</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Chunlin Zhuang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunlin Zhuang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div><div class="loa-info-affiliations-info">Department of Chemistry, Fudan University, Shanghai 200433, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#f68c959a9897829e9798b6c7c0c5d895999b"><span class="__cf_email__" data-cfemail="403a232c2e213428212e007176736e232f2d">[email protected]</span></a> (C.Z.)</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunlin++Zhuang">Chunlin Zhuang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0569-5708" title="Orcid link">http://orcid.org/0000-0002-0569-5708</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00611&amp;href=/doi/10.1021%2Facs.jmedchem.9b00611" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6665–6681</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 16, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 April 2019</li><li><span class="item_label"><b>Published</b> online</span>16 May 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 July 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00611" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00611</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6665%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHao%2BZhang%252C%2BLijuan%2BXu%252C%2BXia%2BQin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D14%26contentID%3Dacs.jmedchem.9b00611%26title%3DN-%25287-Cyano-6-%25284-fluoro-3-%25282-%25283-%2528trifluoromethyl%2529phenyl%2529acetamido%2529phenoxy%2529benzo%255Bd%255Dthiazol-2-yl%2529cyclopropanecarboxamide%2B%2528TAK-632%2529%2BAnalogues%2Bas%2BNovel%2BNecroptosis%2BInhibitors%2Bby%2BTargeting%2BReceptor-Interacting%2BProtein%2BKinase%2B3%2B%2528RIPK3%2529%253A%2BSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationships%252C%2Band%2Bin%2BVivo%2BEfficacy%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6681%26publicationDate%3DJuly%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00611"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2439</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00611" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hao&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Lijuan&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Xia&quot;,&quot;last_name&quot;:&quot;Qin&quot;},{&quot;first_name&quot;:&quot;Xiaofei&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Cong&quot;},{&quot;first_name&quot;:&quot;Longmiao&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Long&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Zhenyuan&quot;,&quot;last_name&quot;:&quot;Miao&quot;},{&quot;first_name&quot;:&quot;Wannian&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zhenyu&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;Chunlin&quot;,&quot;last_name&quot;:&quot;Zhuang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;6665-6681&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00611&quot;},&quot;abstract&quot;:&quot;Necroptosis, a form of programmed cell death, plays a critical role in various diseases, including inflammatory, infectious, and degenerative diseases. We previously identified N-(7-cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) (6) as a potent inhibitor of necroptosis by targeting both receptor-interacting protein kinase 1 (RIPK1) and 3 (RIPK3) kinases. Herein, we performed three rounds of structural optimizations of TAK-632 and elucidated structure–activity relationships to generate more potent inhibitors by targeting RIPK3. The analogues with carbamide groups exhibited great antinecroptotic activities, and compound 42 showed &gt;60-fold selectivity for RIPK3 than RIPK1. It blocked necrosome formation by specifically inhibiting the phosphorylation of RIPK3 in necroptotic cells. In a tumor necrosis factor-induced systemic inflammatory response syndrome model, it significantly protected mice from hypothermia and death at a dose of 5 mg/k&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00611&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00611" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00611&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00611" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00611&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00611" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00611&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00611&amp;href=/doi/10.1021/acs.jmedchem.9b00611" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00611" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00611" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00611%26sid%3Dliteratum%253Aachs%26pmid%3D31095385%26genre%3Darticle%26aulast%3DZhang%26date%3D2019%26atitle%3DN-%25287-Cyano-6-%25284-fluoro-3-%25282-%25283-%2528trifluoromethyl%2529phenyl%2529acetamido%2529phenoxy%2529benzo%255Bd%255Dthiazol-2-yl%2529cyclopropanecarboxamide%2B%2528TAK-632%2529%2BAnalogues%2Bas%2BNovel%2BNecroptosis%2BInhibitors%2Bby%2BTargeting%2BReceptor-Interacting%2BProtein%2BKinase%2B3%2B%2528RIPK3%2529%253A%2BSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationships%252C%2Band%2Bin%2BVivo%2BEfficacy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D14%26spage%3D6665%26epage%3D6681%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/jmcmar.2019.62.issue-14/20190725/jmcmar.2019.62.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Necroptosis, a form of programmed cell death, plays a critical role in various diseases, including inflammatory, infectious, and degenerative diseases. We previously identified <i>N</i>-(7-cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) (<b>6</b>) as a potent inhibitor of necroptosis by targeting both receptor-interacting protein kinase 1 (RIPK1) and 3 (RIPK3) kinases. Herein, we performed three rounds of structural optimizations of TAK-632 and elucidated structure–activity relationships to generate more potent inhibitors by targeting RIPK3. The analogues with carbamide groups exhibited great antinecroptotic activities, and compound <b>42</b> showed >60-fold selectivity for RIPK3 than RIPK1. It blocked necrosome formation by specifically inhibiting the phosphorylation of RIPK3 in necroptotic cells. In a tumor necrosis factor-induced systemic inflammatory response syndrome model, it significantly protected mice from hypothermia and death at a dose of 5 mg/kg, which was much more effective than TAK-632. Moreover, it showed favorable and druglike pharmacokinetic properties in rats with an oral bioavailability of 25.2%. Thus, these RIPK3-targeting small molecules represent promising lead structures for further development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Necroptosis is caspase-independent, programmed necrosis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It plays a critical role in various lethal diseases such as atherosclerosis, myocardial infarction, pancreatitis, ischemic brain damage, kidney damage, and systemic inflammatory response syndrome (SIRS).<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9">(2−9)</a> Thus, targeting the pathologic necroptosis pathway has broad therapeutic relevance. Necroptosis can be induced by the activation of death receptors, such as tumor necrosis factor (TNF) receptor 1, CD95 (FAS), toll-like receptors 3/4, and interferons.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Then, downstream receptor-interacting protein kinase 1 (RIPK1) interacts with RIPK3, initiating the formation of necrosomes and activating RIPK3 through phosphorylation.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Subsequently, activated RIPK3 is recruited, and mixed lineage kinase domain-like protein (MLKL) is phosphorylated.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> Phosphorylated MLKL oligomerizes and then translocates into the plasma membrane to trigger membrane rupture, initiating necroptosis.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15−18)</a> To date, RIPK1, RIPK3, and MLKL have been recognized as critical therapeutic targets in the machinery of necroptosis.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">The first RIPK1 inhibitor, Nec-1 (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), was identified by the Yuan group in 2005.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> However, its poor metabolic stability (<i>t</i><sub>1/2</sub> < 5 min) limited further drug discovery efforts based on this compound. A subsequent analogue, Nec-1s (<b>2</b>), offered improved metabolic stability, but its potency remained moderate.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> GlaxoSmithKline has made great advances in the discovery of necroptosis inhibitors. Compound <b>3</b> (GSK2982772), an RIPK1-specific inhibitor, has been advanced into phase II trials in patients with active ulcerative colitis (NCT02903966), psoriasis (NCT02776033), or moderate to severe rheumatoid arthritis (NCT02858492).<a onclick="showRef(event, 'ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26">(23−26)</a> A blood–brain-barrier-permeable RIPK1 inhibitor, DNL747, with the chemical structure undisclosed, recently has been advanced into phase I trials in patients with amyotrophic lateral sclerosis (NCT03757351) and Alzheimer’s disease (NCT03757325).<a onclick="showRef(event, 'ref9 ref27'); return false;" href="javascript:void(0);" class="ref ref9 ref27">(9,27)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative known necroptosis inhibitors targeting RIPK1, RIPK3, or MLKL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, since RIPK3 can signal necroptosis independent of RIPK1, Nec-1 and these highly potent RIPK1 inhibitors cannot block RIPK3-independent necroptosis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In addition, accumulating evidence suggests that RIPK1 is also involved in other signaling pathways independent of necroptosis such as apoptosis and inflammation.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Thus, identification of small molecules specifically targeting RIPK3 or MLKL is important for the development of new drugs associated with this pathway. A few RIPK3 inhibitors, such as GSK’840, GSK’843, GSK’872, and GW’39B, have been reported.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> However, these RIPK3 inhibitors have been shown to induce RIPK1-dependent apoptosis.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Recently, dabrafenib (<b>5</b>), a Food and Drug Administration-approved drug for patients with Braf<sup>V600E</sup> melanoma, was identified as an RIPK3 kinase inhibitor to block necroptosis.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> However, so far no RIPK3 inhibitors have been used for clinical trials in necroptosis-associated diseases. In addition, although NSA-1 (<b>4</b>) is reported to be an MLKL inhibitor by covalent modification of the protein, it shows high cytotoxicity.<a onclick="showRef(event, 'ref13 ref35'); return false;" href="javascript:void(0);" class="ref ref13 ref35">(13,35)</a> Thus, identification of novel necroptosis inhibitors with lower cytotoxicity will undoubtedly have broad clinical relevance.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p last">Very recently, we identified the pan-Raf inhibitor <i>N</i>-(7-cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) (<b>6</b>) as a novel necroptosis inhibitor by targeting both RIPK1 and RIPK3 kinases from an in-house library of fluorine-containing compounds.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In this study, we aimed to comprehensively analyze the structure–activity relationship (SAR) of TAK-632 and generate more potent analogues to inhibit necroptosis by targeting RIPK3.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Structural variations were introduced at three different positions of TAK-632. First, the amide-linked substituents at R<sup>1</sup> and R<sup>2</sup> were changed, but the cyano group (R<sup>3</sup>) was left intact. Second, the cyano moiety was removed, R<sup>1</sup> was fixed as a cyclopropyl group, and substituents on the phenylamide (R<sup>2</sup>) were varied. Third, a carbamide was introduced at the R<sup>2</sup> position. All compounds in this study were prepared following the general strategies illustrated in <a class="ref internalNav" href="#sch1" aria-label="Schemes1">Schemes1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Key intermediates <b>m11</b>–<b>16</b> were prepared following the procedure established in the literature.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Then, intermediates <b>m17</b>–<b>22</b> were obtained by deprotection of the trifluoroacetyl group. Target compounds (<b>7</b>–<b>34</b>) were then obtained using 2-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (HATU) as the coupling reagent.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH<sub>4</sub>, EtOH/MeOH (20:1), 0 °C to room temperature, 3 h, 95–98%; (b) R<sup>2</sup>COOH, HATU, dry pyridine, 85 °C, 8 h, 19–71%. Details of the synthetic route and procedures for accessing intermediates <b>m11</b>–<b>16</b> are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_001.pdf" class="ext-link">Supporting Information</a>.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>2</sup>SO<sub>2</sub>Cl, dry pyridine, 0 °C to room temperature, 12 h, 45%; (b) R<sup>2</sup>CHO, NaBH<sub>3</sub>CN, AcOH, room temperature, 24 h, 26–32%; (c) R<sup>4</sup>NCO, <i>N</i>,<i>N</i>-dimethylformamide (DMF), MeCN, or dimethyl sulfoxide (DMSO), room temperature, 12 h, 18–54%.</p></p></figure><div class="NLM_p last">The preparation of compounds <b>35</b>–<b>42</b> is shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Compounds <b>36</b> and <b>37</b> were obtained by reductive amination via treating intermediate <b>m21</b> with the appropriate benzaldehyde derivatives. Similarly, compound <b>35</b> was easily prepared by a substitution reaction. Compounds <b>38</b>–<b>42</b> were directly synthesized using different isocyanates. The procedures and characterization data of the key intermediates are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_001.pdf" class="ext-link">Supporting Information</a>. The final structures were fully characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and high-resolution mass spectrometry (HRMS). All target compounds were purified to >95%, as determined by high-performance liquid chromatography (HPLC) analysis, prior to use in subsequent experiments.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structure Optimization, Biological Evaluation, and SAR Analysis Identify Necroptosis Inhibitors by Targeting RIPK3</h3><div class="NLM_p">The antinecroptosis activity of each compound was measured by a chemiluminescence assay using a model based on treating human HT-29 cells with <u class="uu">T</u>NF-α, <u class="uu">S</u>mac mimetic (SM-164) and a caspase inhibitor (<u class="uu">z</u>-VAD-fmk, abbreviated as TSZ).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The first round of optimizations was performed by modifying the substituents at R<sup>1</sup> and R<sup>2</sup> and retaining the cyano group (R<sup>3</sup>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Initially, the cyclopropyl group of TAK-632 was replaced by ethyl (<b>7</b>), phenyl (<b>8</b>), nonyl (<b>9</b>), or benzyloxy (<b>10</b>) groups. The ability to inhibit TSZ-induced necroptosis at a concentration of 20 μM was completely lost; for comparison, the parent compound TAK-632 exhibited an EC<sub>50</sub> value of 1.44 ± 0.62 μM. Then, the cyclopropyl group was restored, and the substituents on the phenylamide (R<sup>2</sup>) were changed. Compounds with <i>para</i>-nitrobenzyl (<b>11</b>), benzyl (<b>12</b>), <i>meta</i>-fluorobenzyl (13), and <i>meta</i>-trifluoromethylphenyl (<b>14</b>) groups showed no inhibitory activities against necroptosis at 20 μM, indicating the importance of the <i>meta</i>-trifluoromethyl group. At <i>ortho</i>-position of the benzyl moiety, an additional fluoro group was introduced to obtain compound <b>15</b>. It showed a similar activity (EC<sub>50</sub> = 2.03 ± 0.86 μM) to that of TAK-632. Thus, these results suggested a narrow window in which the structure of TAK-632 could be further modified.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. First Round of Optimization of TAK-632</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Human HT-29 cells were pretreated with DMSO or the test compound and then stimulated with TNF-α (20 ng/mL), Smac mimetic (10 nM), and z-VAD-fmk (20 μM) (TSZ) for 16 h. The inhibition of TSZ-induced necroptosis in HT-29 cells is presented as the EC<sub>50</sub> ± standard deviation (SD). All experiments were repeated independently at least three times.</p></div></div><div></div></div><div class="NLM_p">TAK-632 is a pan-Raf inhibitor;<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> however, Raf kinase is not involved in the necroptosis signaling pathway.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In a previous study, we experimentally showed that TAK-632 protects cells from necroptosis by targeting RIPK1 (<i>K</i><sub>d</sub> = 480 nM) and RIPK3 (<i>K</i><sub>d</sub> = 105 nM).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Thus, a structural optimization study was performed to improve the antinecroptotic activity and the inhibition of RIPK1 and/or RIPK3. The first potential position for structural optimization was the cyano group of TAK-632, which may slightly improve Raf kinase inhibition but it is not critical to the activity.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> To our delight, compound <b>16</b>, lacking the cyano group, exhibited approximately 8-fold better antinecroptotic activity, ∼4-fold and ∼2-fold better in vitro RIPK1/3 kinase inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), and ∼2-fold lower inhibition of Raf kinase.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> However, it showed slight cytotoxicity with a CC<sub>50</sub> value of 36.50 μM. Encouraged by this cyano-free analogue of TAK-632, we then used <b>16</b> as a lead compound for further optimization. The <i>meta</i>-trifluoromethyl group on the benzylamine of <b>16</b> was critical to the antinecroptotic activity. Compound <b>17</b>, with an <i>ortho</i>-trifluoromethyl group, had an EC<sub>50</sub> value of 11.35 μM, which is a ∼66-fold decrease relative to that of <b>16</b>. Introducing an additional fluorine atom at the ortho- (<b>18</b>) or para-position (<b>19</b>) resulted in ∼3-fold lower effects on necroptosis and RIPK1/3 kinase activity. However, a chlorine atom at the ortho-position (<b>20</b>) completely eliminated the activity. An additional trifluoromethyl group (<b>21</b>) in the meta-position was detrimental to the antinecroptotic activity (EC<sub>50</sub> = 9.7 μM). The presence of two adjacent methyl groups (<b>22</b>) decreased the antinecroptotic effect to 1.67 ± 0.83 μM and the RIPK1 kinase activity to 1.2 μM, whereas the RIPK3 kinase activity (<i>K</i><sub>d</sub> = 72 nM) was similar to that of <b>16</b>. However, more active compounds (<b>18</b>, <b>19</b>, and <b>22</b>) showed unfavorable RIPK1 binding, suggesting that small substituents on the phenyl ring are tolerated and can preserve RIPK3 inhibition ability.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Second Round of Optimization of TAK-632</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0011.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0012.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0013.gif" alt="" id="GRAPHIC-d7e826-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of TSZ-induced necroptosis in HT-29 cells.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">The inhibitory effects of the compounds on RIPK1 and RIPK3 kinases were detected by a KINOMEscan assay. The experiments were conducted in duplicate, and the <i>K</i><sub>d</sub> values are presented as the average.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">These compounds have been included in our previous publication.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">N.D. = not determined if the antinecroptotic activity was higher than 5 μM.</p></div></div><div></div></div><div class="NLM_p">Then, we focused on monosubstituted benzylamines to improve the antinecroptotic potency. The nitro- (<b>23</b>), methyl- (<b>24</b>), and methoxyl- (<b>25</b>) substituted analogues showed antinecroptotic potencies that were 2–4-fold better than that of TAK-632, and they had cell potencies and kinase inhibitory activities similar to those of <b>16</b>. Compounds <b>24</b> and <b>25</b> had better RIPK3 inhibitory activities (<i>K</i><sub>d</sub> = 33 and 55 nM, respectively) than <b>16</b>. Introducing a trifluoromethoxyl group (<b>26</b>) resulted in the best antinecroptosis potency seen in this series (EC<sub>50</sub> = 60 ± 30 nM). In addition, this compound showed increased inhibitory activity for RIPK1 while retaining the inhibitory activity for RIPK3. Replacing the trifluoromethyl group of <b>16</b> with a hydroxyl group (<b>27</b>) completely removed the activity, and the installation of a cyano group (<b>28</b>) was also detrimental to its inhibitory potency, resulting in an EC<sub>50</sub> value of 1.29 ± 0.47 μM. The RIPK1 inhibitory activity of compound <b>28</b> was 8-fold lower, and its RIPK3 inhibitory ability was comparable to that of compound <b>16</b>. Then, the phenyl ring was replaced by a pyridinyl group (<b>29</b>), and the resulting compound possessed an EC<sub>50</sub> of 0.32 ± 0.05 μM against cell necroptosis. However, removing the trifluoromethyl group from compound <b>29</b> to give <b>30</b> was detrimental to the activity, which decreased to 8.3 μM. Introducing heterocycles (<b>31</b> and <b>32</b>) negatively impacted cell necroptosis activity, and <b>31</b> and <b>32</b> showed 10–20-fold lower activities than <b>16</b>. Nevertheless, the selectivity for RIPK3 over RIPK1 was maintained. The binding affinity of compound <b>31</b> for RIPK3 was <i>K</i><sub>d</sub> = 81 nM, and its affinity for RIPK1 was 13-fold lower. Indolyl analogue <b>32</b> had <i>K</i><sub>d</sub> values of 4.8 and 1.4 μM for RIPK1 and RIPK3, respectively. Moreover, it is also reported that the linker in lead molecules might be useful to the selectivity.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Therefore, an additional methylene (<b>33</b>) unit was added in the linker between the trifluoromethylphenyl and amide moieties, but this decreased the antinecroptotic activity approximately 4-fold compared with that of <b>16</b>; however, the activity of <b>33</b> was 2-fold higher than that of TAK-632. Introducing cyclopropyl (<b>34</b>) or sulfamide (<b>35</b>) moieties as the linker destroyed the activity. When the carbonyl of the amide was removed to afford benzyl-substituted compounds <b>36</b> and <b>37</b>, the resulting necroptosis inhibitory activities were undetectable at 20 μM. These results suggest the importance of the amide linker for further optimization. Moreover, the cytotoxicities of these analogues that showed antinecroptotic activities were significantly lower (CC<sub>50</sub> > 50 μM).</div><div class="NLM_p">Next, the third round of optimization (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) focused on the substituents on the amide fragment to improve the selectivity. We first introduced a carbamide group into compound <b>16</b>, which is a potential functional group for kinase binding with an additional hydrogen bond. To our delight, this series of compounds showed great selectivity for RIPK3 over RIPK1; their selectivities were much higher than those of TAK-632 (selectivity = 4.6) and <b>16</b> (no selectivity). Then, different substituents were introduced at the meta-position due to the substantial influence of groups at this position on the antinecroptotic activity. The methoxyl (<b>38</b>) and methyl (<b>39</b>) analogues showed antinecroptosis EC<sub>50</sub> values of 1.37 ± 0.08 and 0.58 ± 0.16 μM, respectively. They possessed binding affinities for RIPK3 with <i>K</i><sub>d</sub> values of 69 and 93 nM and for RIPK1 with <i>K</i><sub>d</sub> values of 3.6 and 2.2 μM, respectively. Compound <b>40</b>, with an ethoxycarbonyl group, showed an RIPK3/1 selectivity of >69.4; however, its EC<sub>50</sub> value was 7.74 ± 1.87 μM, making it less potent than TAK-632. Compound <b>41</b>, with an acetyl group, exhibited the best RIPK3 binding affinity (<i>K</i><sub>d</sub> = 53 nM) and the highest RIPK3/1 selectivity (>94.3). Moreover, its antinecroptotic activity was 7-fold higher than that of compound <b>40</b>. Bromo-substituted compound <b>42</b> had a <i>K</i><sub>d</sub> value of 81 nM toward RIPK3 and no binding for RIPK1 at 5 μM (selectivity >61.7). <b>42</b> also exhibited good antinecroptotic activity with an EC<sub>50</sub> value of 0.44 ± 0.10 μM, which is comparable to that of <b>16</b>, and low cytotoxicity (CC<sub>50</sub> > 50 μM).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structural Optimization of Compound <b>16</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0014.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0015.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of TSZ-induced necroptosis in HT-29 cells.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">The inhibitory effects of the test compounds on RIPK1 and RIPK3 kinases were detected by a KINOMEscan assay. The experiments were conducted in duplicate, and the <i>K</i><sub>d</sub> values are presented as the average.</p></div></div><div></div></div><div class="NLM_p">With the above structural and biological information, SARs can be derived for further structural optimization (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). (1) A narrow SAR of TAK-632 analogues with cyano groups is observed. (2) The removal of the cyano group has a positive effect on the antinecroptotic activity. (3) Small substituents at the para- and ortho-positions are tolerated. The linker between the trifluoromethylphenyl and amide moieties is of great importance to the antinecroptotic activity. (4) The carbamide group has a positive effect on the antinecroptosis activity and the selectivity for binding RIPK3 over RIPK1.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Systematic summary of the SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Kinase Inhibitory Profiles of Compound <b>42</b> and Molecular Docking Analysis</h3><div class="NLM_p">In our screen, we found that compound <b>26</b> showed the highest antinecroptotic activity in HT-29 cells by inhibiting the kinase activities of both RIPK1 and RIPK3. The dual RIPK1 and RIPK3 kinase inhibitors may have off-target effects since RIPK1 is also involved in other signaling pathways independent of necroptosis such as apoptosis and inflammation.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In this study, we aimed to comprehensively analyze the structure–activity relationship (SAR) of TAK-632 and generate more potent analogues to inhibit necroptosis by targeting RIPK3. Thus, we selected compound <b>42</b>, a compound with improved antinecroptotic activity by specifically targeting RIPK3, for further evaluation.</div><div class="NLM_p">The kinase inhibitory profile against 25 different kinases including Raf family kinases was performed based on the previous study<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Similar to TAK-632 and compound <b>16</b>,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> compound <b>42</b> targeted additional six kinases other than RIPK3 in vitro (%ctrl < 10). In cells, the antinecroptotic activity of compound <b>42</b> cannot be explained by these additional targets since vemurafenib (a Raf inhibitor) and vandetanib (a VEGFR2 inhibitor) with similar target profiles did not inhibit necroptosis.<a onclick="showRef(event, 'ref33 ref40'); return false;" href="javascript:void(0);" class="ref ref33 ref40">(33,40)</a> Besides, the identified targets of compound <b>42</b>, including Raf, VEGFR, PDGFR, and SRC, were not involved in the necroptotic signaling pathway.<a onclick="showRef(event, 'ref33 ref41'); return false;" href="javascript:void(0);" class="ref ref33 ref41">(33,41)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Kinase Selectivity of Compound <b>42</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">%ctrl @ 1000 nM</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">%Ctrl @ 1000 nM</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">%ctrl @ 1000 nM (<i>K</i><sub>d</sub>, nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Braf (wt)</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="left">JNK1</td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Braf (V600E)</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">CDK3</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="left">p38α</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">CDK7</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="left">IKKα</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR (L858R)</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">GSK3B</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">IKKβ</td><td class="colsep0 rowsep0" align="left">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK1</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">MAP3K4</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">PDGFRA</td><td class="colsep0 rowsep0" align="left">5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR2</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">MAPKAPK2</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">PDGFRB</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FGFR3</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">MEK1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">SRC</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Raf1</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">MEK2</td><td class="colsep0 rowsep0" align="char" char=".">83</td><td class="colsep0 rowsep0" align="left">MET</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR2</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The inhibitory effects were detected by a KINOMEscan assay and reported as %ctrl (DMSO = 100% ctrl).</p></div></div></div><div class="NLM_p">The molecular docking studies were performed to understand the structural basis of the protein target specificity. Two compounds (<b>16</b> and <b>42</b>) biochemically targeting RIPK1 and/or RIPK3 were selected. Compound <b>16</b> could bind well with RIPK1 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A) and RIPK3 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). Compound <b>42</b> could bind well with RIPK3 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D) but not with RIPK1 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). A key hydrogen-bonding interaction between the thiazole ring and protein residue D156 was observed in the predicted model of the compound <b>16</b>–RIPK1 complex. Besides, the benzothiazole of <b>16</b> formed strong π–π stacking interactions with F162. The aniline group was located in the gatekeeper region (I43, K45, and M92 residues), and the trifluorophenyl group was inserted through the gatekeeper pointing to the solvent-exposed region. However, in the predicted model of the <b>42</b>–RIPK1 complex, the key hydrogen bond with D156 was missing as the benzothiazole ring was flipped (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E). Although the compound showed a similar conformation as that of compound <b>16</b>, the repulsion of the carbamide group and the amide group of K45 slightly moved <b>42</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E). These might disrupt its interaction with RIPK1 and probably made <b>42</b> inactive toward RIPK1. For RIPK3, we generated a homology model of human RIPK3 based on murine RIPK3 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M69">4M69</a>), which shares 69% sequence identity and 77% sequence similarity with each other.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Both <b>16</b> and <b>42</b> showed similar binding conformations in a “U” mode with RIPK3 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F), and a key hydrogen bond between the nitrogen of the thiazole ring and T94 was observed. The trifluorophenyl or bromophenyl group was inserted into the regions of G31, D142, and N147. Besides, the carbamide formed additional hydrogen bonds with S146, and a halogen bond was formed by the bromo group with G31 and N147, which were probably useful to maintain the U conformation and kinase inhibitory activity.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding modes of compound <b>16</b> (carbon in green) or <b>42</b> (carbon in yellow) with RIPK1 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HHO">6HHO</a>) and RIPK3 (a homology model based on PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M66">4M66</a>). (A) Compound <b>16</b> with RIPK1; (B) compound <b>42</b> with RIPK1; (C) compound <b>16</b> with RIPK3; and (D) compound <b>42</b> with RIPK3. Superposition of the binding modes of compound <b>16</b> (carbon in green) or <b>42</b> (carbon in yellow) with RIPK1 or RIPK3. (E) Compounds <b>16</b> and <b>42</b> with RIPK1. (F) Compounds <b>16</b> and <b>42</b> with RIPK3. Residues of enzymes are depicted as gray sticks. Hydrogen bonds and halogen bonds are depicted as green and purple dash lines, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As compound <b>42</b> also inhibited the kinase activity of B-raf, the binding mode of compound <b>42</b> with B-raf kinase was predicted (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_001.pdf" class="ext-link">Figure S1</a>). Compound <b>42</b> showed similar binding conformation with TAK-632 and kept all of the key interactions of TAK-632 with B-raf, including three hydrogen-bonding interactions with D593, E500, and C531, π–π stacking interactions with W530 and F594, and π–cation interaction with K482. Additionally, <b>42</b> formed a hydrogen-bonding interaction with E500 as the introduction of a carbamide group. In the future, it would be of importance to generate more derivatives of TAK-632 to segregate the specificity for RIPK3 from its other targets. Collectively, the molecular docking analysis further supports the experimental results that compound <b>42</b> targets RIPK3 but not RIPK1.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compound <b>42</b> Specifically Inhibits Necroptosis</h3><div class="NLM_p">As compound <b>42</b> has been shown to inhibit the kinase activity of RIPK3 in vitro, we then further evaluate its antinecroptotic ability in cells. It also protected against TNF-α, cycloheximide, and z-VAD-fmk (TCZ)-induced necroptosis in human HT-29 cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A), but it did not protect cells from TNF-α and Smac mimetic (TS)- or TNF-α and cycloheximide (TC)-induced apoptosis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). In murine L929 cells, we found that compound <b>42</b> protected against necroptosis induced by TNF-α and z-VAD-fmk (TZ) in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). The above results indicate that compound <b>42</b> specifically inhibits the necroptosis pathway.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of TAK-632 analogues on necroptosis and apoptosis. (A) HT-29 cells were pretreated with DMSO, compound <b>42</b> (3 μM), or TAK-632 (3 μM) and then stimulated with TNF-α (20 ng/mL), cycloheximide (5 μg/mL), and z-VAD-fmk (20 μM) (TCZ) for 12 h. (B) HT-29 cells were pretreated with DMSO, compound <b>42</b>, or TAK-632 (3 μM) and then stimulated with TNF-α (20 ng/mL) plus cycloheximide (5 μg/mL) (TC) or TNF-α (20 ng/mL) plus Smac mimetic (10 nM) (TS) for 20 h. (C) L929 cells were pretreated with DMSO or compound <b>42</b> at the indicated concentrations and then stimulated with mouse TNF-α (20 ng/mL) and z-VAD-fmk (20 μM) (TZ) for 4 h. ** <i>p</i> < 0.005, *** <i>p</i> < 0.0005, compounds <b>42</b> or TAK-632 vs no treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>42</b> Blocks Necrosome Formation by Inhibiting the Phosphorylation of RIPK3</h3><div class="NLM_p">To investigate the inhibitory mechanism of compound <b>42</b> against necroptosis, we examined phosphorylation of RIPK1, RIPK3, and MLKL in TSZ-treated HT-29 cells with or without compound <b>42</b>. Consistent with the in vitro kinase assay, compound <b>42</b> did not influence the phosphorylation of RIPK1 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). However, it selectively inhibited the phosphorylation of RIPK3 and MLKL. Since the phosphorylation of RIPK1 and RIPK3 is required for RIPK1–RIPK3 necrosome formation,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> we then explored the formation of necrosome in HT-29 cells after pretreating with compound <b>42</b>, and we found that compound <b>42</b> blocked TSZ-induced necrosome formation (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Thus, compound <b>42</b> blocks necrosome formation by inhibiting TSZ-induced phosphorylation of RIPK3.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>42</b> blocks necrosome formation by inhibiting the phosphorylation of RIPK3. (A) HT-29 cells were pretreated with compound <b>42</b> (1 μM) and then stimulated with TSZ at the indicated time points. The cells were lysed and immunoblotted with the indicated antibodies. (B) HT-29 cells were treated with DMSO or compound <b>42</b> (1 μM) for 4 h. The cell lysates were immunoprecipitated with an anti-RIPK1 antibody (IP: RIPK1) and analyzed by immunoblotting with the indicated antibodies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Compound <b>42</b> Protects Mice from TNF-Induced Systemic Inflammatory Response Syndrome (SIRS)</h3><div class="NLM_p">To explore whether compound <b>42</b> protects against RIPK-driven inflammation in vivo, we tested this compound in a TNF-induced SIRS model.<a onclick="showRef(event, 'ref5 ref36'); return false;" href="javascript:void(0);" class="ref ref5 ref36">(5,36)</a> The compound was intragastrically administered 2 h before intravenous (i.v.) injection of mTNF-α. We found that compound <b>42</b> significantly protected mice from hypothermia and death at the doses of 5, 25, or 50 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B), which was much more effective than TAK-632 and its previously reported analogue compound <b>16</b> to protect mice from death and hypothermia.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>42</b> protected mice from SIRS. (A) Body temperature and (B) survival curve of C57BL/6 female mice (<i>n</i> = 10 per group) injected with mTNF-α (400 μg/kg) after pretreatment with different doses of compound <b>42</b> (5, 25, and 50 mg/kg). *** <i>p</i> < 0.0005, treatment group vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compound <b>42</b> Has Favorable and Druglike Pharmacokinetic (PK) Properties in Rats</h3><div class="NLM_p">The pharmacokinetic (PK) characteristics of compound <b>42</b> in rats were evaluated. The key per os (p.o.) and i.v. administration PK parameters are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. After a single i.v. administration with 1 mg/kg compound <b>42</b>, the half-time (<i>t</i><sub>1/2</sub>), the clearance rate (CL), and apparent distribution volume (<i>V</i><sub>ss</sub>) of <b>42</b> are 15.4 h, 2.6 mL/(min kg), and 3.49 L/kg, respectively. When <b>42</b> was administrated by the oral route at 5 mg/kg, its maximum plasma concentration (<i>C</i><sub>max</sub>) was 345 ng/mL. Compound <b>42</b> had a favorable oral bioavailability (<i>F</i>) of 25.2%, suggesting a druglike property. In addition, no apparent adverse effects were observed in rats.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. PK Profile of Compound <b>42</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">1 mg/kg (i.v.)</th><th class="colsep0 rowsep0" align="center" char="±">5 mg/kg (p.o.)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">15.4 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">15.2 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.083</td><td class="colsep0 rowsep0" align="char" char="±">8.67 ± 1.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">4603 ± 554</td><td class="colsep0 rowsep0" align="char" char="±">345 ± 101</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–<i>t</i></sub> (h ng/mL)</td><td class="colsep0 rowsep0" align="left">5563 ± 894</td><td class="colsep0 rowsep0" align="char" char="±">7014 ± 2528</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (h ng/mL)</td><td class="colsep0 rowsep0" align="left">6498 ± 959</td><td class="colsep0 rowsep0" align="char" char="±">9317 ± 4081</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/(min kg))</td><td class="colsep0 rowsep0" align="left">2.6 ± 0.38</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">V<sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">3.49 ± 0.74</td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">25.2 ± 9.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">PK parameters (mean ± SD, <i>n</i> = 3).</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, novel RIPK3-selective inhibitors were successfully identified by three rounds of structural optimization starting from TAK-632 as the lead compound. An obvious SAR was derived to guide further optimizations. Most analogues significantly suppressed necroptotic cell death in both murine and human cells with low cytotoxicity. Compounds with carbamide groups exhibited promising selectivities for RIPK3 over RIPK1 kinase. Of the prepared compounds, compound <b>42</b> showed more than 60-fold selectivity for RIPK3/1 kinase and exhibited good antinecroptotic activity with an EC<sub>50</sub> value of 0.44 ± 0.10 μM in human HT-29 cells. Molecular docking analysis explained the target selectivity of compound <b>42</b> and provided a structural basis for further optimization. Consistent with the in vitro kinase assays, compound <b>42</b> showed no effect on RIPK1 phosphorylation and selectively inhibited RIPK3 and MLKL phosphorylation in cells. Remarkably, compound <b>42</b> significantly protected mice from hypothermia and death at a dose of 5 mg/kg, which was much more effective than its parent chemical TAK-632. Thus, the carbamide small molecules represent promising leads for the development of novel antinecroptotic therapeutic agents.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p last">All starting materials were obtained from commercial sources and were analytically pure. TAK-632 (CAS#1228591-30-7) was purchased from TargetMol with a purity of 98% (TargetMol). The <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on Bruker Avance 300 and 600 MHz spectrometers (Bruker Company, Germany) using tetramethylsilane as an internal standard and CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as solvents. Chemical shifts (δ values) and coupling constants (<i>J</i> values) are given in ppm and hertz (Hz), respectively. The mass spectra were recorded on an Esquire 3000 LC–MS mass spectrometer. High-resolution mass spectrometry data were acquired using a quadrupole time-of-flight micro mass spectrometer. Thin-layer chromatography (TLC) analyses were carried out on silica gel plates GF<sub>254</sub> (Qingdao Haiyang Chemical, China). Column chromatography separations were carried out on a silica gel 200–300 mesh. The purities of the compounds were analyzed by HPLC (Agilent 1260) using a C18 column (Elite Hypersil ODS2, 4.6 × 250 mm<sup>2</sup>, 5 μm) with 85% methanol/15% water as the mobile phase at a flow rate of 0.6 mL/min, and all final compounds exhibited purities greater than 95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure for the Preparation of Compounds <b>7</b>–<b>34</b></h3><div class="NLM_p">To a solution of NaBH<sub>4</sub> (20 equiv) in EtOH (20 mL) was added MeOH (1 mL), and the intermediate (<b>m11</b>–<b>16</b>) (1 equiv) was added to this suspension at 0 °C. The mixture was stirred at 0 °C for 1 h and then warmed to room temperature for 2 h. After the addition was completed, TLC analysis indicated the reaction was complete. The solvent was removed under reduced pressure, and the residue was re-extracted with ethyl acetate. The combined organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give a crude intermediate (<b>m17</b>–<b>22</b>), which was used directly in the next step without purification. A solution of the corresponding intermediate (<b>m17</b>–<b>22</b>) (1 equiv), carboxylic acid derivative (1.2 equiv), and HATU (2 equiv) in anhydrous pyridine was stirred at 85 °C for 8 h under a nitrogen atmosphere, at which time TLC analysis indicated the reaction was completed. The solvent was removed under reduced pressure, and the residue was extracted with ethyl acetate. The organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the crude product, which was then purified by column chromatography on silica gel (petroleum ether/ethyl acetate = 1:1). The product was recrystallized using petroleum ether/ethyl acetate to give the target compounds.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)propionamide (<b>7</b>)</h4><div class="NLM_p last">White solid (28 mg, yield: 64%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.62 (s, 1H), 10.22 (s, 1H), 7.97 (d, 1H, <i>J</i> = 9.0 Hz), 7.84 (s, 1H), 7.68 (s, 1H), 7.60–7.61 (m, 2H), 7.53–7.56 (m, 1H), 7.37 (t, 1H, <i>J</i> = 9.6 Hz), 7.06 (d, 1H, <i>J</i> = 9.0 Hz), 6.96–6.97 (m, 1H), 3.88 (s, 2H), 2.54 (q, 2H, <i>J</i> = 7.2 Hz), 1.12 (t, 3H, <i>J</i> = 7.8 Hz). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 173.61, 169.36, 157.64, 155.65, 151.37, 150.64, 149.84, 144.63, 136.93, 135.92, 133.49, 129.27, 128.94, 127.54, 126.56, 125.87, 125.14, 123.38, 116.72, 115.19, 114.39, 113.70, 95.44, 41.98, 28.41, 8.78. HRMS (electrospray ionization (ESI), positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>18</sub>F<sub>4</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 543.1109, found 543.1105. HPLC analysis: retention time = 12.2 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)benzamide (<b>8</b>)</h4><div class="NLM_p last">White solid (23 mg, yield: 53%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.21 (s, 1H), 10.25 (s, 1H), 8.14 (d, 2H, <i>J</i> = 6.6 Hz), 8.02 (d, 1H, <i>J</i> = 8.7 Hz), 7.87 (s, 1H), 7.57–7.68 (m, 7H), 7.38 (t, 1H, <i>J</i> = 9.6 Hz), 6.99–7.11 (m, 2H), 3.89 (s, 2H). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>18</sub>F<sub>4</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 591.1109, found 591.1116. HPLC analysis: retention time = 7.9 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)nonanamide (<b>9</b>)</h4><div class="NLM_p last">White solid (30 mg, yield: 71%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.66 (s, 1H), 10.23 (s, 1H), 7.98 (d, 1H, <i>J</i> = 9.0 Hz), 7.82–7.85 (m, 1H), 7.68 (s, 1H), 7.52–7.62 (m, 3H), 7.38 (t, 1H, <i>J</i> = 9.3 Hz), 7.06 (d, 1H, <i>J</i> = 9.0 Hz), 6.94–7.00 (m, 1H), 3.88 (s, 2H), 2.50–2.53 (m, 2H), 1.60–1.62 (m, 2H), 1.25–1.27 (m, 10H), 0.83–0.87 (m, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.92, 169.39, 157.50, 155.72, 151.78, 144.59, 136.94, 135.91, 133.52, 129.30, 128.73, 127.55, 126.65, 125.91, 123.37, 116.80, 116.53, 115.25, 114.39, 113.69, 41.98, 35.03, 31.23, 28.65, 28.52, 28.48, 24.42, 22.07, 13.95. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>30</sub>F<sub>4</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 627.2048, found 627.2055. HPLC analysis: retention time = 16.3 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Benzyl(7-cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)carbamate (<b>10</b>)</h4><div class="NLM_p last">White solid (41 mg, 19%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.54 (s, 1H), 10.22 (s, 1H), 7.94 (d, 1H, <i>J</i> = 9.3 Hz), 7.83 (s, 1H), 7.57–7.68 (m, 4H), 7.37–7.46 (m, 6H), 6.95–7.07 (m, 2H), 5.30 (s, 2H), 3.88 (s, 2H). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>20</sub>F<sub>4</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 621.1214, found 621.1219. HPLC analysis: retention time = 10.1 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(7-Cyano-6-(4-fluoro-3-(2-(4-nitrophenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>11</b>)</h4><div class="NLM_p last">White solid (39 mg, yield: 93%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.98 (s, 1H), 10.27 (s, 1H), 8.18 (d, 2H, <i>J</i> = 8.1 Hz), 7.98 (d, 1H, <i>J</i> = 9 Hz), 7.83–7.84 (m, 1H), 7.58 (d, 2H, <i>J</i> = 8.4 Hz), 7.37 (t, 1H, <i>J</i> = 9.6 Hz), 7.07 (d, 1H, <i>J</i> = 9.0 Hz), 6.95–6.98 (m, 1H), 3.94 (s, 2H), 1.98–2.04 (m, 1H), 0.99–1.01 (m, 4H). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>18</sub>FN<sub>5</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 532.1085, found 532.1095. HPLC analysis: retention time = 6.9 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(7-Cyano-6-(4-fluoro-3-(2-phenylacetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>12</b>)</h4><div class="NLM_p last">White solid (20 mg, yield: 53%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.99 (s, 1H), 10.15 (s, 1H), 7.98 (d, 1H, <i>J</i> = 9.0 Hz), 7.84–7.87 (m, 1H), 7.30–7.39 (m, 6H), 7.06 (d, 1H, <i>J</i> = 9.0 Hz), 6.94–6.98 (m, 1H), 1.98–2.03 (m, 1H), 0.99–1.02 (m, 4H). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>19</sub>FN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 487.1235, found 487.1235. HPLC analysis: retention time = 7.8 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(7-Cyano-6-(4-fluoro-3-(2-(3-fluorophenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>13</b>)</h4><div class="NLM_p last">White solid (22 mg, yield: 55%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.99 (s, 1H), 10.18 (s, 1H), 7.99 (d, 1H, <i>J</i> = 9.0 Hz), 7.83–7.86 (m, 1H), 7.31–7.40 (m, 2H), 7.04–7.15 (m, 4H), 6.95–6.99 (m, 1H), 3.78 (s, 2H), 1.98–2.03 (m, 1H), 0.99–1.02 (m, 4H); HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>18</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 505.1140, found 505.1148. HPLC analysis: retention time = 7.7 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(5-((7-cyano-2-(cyclopropanecarboxamido)benzo[<i>d</i>]thiazol-6-yl)oxy)-2-fluorophenyl)-3-(trifluoromethyl)benzamide (<b>14</b>)</h4><div class="NLM_p last">White solid (20 mg, yield: 50%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.99 (s, 1H), 10.50 (s, 1H), 8.23–8.28 (m, 2H), 7.97–8.06 (m, 2H), 7.78 (t, 1H, <i>J</i> = 7.8 Hz), 7.50–7.53 (m, 1H), 7.43 (t, 1H, <i>J</i> = 9.6 Hz), 7.11–7.18 (m, 2H), 1.99–2.04 (m, 1H), 0.99–1.02 (m, 4H). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>16</sub>F<sub>4</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 541.0952, found 541.0945. HPLC analysis: retention time = 8.1 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(7-Cyano-6-(4-fluoro-3-(2-(2-fluoro-3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>15</b>)</h4><div class="NLM_p last">White solid (33 mg, yield: 55%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.95 (s, 1H), 10.28 (s, 1H), 7.98 (d, 1H, <i>J</i> = 9 Hz), 7.82–7.85 (m, 1H), 7.65–7.74 (m, 2H), 7.34–7.41 (m, 2H), 7.08 (d, 1H, <i>J</i> = 9.0 Hz), 6.95–7.00 (m, 1H), 3.96 (s, 2H), 1.98–2.03 (m, 1H), 0.98–1.01 (m, 4H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −59.91 (d, <i>J</i> = 12.4 Hz, C<i>F</i><sub>3</sub>), −119.86 (Ar–<i>F</i>), −129.81 (Ar–<i>F</i>). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>17</sub>F<sub>5</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 573.1014, found 573.1024. HPLC analysis: retention time = 7.1 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(6-(4-Fuoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>16</b>)</h4><div class="NLM_p last">White solid (100 mg, yield: 56%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (s, 1H), 10.11 (s, 1H), 7.67–7.72 (m, 3H), 7.63 (d, 1H, <i>J</i> = 2.4 Hz), 7.59–7.61 (m, 2H), 7.53–7.56 (m, 1H), 7.26–7.29 (m, 1H), 7.10 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.4 Hz), 6.78–6.81 (m, 1H), 3.86 (s, 2H), 1.97–2.01 (m, 1H), 0.93–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.71, 169.17, 157.56, 153.07, 152.78, 149.08, 144.93, 137.00, 133.45, 132.87, 129.26, 128.94, 127.15, 125.78, 125.13, 123.33, 121.45, 118.02, 116.24, 114.34, 112.99, 111.56, 41.99, 13.75, 8.61. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>19</sub>F<sub>4</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 530.1156, found 530.1169. HPLC analysis: retention time = 9.0 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-(6-(4-Fluoro-3-(2-(2-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>17</b>)</h4><div class="NLM_p last">White solid (20 mg, yield: 32%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.60 (s, 1H), 10.10 (s, 1H), 7.70 (d, 1H, <i>J</i> = 8.4 Hz), 7.67–7.68 (m, 2H), 7.63 (d, 1H, <i>J</i> = 2.4 Hz), 7.61 (t, 1H, <i>J</i> = 7.8 Hz), 7.44–7.49 (m, 2H), 7.28 (t, 1H, <i>J</i> = 9.6 Hz), 7.10 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.4 Hz), 6.78–6.80 (m, 1H), 4.00 (s, 2H), 1.97–2.01 (m, 1H), 0.94–0.95 (m, 4H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.71, 168.76, 157.57, 153.11, 152.77, 149.02, 144.94, 133.64, 133.39, 132.87, 132.18, 127.46, 127.28, 125.57, 125.33, 123.52, 121.44, 118.03, 116.21, 114.18, 112.89, 111.58, 13.75, 8.59. <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −58.65 (<i>CF</i><sub>3</sub>), −131.94 (Ar–<i>F</i>). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>19</sub>F<sub>4</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 530.1156, found 530.1173. HPLC analysis: retention time = 8.7 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-(6-(4-Fluoro-3-(2-(2-fluoro-3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>18</b>)</h4><div class="NLM_p last">White solid (25 mg, yield: 38%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.60 (s, 1H), 10.17 (s, 1H), 7.66–7.72 (m, 4H), 7.63 (d, 1H, <i>J</i> = 2.4 Hz), 7.36 (t, 1H, <i>J</i> = 7.8 Hz), 7.27–7.30 (m, 1H), 7.09 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 9.0 Hz), 6.79–6.82 (m, 1H), 3.93 (s, 2H), 1.97–2.01 (m, 1H), 0.93–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.70, 168.64, 157.57, 153.09, 152.81, 149.16, 144.95, 138.92, 132.89, 130.35, 129.88, 127.06, 126.06, 124.26, 122.45, 121.44, 120.36, 117.97, 116.24, 114.48, 113.14, 111.51, 41.51, 13.74, 8.57. <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −59.91 (d, <i>J</i> = 12.4 Hz, C<i>F</i><sub>3</sub>), −119.87 (Ar–<i>F</i>), −131.79 (Ar–<i>F</i>). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>18</sub>F<sub>5</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 548.1056, found 548.1074. HPLC analysis: retention time = 8.8 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-(6-(4-Fluoro-3-(2-(4-fluoro-3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>19</b>)</h4><div class="NLM_p last">White solid (26 mg, yield: 40%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.60 (s, 1H), 10.09 (s, 1H), 7.64–7.72 (m, 4H), 7.62 (d, 1H, <i>J</i> = 2.4 Hz), 7.42–7.48 (m, 1H), 7.26–7.29 (m, 1H), 7.09 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 9.0 Hz), 6.78–6.81 (m, 1H), 3.84 (s, 2H), 1.98–2.00 (m, 1H), 0.94–0.95 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.72, 169.13, 157.79, 157.58, 153.10, 152.79, 149.08, 144.95, 136.04, 132.88, 132.74, 127.88, 127.15, 123.56, 121.75, 121.46, 118.02, 116.96, 116.20, 114.37, 112.98, 111.56, 41.11, 13.76, 8.60. <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −59.98 (d, <i>J</i> = 12.1 Hz, C<i>F</i><sub>3</sub>), −119.23 (Ar–<i>F</i>), −131.83 (Ar–<i>F</i>). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>18</sub>F<sub>5</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 548.1062, found 548.1069. HPLC analysis: retention time = 8.9 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(6-(3-(2-(2-Chloro-3-(trifluoromethyl)phenyl)acetamido)-4-fluorophenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>20</b>)</h4><div class="NLM_p last">White solid (21 mg, yield: 31%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.60 (s, 1H), 10.19 (s, 1H), 7.75 (d, 1H, <i>J</i> = 7.8 Hz), 7.70–7.72 (m, 3H), 7.62 (d, 1H, <i>J</i> = 3 Hz), 7.50 (t, 1H, <i>J</i> = 7.8 Hz), 7.26–7.30 (m, 1H), 7.10 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.4 Hz), 6.78–6.81 (m, 1H), 4.06 (s, 2H), 1.97–2.00 (m, 1H), 0.94–0.95 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.72, 168.19, 157.59, 153.14, 152.78, 149.00, 144.96, 136.73, 136.45, 132.89, 131.31, 127.26, 126.93, 126.43, 123.91, 122.10, 121.45, 118.03, 116.24, 114.23, 112.89, 111.59, 40.49, 13.76, 8.60. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>18</sub>ClF<sub>4</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 564.0766, found 564.0767. HPLC analysis: retention time = 9.3 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(6-(3-(2-(3,5-Bis(trifluoromethyl)phenyl)acetamido)-4-fluorophenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>21</b>)</h4><div class="NLM_p last">White solid (32 mg, yield: 46%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.59 (s, 1H), 10.15 (s, 1H), 8.01 (s, 2H), 7.98 (s, 1H), 7.71 (d, 1H, <i>J</i> = 9.0 Hz), 7.65–7.67 (m, 1H), 7.62 (d, 1H, <i>J</i> = 2.4 Hz), 7.27–7.30 (m, 1H), 7.09 (dd, 1H, <i>J</i><sub>1</sub> = 3.0 Hz, <i>J</i><sub>2</sub> = 9.0 Hz), 6.79–6.82 (m, 1H), 3.31 (s, 2H), 1.97–2.00 (m, 1H), 0.93–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.71, 168.12, 157.58, 157.39, 153.11, 152.79, 149.54, 144.95, 136.93, 132.89, 127.12, 125.78, 124.72, 124.55, 123.64, 121.84, 121.44, 118.01, 116.24, 114.37, 112.96, 111.56, 35.46, 13.75, 8.59. <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ -61.24 (<i>CF</i><sub>3</sub>), −131.72 (Ar–<i>F</i>). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>18</sub>F<sub>7</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 598.1024, found 598.1032. HPLC analysis: retention time = 11.4 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(6-(3-(2-(3,4-Dimethylphenyl)acetamido)-4-fluorophenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>22</b>)</h4><div class="NLM_p last">White solid (26 mg, yield: 45%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.63 (s, 1H), 9.96 (s, 1H), 7.70 (d, 1H, <i>J</i> = 8.7 Hz), 7.62 (d, 1H, <i>J</i> = 2.1 Hz), 7.26 (t, 1H, <i>J</i> = 9.6 Hz), 6.99–7.11 (m, 4H), 6.76–6.80 (m, 1H), 3.63 (s, 2H), 2.15–2.16 (m, 6H), 1.98–2.02 (m, 1H), 0.94–0.95 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.75, 170.02, 157.60, 153.10, 152.82, 148.99, 144.96, 135.90, 134.28, 132.92, 132.91, 130.27, 129.36, 127.41, 126.47, 121.48, 118.06, 116.18, 114.08, 112.86, 111.59, 42.26, 19.35, 18.95, 13.80, 8.67. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 490.1595, found 490.1597. HPLC analysis: retention time = 7.2 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(6-(4-Fluoro-3-(2-(3-nitrophenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>23</b>)</h4><div class="NLM_p last">White solid (22 mg, yield: 33%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.59 (s, 1H), 10.14 (s, 1H), 8.20 (s, 1H), 8.09–8.11 (m, 1H), 7.75 (d, 1H, <i>J</i> = 7.8 Hz), 7.70–7.71 (m, 2H), 7.59–7.62 (m, 2H), 7.28 (t, 1H, <i>J</i> = 10.2 Hz), 7.09 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.4 Hz), 6.78–6.81 (m, 1H), 3.92 (s, 2H), 1.97–2.00 (m, 1H), 0.94–0.95 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.71, 168.93, 157.57, 153.11, 152.76, 149.02, 147.64, 144.94, 137.76, 136.17, 132.87, 129.65, 127.13, 123.97, 121.63, 121.45, 118.03, 116.23, 114.32, 112.88, 111.57, 41.75, 13.75, 8.60. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>19</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 507.1127, found 507.1151. HPLC analysis: retention time = 8.2 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(6-(4-Fluoro-3-(2-(<i>m</i>-tolyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>24</b>)</h4><div class="NLM_p last">White solid (21 mg, yield: 38%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.60 (s, 1H), 9.98 (s, 1H), 7.71 (d, 1H, <i>J</i> = 8.4 Hz), 7.62 (d, 1H, <i>J</i> = 2.4 Hz), 7.24–7.28 (m, 1H), 7.18 (t, 1H, <i>J</i> = 7.8 Hz), 7.08–7.11 (m, 3H), 7.02 (d, 1H, <i>J</i> = 7.2 Hz), 6.77–6.79 (m, 1H), 3.67 (s, 2H), 2.26 (s, 3H), 1.98–2.00 (m, 1H), 0.94–0.95 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.70, 169.78, 157.56, 153.05, 152.79, 148.99, 144.92, 137.28, 135.53, 132.87, 129.75, 128.14, 127.33, 127.14, 126.17, 121.44, 118.02, 116.16, 114.16, 112.89, 111.55, 42.53, 20.92, 13.75, 8.60. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 476.1439, found 476.1449. HPLC analysis: retention time = 9.3 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(6-(4-Fluoro-3-(2-(3-methoxyphenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>25</b>)</h4><div class="NLM_p last">White solid (30 mg, yield: 52%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.62 (s, 1H), 10.01 (s, 1H), 7.68–7.73 (m, 2H), 7.63 (d, 1H, <i>J</i> = 2.4 Hz), 7.18–7.30 (m, 2H), 7.10 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.7 Hz), 6.85–6.88 (m, 2H), 6.76–6.81 (m, 2H), 3.72 (s, 3H), 3.68 (s, 2H), 1.97–2.01 (m, 1H), 0.94–0.96 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.75, 169.64, 159.18, 157.59, 153.07, 152.80, 149.04, 144.95, 137.12, 132.89, 129.30, 127.32, 121.49, 121.38, 118.06, 116.23, 114.90, 114.21, 112.92, 111.98, 111.60, 54.94, 42.66, 13.79, 8.66. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 492.1388, found 492.1399. HPLC analysis: retention time = 8.4 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(6-(4-Fluoro-3-(2-(3-(trifluoromethoxy)phenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>26</b>)</h4><div class="NLM_p last">White solid (32 mg, yield: 49%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.63 (s, 1H), 10.11 (s, 1H), 7.63–7.73 (m, 3H), 7.44 (t, 1H, <i>J</i> = 7.8 Hz), 7.22–7.34 (m, 4H), 7.10 (d, 1H, <i>J</i> = 8.4 Hz), 6.78–6.81 (m, 1H), 3.80 (s, 1H), 1.99–2.01 (m, 1H), 0.93–0.95 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.75, 169.16, 157.61, 153.13, 152.79, 149.09, 148.30, 144.97, 138.32, 132.91, 130.12, 128.44, 127.19, 121.66, 121.49, 119.12, 118.39, 118.07, 116.27, 114.40, 112.99, 111.62, 42.01, 13.79, 8.66. <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −56.66 (O<i>CF</i><sub>3</sub>), −131.82 (Ar–<i>F</i>). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>19</sub>F<sub>4</sub>N<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 546.1105, found 546.1121. HPLC analysis: retention time = 9.3 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(6-(4-Fluoro-3-(2-(3-hydroxyphenyl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>27</b>)</h4><div class="NLM_p last">White solid (26 mg, yield: 46%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (s, 1H), 9.97 (s, 1H), 9.31 (s, 1H), 7.71–7.73 (m, 2H), 7.63 (d, 1H, <i>J</i> = 2.4 Hz), 7.24–7.28 (m, 1H), 7.06–7.11 (m, 2H), 6.76–6.79 (m, 1H), 6.71–6.73 (m, 2H), 6.61–6.63 (m, 1H), 3.62 (s, 2H) 1.98–2.00 (m, 1H), 0.94–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.73, 169.76, 157.58, 157.25, 153.07, 152.81, 148.98, 144.95, 136.91, 132.89, 129.19, 127.36, 121.47, 119.75, 118.05, 116.18, 116.00, 114.12, 113.56, 112.85, 111.58, 42.65, 13.78, 8.63. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 478.1231, found 478.1244. HPLC analysis: retention time = 7.2 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(6-(3-(2-(3-Cyanophenyl)acetamido)-4-fluorophenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>28</b>)</h4><div class="NLM_p last">White solid (32 mg, yield: 55%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.62 (s, 1H), 10.12 (s, 1H), 7.70–7.74 (m, 4H), 7.62–7.64 (m, 2H), 7.51 (t, 1H, <i>J</i> = 7.8 Hz), 7.28 (t, 1H, <i>J</i> = 9.3 Hz), 7.09 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.7 Hz), 6.77–6.82 (m, 1H), 3.83 (s, 2H), 1.98–2.01 (m, 1H), 0.93–0.95 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.77, 169.04, 157.61, 153.12, 152.80, 149.06, 144.97, 137.24, 134.42, 132.92, 130.48, 129.49, 127.19, 121.50, 118.78, 118.08, 116.27, 114.36, 112.96, 111.62, 111.20, 41.76, 13.81, 8.68. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>19</sub>FN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 487.1352, found 487.1244. HPLC analysis: retention time = 7.1 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(6-(4-Fluoro-3-(2-(6-(trifluoromethyl)pyridin-2-yl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>29</b>)</h4><div class="NLM_p last">White solid (30 mg, yield: 41%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.62 (s, 1H), 10.21 (s, 1H), 8.04 (t, 1H, <i>J</i> = 7.8 Hz), 7.63–7.78 (m, 5H), 7.29 (t, 1H, <i>J</i> = 9.6 Hz), 7.10 (dd, 1H, <i>J</i><sub>1</sub> = 2.1 Hz, <i>J</i><sub>2</sub> = 8.7 Hz), 6.79–6.83 (m, 1H), 4.08 (s, 2H), 1.98–2.01 (m, 1H), 0.93–0.95 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.75, 168.21, 157.62, 156.77, 153.16, 152.78, 148.99, 145.86, 144.98, 138.75, 132.91, 128.05, 127.14, 121.58, 121.49, 118.90, 118.09, 116.28, 114.23, 112.84, 111.64, 44.68, 13.79, 8.66. <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ −66.37 (<i>CF</i><sub>3</sub>), −131.96 (Ar–<i>F</i>). HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>18</sub>F<sub>4</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 531.1109, found 531.1120. HPLC analysis: retention time = 8.5 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(6-(4-Fluoro-3-(2-(pyridin-2-yl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>30</b>)</h4><div class="NLM_p last">White solid (23 mg, yield: 42%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.60 (s, 1H), 10.21 (s, 1H), 8.49 (d, 1H, <i>J</i> = 3.6 Hz), 7.70–7.76 (m, 3H), 7.63 (d, 1H, <i>J</i> = 2.4 Hz), 7.36 (d, 1H, <i>J</i> = 7.8 Hz), 7.25–7.29 (m, 2H), 7.10 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 9.0 Hz), 6.77–6.80 (m, 1H), 3.93 (s, 2H), 1.97–2.01 (m, 1H), 0.94–0.95 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.71, 168.67, 157.56, 155.65, 153.09, 152.79, 148.88, 148.83, 144.93, 136.66, 132.87, 127.31, 124.03, 121.93, 121.46, 118.04, 116.15, 114.06, 112.60, 111.57, 45.05, 13.75, 8.61. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>19</sub>FN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 463.1325, found 463.1248. HPLC analysis: retention time = 7.7 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(6-(3-(2-(Benzo[<i>d</i>][1,3]dioxol-5-yl)acetamido)-4-fluorophenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>31</b>)</h4><div class="NLM_p last">White solid (30 mg, yield: 50%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.62 (s, 1H), 9.96 (s, 1H), 7.70–7.73 (m, 2H), 7.62 (d, 1H, <i>J</i> = 2.1 Hz), 7.26 (t, 1H, <i>J</i> = 10.2 Hz), 7.10 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.7 Hz), 6.74–6.86 (m, 4H), 5.96 (s, 2H), 3.62 (s, 2H), 1.98–2.01 (m, 1H), 0.93–0.95 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.75, 169.90, 157.59, 153.10, 152.81, 148.99, 147.12, 145.94, 144.95, 132.89, 129.26, 127.35, 122.21, 121.49, 118.07, 116.21, 114.21, 112.85, 111.61, 109.59, 108.06, 100.79, 42.18, 13.79, 8.66. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 506.1180, found 506.1189. HPLC analysis: retention time = 8.0 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(6-(4-Fluoro-3-(2-(1-methyl-1<i>H</i>-indol-3-yl)acetamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>32</b>)</h4><div class="NLM_p last">White solid (25 mg, yield: 41%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.59 (s, 1H), 9.90 (s, 1H), 7.69–7.72 (m, 2H), 7.62 (d, 1H, <i>J</i> = 2.4 Hz), 7.58 (d, 1H, <i>J</i> = 7.8 Hz), 7.37 (d, 1H, <i>J</i> = 8.4 Hz), 7.24–7.27 (m, 1H), 7.21 (s, 1H), 7.11–7.14 (m, 1H), 7.09 (dd, 1H, <i>J</i><sub>1</sub> = 3.0 Hz, <i>J</i><sub>2</sub> = 9.0 Hz), 6.99–7.01 (m, 1H), 6.75–6.78 (m, 1H), 3.80 (s, 2H), 3.74 (s, 3H), 1.98–2.01 (m, 1H), 0.93–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.70, 170.17, 157.54, 153.04, 152.79, 148.97, 144.90, 136.47, 132.85, 128.24, 127.47, 121.44, 121.07, 118.80, 118.47, 118.01, 116.12, 114.00, 112.82, 111.53, 109.50, 107.45, 32.87, 32.22, 13.74, 8.59. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>23</sub>FN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 515.1548, found 515.1560. HPLC analysis: retention time = 7.7 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(6-(4-Fluoro-3-(3-(3-(trifluoromethyl)phenyl)propanamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>33</b>)</h4><div class="NLM_p last">White solid (25 mg, yield: 39%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (s, 1H), 9.79 (s, 1H), 7.73 (d, 1H, <i>J</i> = 8.4 Hz), 7.66–7.67 (m, 1H), 7.63 (d, 1H, <i>J</i> = 2.4 Hz), 7.59 (s, 1H), 7.48–7.54 (m, 3H), 7.23–7.26 (m, 1H), 7.10 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.4 Hz), 6.76–6.79 (m, 1H), 2.96 (t, 2H, <i>J</i> = 7.8 Hz), 2.74 (t, 2H, <i>J</i> = 7.8 Hz), 1.98–2.01 (m, 1H), 0.94–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.73, 170.76, 157.59, 153.09, 152.76, 149.00, 144.97, 142.46, 132.89, 132.51, 129.22, 128.93, 127.22, 124.77, 124.28, 122.71, 121.46, 118.09, 116.15, 114.04, 112.97, 111.62, 36.99, 30.32, 13.76, 8.60. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>21</sub>F<sub>4</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 544.1313, found 544.1324. HPLC analysis: retention time = 9.5 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(5-((2-(Cyclopropanecarboxamido)benzo[<i>d</i>]thiazol-6-yl)oxy)-2-fluorophenyl)-1-(3-(trifluoromethyl)phenyl)cyclopropanecarboxamide (<b>34</b>)</h4><div class="NLM_p last">White solid (18 mg, yield: 27%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.64 (s, 1H), 8.62 (s, 1H), 7.58–7.75 (m, 6H), 7.28–7.31 (m, 1H), 7.22 (t, 1H, <i>J</i> = 9.9 Hz), 7.10 (dd, 1H, <i>J</i><sub>1</sub> = 2.7 Hz, <i>J</i><sub>2</sub> = 9.0 Hz), 6.81–6.87 (m, 1H), 1.97–2.01 (m, 1H), 1.48–1.51 (m, 2H), 1.18–1.22 (m, 2H), 0.94–0.97 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.76, 170.78, 157.64, 153.06, 152.69, 150.36, 145.03, 140.76, 134.13, 132.90, 129.77, 129.38, 126.81, 126.38, 124.27, 124.13, 121.52, 118.16, 116.28, 115.45, 114.53, 111.76, 30.85, 15.48, 13.78, 8.67. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>21</sub>F<sub>4</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 556.1313, found 556.1316. HPLC analysis: retention time = 9.3 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Procedure for the Preparation of <i>N</i>-(6-(4-Fluoro-3-(3-(trifluoromethyl)phenylsulfonamido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>35</b>)</h4><div class="NLM_p last">A solution of intermediate <b>m21</b> (1 equiv) in anhydrous pyridine was cooled to 0 °C under a nitrogen atmosphere. The 3-(trifluoromethyl)benzene-1-sulfonyl chloride (2 equiv) was added, and then the mixture was stirred at 0 °C overnight. After the addition was completed, TLC analysis indicated the reaction was complete. The solvent was removed under reduced pressure, and the residue was extracted with ethyl acetate. The organic layer was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel (petroleum ether/ethyl acetate = 1:1) to provide the target compound <b>35</b>. White solid (30 mg, yield: 45%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.64 (s, 1H), 10.48 (s, 1H), 8.01 (d, 1H, <i>J</i> = 7.8 Hz), 7.94–7.98 (m, 2H), 7.79 (t, 1H, <i>J</i> = 7.8 Hz), 7.71 (d, 1H, <i>J</i> = 8.4 Hz), 7.60 (d, 1H, <i>J</i> = 2.4 Hz), 7.20 (t, 1H, <i>J</i> = 9.6 Hz), 7.01 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.4 Hz), 6.88–6.91 (m, 1H), 6.74–6.75 (m, 1H), 1.98–2.02 (m, 1H), 0.95–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.78, 157.77, 153.50, 152.08, 151.55, 145.24, 140.74, 132.92, 130.84, 130.56, 129.94, 129.72, 124.66, 123.24, 123.10, 121.50, 118.15, 117.17, 168.98, 115.54, 111.98, 13.77, 8.63. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>17</sub>F<sub>4</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> 552.0669, found 552.0669. HPLC analysis: retention time = 7.2 min; peak area, >95% (210, 254 nm).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> General Procedure for the Preparation of Compounds <b>36</b> and <b>37</b></h3><div class="NLM_p">To a solution of intermediate <b>m21</b> and the appropriate benzaldehyde derivative (1 equiv) in MeOH was added a catalytic amount of acetic acid. The solution was stirred at room temperature for 12 h. Then, NaBH<sub>3</sub>CN (2 equiv) was added, and the mixture was stirred at room temperature for another 12 h, after which TLC analysis indicated the reaction was completed. The solvent was removed under reduced pressure, and the residue was re-extracted with ethyl acetate. The combined organic phase was washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The crude product was purified by column chromatography on silica gel (DCM/MeOH = 100:1) to provide target compounds <b>36–37</b>.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(6-(3-((Benzo[<i>d</i>][1,3]dioxol-5-ylmethyl)amino)-4-fluorophenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>36</b>)</h4><div class="NLM_p last">White solid (15 mg, yield: 26%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.59 (s, 1H), 7.64 (d, 1H, <i>J</i> = 8.7 Hz), 7.47 (d, 1H, <i>J</i> = 2.4 Hz), 6.95–7.01 (m, 2H), 6.84–6.85 (m, 1H), 6.69–6.78 (m, 2H), 6.30–6.41 (m, 1H), 6.23 (dd, 1H, <i>J</i><sub>1</sub> = 2.7 Hz, <i>J</i><sub>2</sub> = 7.5 Hz), 6.05–6.10 (m, 1H), 5.95 (s, 2H), 4.17 (d, 2H, <i>J</i> = 5.4 Hz), 1.97–2.01 (m, 1H), 0.94–0.96 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.70, 157.31, 153.77, 153.08, 147.31, 147.08, 145.94, 144.56, 137.52, 133.38, 132.72, 121.21, 119.99, 117.75, 114.77, 111.00, 107.86, 107.36, 104.20, 103.08, 100.75, 45.54, 13.75, 8.63. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 478.1231, found 478.1240. HPLC analysis: retention time = 11.0 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(6-(4-Fluoro-3-((3-(trifluoromethyl)benzyl)amino)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>37</b>)</h4><div class="NLM_p last">White solid (19 mg, yield: 32%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.59 (s, 1H), 7.44–7.65 (m, 6H), 6.91–7.05 (m, 2H), 6.55 (t, 1H, <i>J</i> = 4.5 Hz), 6.25 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 7.2 Hz), 6.08–6.10 (m, 1H), 4.38 (d, 2H, <i>J</i> = 6.0 Hz), 1.97–2.01 (m, 1H), 0.93–0.95 (m, 4H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.69, 157.27, 153.73, 153.14, 147.14, 144.53, 141.26, 137.36, 132.72, 131.06, 129.25, 127.45, 123.46, 122.47, 121.18, 117.52, 115.01, 110.84, 104.67, 103.10, 45.21, 13.71, 8.62. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>19</sub>F<sub>4</sub>N<sub>3</sub>O<sub>2</sub>S [M – H]<sup>−</sup> 500.1061, found 500.1046. HPLC analysis: retention time = 7.1 min; peak area, >95% (210, 254 nm).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> General Procedure for Preparing Compounds <b>38</b>–<b>42</b></h3><div class="NLM_p">A solution of intermediate <b>m21</b> (1 equiv) and the appropriate phenyl isocyanate derivative (1.5 equiv) in DMF, MeCN, or DMSO was stirred at room temperature for 24 h. After this time, TLC analysis indicated the reaction was completed. The mixture was poured into water and extracted with ethyl acetate. The organic layer was washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure, and the crude product was purified by column chromatography on silica gel (DCM/MeOH = 100:2) to provide target compounds <b>38</b>–<b>42</b>.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(6-(4-Fluoro-3-(3-(3-methoxyphenyl)ureido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>38</b>)</h4><div class="NLM_p last">Light-yellow solid (32 mg, yield: 54%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (s, 1H), 9.11 (s, 1H), 8.65 (d, 1H, <i>J</i> = 2.4 Hz), 7.93 (dd, 1H, <i>J</i><sub>1</sub> = 3.0 Hz, <i>J</i><sub>2</sub> = 6.6 Hz), 7.73 (d, 1H, <i>J</i> = 8.4 Hz), 7.66 (d, 1H, <i>J</i> = 2.4 Hz), 7.24–7.27 (m, 1H), 7.17 (t, 1H, <i>J</i> = 7.8 Hz), 7.11 (dd, 1H, <i>J</i><sub>1</sub> = 3.0 Hz, <i>J</i><sub>2</sub> = 9.0 Hz), 7.10 (t, 1H, <i>J</i> = 2.4 Hz), 6.89–6.90 (m, 1H), 6.63–6.66 (m, 1H), 6.55 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 8.4 Hz), 3.71 (s, 3H), 1.98–2.00 (m, 1H), 0.94–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.69, 159.69, 157.47, 153.17, 153.10, 151.88, 147.78, 144.79, 140.33, 132.86, 129.62, 128.69, 121.43, 117.84, 115.64, 111.60, 111.25, 110.47, 110.19, 107.64, 103.91, 54.92, 13.74, 8.59. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>21</sub>FN<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 493.1340, found 493.1350. HPLC analysis: retention time = 9.2 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(6-(4-Fluoro-3-(3-(<i>m</i>-tolyl)ureido)phenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>39</b>)</h4><div class="NLM_p last">Light-yellow solid (32 mg, yield: 56%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.62 (s, 1H), 9.03 (s, 1H), 8.66 (s, 1H), 7.95–7.96 (m, 1H), 7.72 (d, 1H, <i>J</i> = 8.4 Hz), 7.64 (s, 1H), 7.11–7.25 (m, 5H), 6.78 (d, 1H, <i>J</i> = 7.2 Hz), 6.63–6.64 (m, 1H), 2.25 (s, 3H), 1.98–2.01 (m, 1H), 0.94–0.95 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.71, 157.51, 153.26, 153.12, 151.95, 147.74, 144.82, 139.08, 138.07, 132.90, 128.87, 128.67, 122.94, 121.44, 118.67, 117.89, 115.56, 115.36, 111.47, 111.30, 110.04, 21.14, 13.78, 8.61. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>21</sub>FN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 477.1386, found 477.1400. HPLC analysis: retention time = 10.2 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Ethyl-3-(3-(5-((2-(cyclopropanecarboxamido)benzo[<i>d</i>]thiazol-6-yl)oxy)-2-fluorophenyl)ureido)benzoate (<b>40</b>)</h4><div class="NLM_p last">White solid (35 mg, yield: 55%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.62 (s, 1H), 9.34 (s, 1H), 8.66 (s, 1H), 8.07 (t, 1H, <i>J</i> = 2.1 Hz), 7.91 (dd, 1H, <i>J</i><sub>1</sub> = 3.0 Hz, <i>J</i><sub>2</sub> = 7.2 Hz), 7.73 (d, 1H, <i>J</i> = 9 Hz), 7.65 (d, 1H, <i>J</i> = 2.4 Hz), 7.56–7.61 (m, 2H), 7.41 (t, 1H, <i>J</i> = 7.8 Hz), 7.24–7.28 (m, 1H), 7.13 (dd, 1H, <i>J</i><sub>1</sub> = 3.0 Hz, <i>J</i><sub>2</sub> = 9.0 Hz), 6.65–6.68 (m, 1H), 4.29 (q, 2H, <i>J</i> = 7.2 Hz), 1.97–2.01 (m, 1H), 1.30 (t, 3H, <i>J</i> = 7.2 Hz), 0.94–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.70, 165.55, 157.51, 153.31, 152.98, 151.92, 147.83, 144.86, 139.54, 132.87, 130.51, 129.27, 128.49, 122.80, 122.57, 121.45, 118.41, 117.97, 115.70, 111.74, 111.43, 110.16, 60.73, 14.10, 13.75, 8.60. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>23</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 535.1446, found 535.1459. HPLC analysis: retention time = 10.5 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(6-((3-(3-Acetylphenyl)ureido)-4-fluorophenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>41</b>)</h4><div class="NLM_p last">White solid (30 mg, yield: 50%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (s, 1H), 9.32 (s, 1H), 8.69 (s, 1H), 7.98 (t, 1H, <i>J</i> = 1.8 Hz), 7.92 (dd, 1H, <i>J</i><sub>1</sub> = 3.0 Hz, <i>J</i><sub>2</sub> = 6.6 Hz), 7.73 (d, 1H, <i>J</i> = 9.0 Hz), 7.58–7.65 (m, 3H), 7.42 (t, 1H, <i>J</i> = 7.8 Hz), 7.25–7.28 (m, 1H), 7.12 (dd, 1H, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 9.0 Hz), 6.65–6.67 (m, 1H), 2.54 (s, 1H), 1.97–2.01 (m, 1H), 0.94–0.96 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 197.62, 172.70, 157.50, 153.26, 153.05, 151.99, 148.36, 144.83, 139.55, 137.45, 132.88, 129.26, 128.53, 122.71, 122.26, 121.45, 117.92, 117.24, 115.70, 111.78, 111.35, 110.27, 26.71, 13.75, 8.60. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>21</sub>FN<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 505.1340, found 505.1351. HPLC analysis: retention time = 7.7 min; peak area, >95% (210, 254 nm).</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(6-(3-(3-(3-Bromophenyl)ureido)-4-fluorophenoxy)benzo[<i>d</i>]thiazol-2-yl)cyclopropanecarboxamide (<b>42</b>)</h4><div class="NLM_p last">White solid (35 mg, yield: 54%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (s, 1H), 9.27 (s, 1H), 8.71 (s, 1H), 7.89–7.91 (m, 1H), 7.79 (t, 1H, <i>J</i> = 1.2 Hz), 7.73 (d, 1H, <i>J</i> = 9.0 Hz), 7.63 (d, 1H, <i>J</i> = 2.4 Hz), 7.21–7.27 (m, 3H), 7.12–7.16 (m, 2H), 6.65–6.68 (m, 1H), 1.97–2.00 (m, 1H), 0.94–0.95 (m, 4H). <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.71, 157.51, 153.26, 153.04, 151.83, 147.88, 144.84, 140.80, 132.88, 130.77, 128.41, 124.76, 121.75, 121.45, 120.35, 117.91, 117.02, 115.72, 111.89, 111.35, 110.31, 13.76, 8.76. HRMS (ESI, positive) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>18</sub>BrFN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 541.0340, found 541.0346. HPLC analysis: retention time = 11.6 min; peak area, >95% (210, 254 nm).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Biology</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Reagents and Antibodies</h4><div class="NLM_p last">Recombinant mouse/human TNF-α and z-VAD-fmk were purchased from R&D System (Minneapolis, MN). Protease inhibitor cocktail was purchased from Sigma-Aldrich (St. Louis, MO). Smac mimetic (SM-164) was a gift from Dr. Zheng-gang Liu (NCI, NIH). The antibodies were obtained from commercial sources: anti-RIPK1 (610458) from BD Biosciences; antihuman phospho-RIPK1 (65746) from Cell Signaling Technology; antihuman-RIPK3 (ab56164), antihuman phospho-RIPK3 (ab209384), antihuman MLKL (ab184718), and antihuman phospho-MLKL (ab187091) from Abcam; and antiactin (A3853) from Sigma.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Cell Culture</h4><div class="NLM_p last">HT-29 and L929 cells were cultured in Dulbecco’s modified Eagle’s medium. All media were supplemented with 10% fetal bovine serum (v/v), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, and 100 U/mL penicillin/streptomycin. Cells were grown at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>, and for all experiments, cells were harvested from exponentially growing cultures.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Necroptosis Induction and Cell Viability Assays</h4><div class="NLM_p last">Necroptosis was induced by pretreatment with z-VAD-fmk (20 μM) and Smac mimetic (10 nM) for 30 min followed by treatment with TNF-α (20 ng/mL) for the indicated time periods. Apoptosis was induced by treatment with TNF-α (20 ng/mL) and Smac mimetic (10 nM) for the indicated time periods. After the cells were exposed to one of the above combinations, they were incubated with the test compounds at the indicated concentrations for 12 h. The cell viability was then examined using the CellTiter-Glo Luminescent Cell Viability Assay kit (Promega). The luminescence was recorded with a BioTek 312e microplate reader (BioTek Instruments, Winooski, VT).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Immunoblotting and Immunoprecipitation</h4><div class="NLM_p last">Cells were collected and lysed in M2 buffer (20 mM Tris, pH 7, 0.5% NP40, 250 mM NaCl, 3 mM ethylenediaminetetraacetic acid, 3 mM ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid, 2 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride, 20 mM glycerol phosphate, 1 mM sodium vanadate, and 1 μg/mL leupeptin). Cell lysates were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and analyzed by immunoblotting. The dilution ratio of the antibodies used for western blotting was 1:1000. The proteins were visualized by enhanced chemiluminescence according to the manufacturer’s instructions (Amersham). For immunoprecipitation analysis, the cells were washed three times with ice-cold phosphate-buffered saline (PBS) and lysed in M2 buffer. The samples were precipitated with the indicated antibodies (1 μg) and protein A/G-agarose beads (Santa Cruze) by incubating at 4 °C overnight. The beads were washed four times with 1 mL of M2 buffer, the bound proteins were removed by boiling in SDS buffer, and the samples were resolved in 4–20% SDS-polyacrylamide gels by western blotting analysis.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Kinase Assays</h4><div class="NLM_p last">The inhibitory effects of the test compounds on kinases were detected by a KINOMEscan assay. Briefly, kinase-tagged T7 phage strain lysates were tagged with DNA for quantitative polymerase chain reaction (qPCR) detection. Binding reactions were conducted by combining the kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17× PBS, 0.05% Tween 20, and 6 mM DTT). The compounds were used in the form of 10 mM solutions in 100% DMSO. Equilibrium dissociation constants (<i>K</i><sub>d</sub> values) were determined using a 10-point 3-fold compound dilution series with three DMSO control points. All reactions were performed in polypropylene 384-well plates. The assay plates were incubated at room temperature with shaking for 1 h, and the affinity beads were washed with wash buffer (1× PBS with 0.05% Tween 20). The beads were then resuspended in an elution buffer (1× PBS, 0.05% Tween 20, and 0.5 μM nonbiotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentrations in the eluates were measured by qPCR. The assays are similar for other kinases. The test compound was prepared as 40× stocks in 100% DMSO and directly diluted into the assays with the final concentration of 1000 nM.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Molecular Modeling Study</h4><div class="NLM_p last">All of the modeling studies were carried out using Schrödinger Maestro 11.4. The PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HHO">6HHO</a> was chosen for the RIPK1 docking study.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The murine RIPK3 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M69">4M69</a>) was selected as the template to build the three-dimensional structure of human RIPK3.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KSP">4KSP</a> was chosen for the B-raf docking study.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Schrodinger Prime was used to perform the homology modeling and refinement with the default parameters. The amino acid residues were numbered according to the sequence <a href="https://NP_006862" class="ext-link">NP_006862</a>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The protein preparation followed our previous standard protocol.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> Glide docking was used to dock compounds into RIPK1 (docking pocket: GSK547 binding pocket), RIPK3 (docking pocket: ANP binding pocket), or B-raf (docking pocket: TAK-632 binding pocket) with extra precision. Molecular docking result is generated using PyMol (<a href="http://pymol.sourceforge.net/" class="extLink">http://pymol.sourceforge.net/</a>).</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Animal Experiments</h4><div class="NLM_p last">All animal experiments were performed in accordance with the National Institutes of Health guidelines and approved by the Animal Care and Use Committee of the Second Military Medical University. For TNF-induced SIRS, female C57BL/6 J mice (6–8 weeks old) were purchased from Shanghai SLAC Laboratory Animal Co. (Shanghai, China) and raised in a pathogen-free environment (23 ± 2 °C and 55 ± 5% humidity). The test compounds were suspended in pH 8.0 distilled water containing 0.5% carboxymethyl cellulose sodium. Overnight-fasted mice were given the test compound (5, 25, and 50 mg/kg) by oral gavage 2 h before mTNF-α injection. z-VAD-fmk (180 μg) was intraperitoneally injected, and after 15 min, mTNF-α diluted in 272 μL of endotoxin-free PBS was intravenously injected (400 μg/kg). Then, 1 h after mTNF-α treatment, another dose of z-VAD-fmk (70 μg) was intraperitoneally injected. The body temperatures of the mice were monitored with an electric thermometer at different time points.</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> PK Study</h4><div class="NLM_p last">Male Sprague-Dawley rats (<i>n</i> = 3, 180–230 g, Shanghai Caerulum Pharma Discovery Co., Ltd.) were used in the PK studies of compound <b>42</b>. The compound was dissolved and vortexed in 5% DMSO, 10% Tween 80, and 75% physiological saline for concentrations of 0.2 and 1 mg/mL. The rats were housed in a room with controlled temperature and humidity and allowed free access to food and water. The male Sprague-Dawley rats were split into the intravenous injection group (<b>42</b>, 1 mg/kg) and the intragastric administration group (<b>42</b>, 5 mg/kg) before starting treatment. At different time points, the blood samples were collected and centrifuged at 4 °C to obtain plasma, which was stored at −80 °C until analysis by liquid chromatography/tandem mass spectrometry. PK parameters were determined from individual animal data using noncompartmental analysis in winNonlin 6.3.</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Statistical Analysis</h4><div class="NLM_p last">The one-way analysis of variance was used to compare differences among groups represented by the mean values ± SD. A log-rank (Mantel–Cox) test was performed for survival curve analysis. <i>P</i> < 0.05 was considered statistically significant.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00611" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00611" class="ext-link">10.1021/acs.jmedchem.9b00611</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic protocols, detailed experimental procedures, <sup>1</sup>H and <sup>13</sup>C NMR spectra, HRMS spectra, and HPLC chromatograms showing the purity of the target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_001.pdf">jm9b00611_si_001.pdf (18.72 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_002.csv">jm9b00611_si_002.csv (2.89 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00611" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wannian Zhang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9ee4f6fff0f9e9f0f5def6f1eaf3fff7f2b0fdf1f3"><span class="__cf_email__" data-cfemail="fb81939a959c8c9590bb93948f969a9297d5989496">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenyu Cai</span> - <span class="hlFld-Affiliation affiliation">National
Center for Liver Cancer, Second Military
Medical University, 225
Changhai Road, Shanghai 200438, China</span>; 
    <span class="hlFld-Affiliation affiliation">Cancer
Institute, Fudan University Shanghai Cancer
Center, Shanghai 200032, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e6829485878f9c8e83889f93a6d7d4d0c885898b"><span class="__cf_email__" data-cfemail="096d7b6a686073616c67707c49383b3f276a6664">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunlin Zhuang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Fudan University, Shanghai 200433, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0569-5708" title="Orcid link">http://orcid.org/0000-0002-0569-5708</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bfc5dcd3d1decbd7ded1ff8e898c91dcd0d2"><span class="__cf_email__" data-cfemail="3d475e51535c49555c537d0c0b0e135e5250">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hao Zhang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lijuan Xu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xia Qin</span> - <span class="hlFld-Affiliation affiliation">National
Center for Liver Cancer, Second Military
Medical University, 225
Changhai Road, Shanghai 200438, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaofei Chen</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Cong</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Longmiao Hu</span> - <span class="hlFld-Affiliation affiliation">National
Center for Liver Cancer, Second Military
Medical University, 225
Changhai Road, Shanghai 200438, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Long Chen</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenyuan Miao</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7839-4183" title="Orcid link">http://orcid.org/0000-0001-7839-4183</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>H.Z., L.X., and X.Q. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4763-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was funded by grants from the National Natural Science Foundation of China (81872791 to C.Z. and 81773075 to Z.C.), the Young Elite Scientists Sponsorship Program by the China Association for Science and Technology (2017QNRC061 to C.Z.), China’s 1000 Young Talents Program (Z.C.), the Shanghai Municipal Commission of Health and Family Planning (2017YQ052 to C.Z.), the Key Research and Development Program of Ningxia (2018BFH02001 to W.Z. and 2018BFH02001-01, 2019BFG02017 to C.Z.), the Shanghai International Cooperation and Exchange Project (No.18410720600 to Z.C.), and the Shanghai “ChenGuang” Project (16CG42 to C.Z.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">MLKL</td><td class="NLM_def"><p class="first last">mixed lineage kinase domain-like protein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">RIPK1</td><td class="NLM_def"><p class="first last">receptor-interacting protein kinase 1</p></td></tr><tr><td class="NLM_term">RIPK3</td><td class="NLM_def"><p class="first last">receptor-interacting protein kinase 3</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SIRS</td><td class="NLM_def"><p class="first last">systemic inflammatory response syndrome</p></td></tr><tr><td class="NLM_term">TC</td><td class="NLM_def"><p class="first last">TNF-α and cycloheximide</p></td></tr><tr><td class="NLM_term">TCZ</td><td class="NLM_def"><p class="first last">TNF-α, cycloheximide, and z-VAD-fmk</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoroacetic anhydride</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">FAS</td><td class="NLM_def"><p class="first last">CD95</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">TS</td><td class="NLM_def"><p class="first last">TNF-α and Smac mimetic</p></td></tr><tr><td class="NLM_term">TSZ</td><td class="NLM_def"><p class="first last">TNF-α, Smac mimetic, and z-VAD-fmk</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84031" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84031" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jäättelä, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Caspase-independent cell death in T lymphocytes</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1038/ni0503-416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fni0503-416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=12719731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A280%3ADC%252BD3s7pvF2qtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=416-423&author=M.+J%C3%A4%C3%A4ttel%C3%A4author=J.+Tschopp&title=Caspase-independent+cell+death+in+T+lymphocytes&doi=10.1038%2Fni0503-416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-independent cell death in T lymphocytes</span></div><div class="casAuthors">Jaattela Marja; Tschopp Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Nature immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">416-23</span>
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    </div><div class="casAbstract">T lymphocyte death is essential for proper function of the immune system.  During the decline of an immune response, most of the activated T cells die.  Cell death is also responsible for eliminating autoreactive lymphocytes.  Although recent studies have focused on caspase-dependent apoptotic signals, much evidence now shows that caspase- independent, necrotic cell death pathways are as important.  An understanding of the molecular control of these alternative pathways is beginning to emerge.  Damage of organelles including mitochondria, endoplasmic reticulum or lysozymes, leading to an increase in calcium and reactive oxygen species and the release of effector proteins, is frequently involved in caspase-independent cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMmc36aJI4XI2y4bB4mnvYfW6udTcc2ea-5sGcwAndC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7pvF2qtA%253D%253D&md5=890aedf63623db4cace6f4d958c8c80b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fni0503-416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni0503-416%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25A4%25C3%25A4ttel%25C3%25A4%26aufirst%3DM.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DCaspase-independent%2520cell%2520death%2520in%2520T%2520lymphocytes%26jtitle%3DNat.%2520Immunol.%26date%3D2003%26volume%3D4%26spage%3D416%26epage%3D423%26doi%3D10.1038%2Fni0503-416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and its role in inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>517</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/nature14191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fnature14191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=25592536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2015&pages=311-320&author=M.+Pasparakisauthor=P.+Vandenabeele&title=Necroptosis+and+its+role+in+inflammation&doi=10.1038%2Fnature14191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and its role in inflammation</span></div><div class="casAuthors">Pasparakis, Manolis; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">517</span>
        (<span class="NLM_cas:issue">7534</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Regulated cell death has essential functions in development and in adult tissue homeostasis.  Necroptosis is a newly discovered pathway of regulated necrosis that requires the proteins RIPK3 and MLKL and is induced by death receptors, interferons, toll-like receptors, intracellular RNA and DNA sensors, and probably other mediators.  RIPK1 has important kinase-dependent and scaffolding functions that inhibit or trigger necroptosis and apoptosis.  Mouse-model studies have revealed important functions for necroptosis in inflammation and suggested that it could be implicated in the pathogenesis of many human inflammatory diseases.  We discuss the mechanisms regulating necroptosis and its potential role in inflammation and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA9_ozm2Tq27Vg90H21EOLACvtfcHk0lhaGsKRb9lQPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2mtA%253D%253D&md5=3acc43a5a345c231eb47ba079211783e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature14191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14191%26sid%3Dliteratum%253Aachs%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DNecroptosis%2520and%2520its%2520role%2520in%2520inflammation%26jtitle%3DNature%26date%3D2015%26volume%3D517%26spage%3D311%26epage%3D320%26doi%3D10.1038%2Fnature14191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Zen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwendener, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span> <span> </span><span class="NLM_article-title">Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-alpha-induced shock</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.2119/molmed.2011.00423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.2119%2Fmolmed.2011.00423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22371307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGmurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=577-586&author=A.+Linkermannauthor=J.+H.+Brasenauthor=F.+De+Zenauthor=R.+Weinlichauthor=R.+A.+Schwendenerauthor=D.+R.+Greenauthor=U.+Kunzendorfauthor=S.+Krautwald&title=Dichotomy+between+RIP1-+and+RIP3-mediated+necroptosis+in+tumor+necrosis+factor-alpha-induced+shock&doi=10.2119%2Fmolmed.2011.00423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-α-induced shock</span></div><div class="casAuthors">Linkermann, Andreas; Braesen, Jan H.; De Zen, Federica; Weinlich, Ricardo; Schwendener, Reto A.; Green, Douglas R.; Kunzendorf, Ulrich; Krautwald, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">577-586</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Tumor necrosis factor receptor (TNFR) signaling may result in survival, apoptosis or programmed necrosis.  The latter is called necroptosis if the receptor-interacting protein 1 (RIP1) inhibitor necrostatin-1 (Nec-1) or genetic knockout of RIP3 prevents it.  In the lethal mouse model of TNFα-mediated shock, addn. of the pan-caspase inhibitor zVAD-fmk (zVAD) accelerates time to death.  Here, we demonstrate that RIP3-deficient mice are protected markedly from TNFα-mediated shock in the presence and absence of caspase inhibition.  We further show that the fusion protein TAT-crmA, previously demonstrated to inhibit apoptosis, also prevents necroptosis in L929, HT29 and FADD-deficient Jurkat cells.  In contrast to RIP3-deficient mice, blocking necroptosis by Nec-1 or TAT-crmA did not protect from TNFα/zVAD-mediated shock, but further accelerated time to death.  Even in the absence of caspase inhibition, Nec-1 application led to similar kinetics.  Depletion of macrophages, natural killer (NK) cells, granulocytes or genetic deficiency for T lymphocytes did not influence this model.  Because RIP3-deficient mice are known to be protected from caerulein-induced pancreatitis (CIP), we applied Nec-1 and TAT-crmA in this model and demonstrated the deterioration of pancreatic damage upon addn. of these substances.  These data highlight the importance of sepg. genetic RIP3 deficiency from RIP1 inhibition by Nec-1 application in vivo and challenge the current definition of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp7Qyxdz0VLrVg90H21EOLACvtfcHk0livCbv0vazd9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGmurnL&md5=81217487911e74332e9c13cfd4b62a25</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2011.00423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2011.00423%26sid%3Dliteratum%253Aachs%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DDe%2BZen%26aufirst%3DF.%26aulast%3DWeinlich%26aufirst%3DR.%26aulast%3DSchwendener%26aufirst%3DR.%2BA.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DKunzendorf%26aufirst%3DU.%26aulast%3DKrautwald%26aufirst%3DS.%26atitle%3DDichotomy%2520between%2520RIP1-%2520and%2520RIP3-mediated%2520necroptosis%2520in%2520tumor%2520necrosis%2520factor-alpha-induced%2520shock%26jtitle%3DMol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D577%26epage%3D586%26doi%3D10.2119%2Fmolmed.2011.00423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmerkus, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span> <span> </span><span class="NLM_article-title">Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1038/ki.2011.450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fki.2011.450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22237751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvV2rtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=751-761&author=A.+Linkermannauthor=J.+H.+Brasenauthor=N.+Himmerkusauthor=S.+Liuauthor=T.+B.+Huberauthor=U.+Kunzendorfauthor=S.+Krautwald&title=Rip1+%28receptor-interacting+protein+kinase+1%29+mediates+necroptosis+and+contributes+to+renal+ischemia%2Freperfusion+injury&doi=10.1038%2Fki.2011.450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury</span></div><div class="casAuthors">Linkermann, Andreas; Braesen, Jan H.; Himmerkus, Nina; Liu, Shuya; Huber, Tobias B.; Kunzendorf, Ulrich; Krautwald, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">751-761</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Loss of kidney function in renal ischemia/reperfusion injury is due to programmed cell death, but the contribution of necroptosis, a newly discovered form of programmed necrosis, has not been evaluated.  Here, we identified the presence of death receptor-mediated but caspase-independent cell death in murine tubular cells and characterized it as necroptosis by the addn. of necrostatin-1, a highly specific receptor-interacting protein kinase 1 inhibitor.  The detection of receptor-interacting protein kinase 1 and 3 in whole-kidney lysates and freshly isolated murine proximal tubules led us to investigate the contribution of necroptosis in a mouse model of renal ischemia/reperfusion injury.  Treatment with necrostatin-1 reduced organ damage and renal failure, even when administered after reperfusion, resulting in a significant survival benefit in a model of lethal renal ischemia/reperfusion injury.  Unexpectedly, specific blockade of apoptosis by zVAD, a pan-caspase inhibitor, did not prevent the organ damage or the increase in urea and creatinine in vivo in renal ischemia/reperfusion injury.  Thus, necroptosis is present and has functional relevance in the pathophysiol. course of ischemic kidney injury and shows the predominance of necroptosis over apoptosis in this setting.  Necrostatin-1 may have therapeutic potential to prevent and treat renal ischemia/reperfusion injury.  Kidney International (2012) 81, 751-761; doi:10.1038/ki.2011.450; published online 11 Jan. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKdkP2OeYjeLVg90H21EOLACvtfcHk0livCbv0vazd9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvV2rtbo%253D&md5=5eea0d0e70f6a604223d5a8eb848ae5e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fki.2011.450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2011.450%26sid%3Dliteratum%253Aachs%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DHimmerkus%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DT.%2BB.%26aulast%3DKunzendorf%26aufirst%3DU.%26aulast%3DKrautwald%26aufirst%3DS.%26atitle%3DRip1%2520%2528receptor-interacting%2520protein%2520kinase%25201%2529%2520mediates%2520necroptosis%2520and%2520contributes%2520to%2520renal%2520ischemia%252Freperfusion%2520injury%26jtitle%3DKidney%2520Int.%26date%3D2012%26volume%3D81%26spage%3D751%26epage%3D761%26doi%3D10.1038%2Fki.2011.450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duprez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hauwermeiren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandendriessche, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwels, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2011.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.immuni.2011.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22195746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1KrtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=908-918&author=L.+Duprezauthor=N.+Takahashiauthor=F.+Van+Hauwermeirenauthor=B.+Vandendriesscheauthor=V.+Goossensauthor=T.+Vanden+Bergheauthor=W.+Declercqauthor=C.+Libertauthor=A.+Cauwelsauthor=P.+Vandenabeele&title=RIP+kinase-dependent+necrosis+drives+lethal+systemic+inflammatory+response+syndrome&doi=10.1016%2Fj.immuni.2011.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome</span></div><div class="casAuthors">Duprez, Linde; Takahashi, Nozomi; Van Hauwermeiren, Filip; Vandendriessche, Benjamin; Goossens, Vera; Vanden Berghe, Tom; Declercq, Wim; Libert, Claude; Cauwels, Anje; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">908-918</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Engagement of tumor necrosis factor receptor 1 signals two diametrically opposed pathways: survival-inflammation and cell death.  An addnl. switch decides, depending on the cellular context, between caspase-dependent apoptosis and RIP kinase (RIPK)-mediated necrosis, also termed necroptosis.  We explored the contribution of both cell death pathways in TNF-induced systemic inflammatory response syndrome (SIRS).  Deletion of apoptotic executioner caspases (caspase-3 or -7) or inflammatory caspase-1 had no impact on lethal SIRS.  However, deletion of RIPK3 conferred complete protection against lethal SIRS and reduced the amts. of circulating damage-assocd. mol. patterns.  Pretreatment with the RIPK1 kinase inhibitor, necrostatin-1, provided a similar effect.  These results suggest that RIPK1-RIPK3-mediated cellular damage by necrosis drives mortality during TNF-induced SIRS.  RIPK3 deficiency also protected against cecal ligation and puncture, underscoring the clin. relevance of RIPK kinase inhibition in sepsis and identifying components of the necroptotic pathway that are potential therapeutic targets for treatment of SIRS and sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiE2quF2rmSLVg90H21EOLACvtfcHk0livCbv0vazd9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1KrtrfJ&md5=191d5b38562d315da4dd18e267da5246</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2011.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2011.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DDuprez%26aufirst%3DL.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DVan%2BHauwermeiren%26aufirst%3DF.%26aulast%3DVandendriessche%26aufirst%3DB.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DCauwels%26aufirst%3DA.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DRIP%2520kinase-dependent%2520necrosis%2520drives%2520lethal%2520systemic%2520inflammatory%2520response%2520syndrome%26jtitle%3DImmunity%26date%3D2011%26volume%3D35%26spage%3D908%26epage%3D918%26doi%3D10.1016%2Fj.immuni.2011.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskowitz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1038/nchembio711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fnchembio711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=16408008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1OmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=112-119&author=A.+Degterevauthor=Z.+Huangauthor=M.+Boyceauthor=Y.+Liauthor=P.+Jagtapauthor=N.+Mizushimaauthor=G.+D.+Cunyauthor=T.+J.+Mitchisonauthor=M.+A.+Moskowitzauthor=J.+Yuan&title=Chemical+inhibitor+of+nonapoptotic+cell+death+with+therapeutic+potential+for+ischemic+brain+injury&doi=10.1038%2Fnchembio711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury</span></div><div class="casAuthors">Degterev, Alexei; Huang, Zhihong; Boyce, Michael; Li, Yaqiao; Jagtap, Prakash; Mizushima, Noboru; Cuny, Gregory D.; Mitchison, Timothy J.; Moskowitz, Michael A.; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-119</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death.  Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, the authors demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which the authors term necroptosis.  The authors showed that necroptosis is characterized by necrotic cell death morphol. and activation of autophagy.  The authors identified a specific and potent small-mol. inhibitor of necroptosis, necrostatin-1, which blocks a crit. step in necroptosis.  The authors demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection.  Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiiBDVRJkdUbVg90H21EOLACvtfcHk0lj7ejgETXDkIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1OmsLg%253D&md5=83f8c363ffb73ccc14bf11ec02577336</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnchembio711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio711%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DChemical%2520inhibitor%2520of%2520nonapoptotic%2520cell%2520death%2520with%2520therapeutic%2520potential%2520for%2520ischemic%2520brain%2520injury%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2005%26volume%3D1%26spage%3D112%26epage%3D119%26doi%3D10.1038%2Fnchembio711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">A role of RIP3-mediated macrophage necrosis in atherosclerosis development</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2012.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.celrep.2012.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=23333278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Gjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=200-210&author=J.+Linauthor=H.+Liauthor=M.+Yangauthor=J.+Renauthor=Z.+Huangauthor=F.+Hanauthor=J.+Huangauthor=J.+Maauthor=D.+Zhangauthor=Z.+Zhangauthor=J.+Wuauthor=D.+Huangauthor=M.+Qiaoauthor=G.+Jinauthor=Q.+Wuauthor=Y.+Huangauthor=J.+Duauthor=J.+Han&title=A+role+of+RIP3-mediated+macrophage+necrosis+in+atherosclerosis+development&doi=10.1016%2Fj.celrep.2012.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A Role of RIP3-Mediated Macrophage Necrosis in Atherosclerosis Development</span></div><div class="casAuthors">Lin, Juan; Li, Hanjie; Yang, Min; Ren, Junming; Huang, Zhe; Han, Felicia; Huang, Jian; Ma, Jianhui; Zhang, Duanwu; Zhang, Zhirong; Wu, Jianfeng; Huang, Deli; Qiao, Muzhen; Jin, Guanghui; Wu, Qiao; Huang, Yinghui; Du, Jie; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">200-210</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Necrotic death of macrophages has long been known to be present in atherosclerotic lesions but has not been studied.  We examd. the role of receptor interacting protein (RIP) 3, a mediator of necrotic cell death, in atherosclerosis and found that RIP3-/-;Ldlr-/- mice were no different from RIP3+/+;Ldlr-/- mice in early atherosclerosis but had significant redn. in advanced atherosclerotic lesions.  Similar results were obsd. in Apoe-/- background mice.  Bone marrow transplantation revealed that loss of RIP3 expression from bone-marrow-derived cells is responsible for the reduced disease progression.  While no difference was found in apoptosis between RIP3-/-;Ldlr-/- and RIP3+/+;Ldlr-/- mice, electron microscopy revealed a significant redn. of macrophage primary necrosis in the advanced lesions of RIP3-/- mice.  In vitro cellular studies showed that RIP3 deletion had no effect on oxidized low-d. lipoprotein (LDL)-induced macrophage apoptosis, but prevented macrophage primary necrosis occurring in response to oxidized LDL under caspase inhibition or RIP3 overexpression conditions.  RIP3-dependent necrosis is not postapoptotic, and the increased primary necrosis in advanced atherosclerotic lesions most likely resulted from the increase of RIP3 expression.  Our data demonstrate that primary necrosis of macrophages is proatherogenic during advanced atherosclerosis development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdqCpSUOrMbVg90H21EOLACvtfcHk0lj7ejgETXDkIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Gjtr8%253D&md5=9209a0f4999a29c821a9b732ce7a17f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DQiao%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DA%2520role%2520of%2520RIP3-mediated%2520macrophage%2520necrosis%2520in%2520atherosclerosis%2520development%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D200%26epage%3D210%26doi%3D10.1016%2Fj.celrep.2012.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlic, M.</span></span> <span> </span><span class="NLM_article-title">The diverse role of RIP kinases in necroptosis and inflammation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1038/ni.3206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fni.3206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=26086143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OmtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=689-697&author=J.+Silkeauthor=J.+A.+Rickardauthor=M.+Gerlic&title=The+diverse+role+of+RIP+kinases+in+necroptosis+and+inflammation&doi=10.1038%2Fni.3206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse role of RIP kinases in necroptosis and inflammation</span></div><div class="casAuthors">Silke, John; Rickard, James A.; Gerlic, Motti</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">689-697</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammation is a healthy response to infection or danger and should be rapid, specific and terminated once the threat has passed.  Inflammatory diseases, where this regulation fails, cause considerable human suffering.  Treatments have successfully targeted pro-inflammatory cytokines, such as tumor-necrosis factor (TNF), that directly induce genes encoding inflammatory products.  Inflammatory signals, including TNF, may also directly induce caspase-independent cell death (necroptosis), which can also elicit inflammation.  Necroptosis was originally defined as being dependent on the kinase RIPK1 but is now known to be dependent on RIPK3 and the pseudo-kinase MLKL.  Therefore, RIPK1, RIPK3 and MLKL are potential therapeutic targets.  RIPK1 and RIPK3 also directly regulate inflammatory signaling, which complicates interpretation of their function but might alter their therapeutic utility.  This Review examines the role of cell death, particularly necroptosis, in inflammation, in the context of recent insights into the roles of the key necroptosis effector mols. RIPK1, RIPK3 and MLKL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQwQIKren3X7Vg90H21EOLACvtfcHk0lj7ejgETXDkIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OmtL3E&md5=124026d3c7caa25e1d416c6cb2bd8d87</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fni.3206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3206%26sid%3Dliteratum%253Aachs%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DRickard%26aufirst%3DJ.%2BA.%26aulast%3DGerlic%26aufirst%3DM.%26atitle%3DThe%2520diverse%2520role%2520of%2520RIP%2520kinases%2520in%2520necroptosis%2520and%2520inflammation%26jtitle%3DNat.%2520Immunol.%26date%3D2015%26volume%3D16%26spage%3D689%26epage%3D697%26doi%3D10.1038%2Fni.3206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1038/s41583-018-0093-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fs41583-018-0093-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=30467385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFegtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=19-33&author=J.+Yuanauthor=P.+Aminauthor=D.+Ofengeim&title=Necroptosis+and+RIPK1-mediated+neuroinflammation+in+CNS+diseases&doi=10.1038%2Fs41583-018-0093-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases</span></div><div class="casAuthors">Yuan, Junying; Amin, Palak; Ofengeim, Dimitry</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-33</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Apoptosis is crucial for the normal development of the nervous system, whereas neurons in the adult CNS are relatively resistant to this form of cell death.  However, under pathol. conditions, upregulation of death receptor family ligands, such as tumor necrosis factor (TNF), can sensitize cells in the CNS to apoptosis and a form of regulated necrotic cell death known as necroptosis that is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL).  Necroptosis promotes further cell death and neuroinflammation in the pathogenesis of several neurodegenerative diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease and Alzheimer disease.  In this Review, we outline the evidence implicating necroptosis in these neurol. diseases and suggest that targeting RIPK1 might help to inhibit multiple cell death pathways and ameliorate neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5SkNdlkg47rVg90H21EOLACvtfcHk0lhiz-8f5b2Ujg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFegtL7O&md5=935fd7ac622d04317a9f7c2c21f40717</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fs41583-018-0093-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41583-018-0093-1%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DP.%26aulast%3DOfengeim%26aufirst%3DD.%26atitle%3DNecroptosis%2520and%2520RIPK1-mediated%2520neuroinflammation%2520in%2520CNS%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2019%26volume%3D20%26spage%3D19%26epage%3D33%26doi%3D10.1038%2Fs41583-018-0093-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grootjans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghe, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Initiation and execution mechanisms of necroptosis: an overview</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1184</span>– <span class="NLM_lpage">1195</span>, <span class="refDoi"> DOI: 10.1038/cdd.2017.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcdd.2017.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=28498367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1184-1195&author=S.+Grootjansauthor=T.+V.+Bergheauthor=P.+Vandenabeele&title=Initiation+and+execution+mechanisms+of+necroptosis%3A+an+overview&doi=10.1038%2Fcdd.2017.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation and execution mechanisms of necroptosis: an overview</span></div><div class="casAuthors">Grootjans, Sasker; Vanden Berghe, Tom; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1184-1195</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis is a form of regulated cell death, which is induced by ligand binding to TNF family death domain receptors, pattern recognizing receptors and virus sensors.  The common feature of these receptor systems is the implication of proteins, which contain a receptor interaction protein kinase (RIPK) homol. interaction motif (RHIM) mediating recruitment and activation of receptor-interacting protein kinase 3 (RIPK3), which ultimately activates the necroptosis executioner mixed lineage kinase domain-like (MLKL).  In case of the TNF family members, the initiator is the survival- and cell death-regulating RIPK1 kinase, in the case of Toll-like receptor 3/4 (TLR3/4), a RHIM-contg. adaptor, called TRIF, while in the case of Z-DNA-binding protein ZBP1/DAI, the cytosolic viral sensor itself contains a RHIM domain.  In this review, we discuss the different protein complexes that serve as nucleation platforms for necroptosis and the mechanism of execution of necroptosis.  Transgenic models (knockout, kinase-dead knock-in) and pharmacol. inhibition indicate that RIPK1, RIPK3 or MLKL are implicated in many inflammatory, degenerative and infectious diseases.  However, the conclusion of necroptosis being solely involved in the etiol. of diseases is blurred by the pleiotropic roles of RIPK1 and RIPK3 in other cellular processes such as apoptosis and inflammasome activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraHklySa3j_rVg90H21EOLACvtfcHk0lhiz-8f5b2Ujg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjsLjL&md5=9128fd271b67c02c9ca5d40fba222318</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2017.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2017.65%26sid%3Dliteratum%253Aachs%26aulast%3DGrootjans%26aufirst%3DS.%26aulast%3DBerghe%26aufirst%3DT.%2BV.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DInitiation%2520and%2520execution%2520mechanisms%2520of%2520necroptosis%253A%2520an%2520overview%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2017%26volume%3D24%26spage%3D1184%26epage%3D1195%26doi%3D10.1038%2Fcdd.2017.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.cell.2009.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=19524512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1100-1111&author=S.+Heauthor=L.+Wangauthor=L.+Miaoauthor=T.+Wangauthor=F.+Duauthor=L.+Zhaoauthor=X.+Wang&title=Receptor+interacting+protein+kinase-3+determines+cellular+necrotic+response+to+TNF-alpha&doi=10.1016%2Fj.cell.2009.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α</span></div><div class="casAuthors">He, Sudan; Wang, Lai; Miao, Lin; Wang, Tao; Du, Fenghe; Zhao, Liping; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1100-1111</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Smac mimetics induce apoptosis synergistically with TNF-α by triggering the formation of a caspase-8-activating complex contg. receptor interacting protein kinase-1 (RIPK1).  Caspase inhibitors block this form of apoptosis in many types of cells.  However, in several other cell lines, caspase inhibitors switch the apoptotic response to necrosis.  A genome wide siRNA screen revealed another member of the RIP kinase family, RIP3, to be required for necrosis.  The expression of RIP3 in different cell lines correlates with their responsiveness to necrosis induction.  The kinase activity of RIP3 is essential for necrosis execution.  Upon induction of necrosis, RIP3 is recruited to RIPK1 to form a necrosis-inducing complex.  Embryonic fibroblasts from RIP3 knockout mice are resistant to necrosis and RIP3 knockout animals are devoid of inflammation inflicted tissue damage in an acute pancreatitis model.  These data indicate RIP3 as the determinant for cellular necrosis in response to TNF-α family of death-inducing cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoymGY6l3d1LbVg90H21EOLACvtfcHk0lhiz-8f5b2Ujg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiu70%253D&md5=6397b34b896f8fe36c726f6d2ab39933</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DReceptor%2520interacting%2520protein%2520kinase-3%2520determines%2520cellular%2520necrotic%2520response%2520to%2520TNF-alpha%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D1100%26epage%3D1111%26doi%3D10.1016%2Fj.cell.2009.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Challa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moquin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guildford, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.cell.2009.05.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=19524513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1112-1123&author=Y.+S.+Choauthor=S.+Challaauthor=D.+Moquinauthor=R.+Gengaauthor=T.+D.+Rayauthor=M.+Guildfordauthor=F.+K.+Chan&title=Phosphorylation-driven+assembly+of+the+RIP1-RIP3+complex+regulates+programmed+necrosis+and+virus-induced+inflammation&doi=10.1016%2Fj.cell.2009.05.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation</span></div><div class="casAuthors">Cho, YoungSik; Challa, Sreerupa; Moquin, David; Genga, Ryan; Dutta Ray, Tathagat; Guildford, Melissa; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1112-1123</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Programmed necrosis is a form of caspase-independent cell death whose mol. regulation is poorly understood.  The kinase RIP1 is crucial for programmed necrosis, but also mediates activation of the prosurvival transcription factor NF-κB.  The authors postulated that addnl. mols. are required to specifically activate programmed necrosis.  Using a RNA interference screen, the authors identified the kinase RIP3 as a crucial activator for programmed necrosis induced by TNF and during virus infection.  RIP3 regulates necrosis-specific RIP1 phosphorylation.  The phosphorylation of RIP1 and RIP3 stabilizes their assocn. within the pronecrotic complex, activates the pronecrotic kinase activity, and triggers downstream reactive oxygen species prodn.  The pronecrotic RIP1-RIP3 complex is induced during vaccinia virus infection.  Consequently, RIP3-/- mice exhibited severely impaired virus-induced tissue necrosis, inflammation, and control of viral replication.  The authors' findings suggest that RIP3 controls programmed necrosis by initiating the pronecrotic kinase cascade, and that this is necessary for the inflammatory response against virus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmgsGJGayANrVg90H21EOLACvtfcHk0lhiz-8f5b2Ujg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiu7o%253D&md5=6c158081daa49222becf864ac4a23885</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.037%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DChalla%26aufirst%3DS.%26aulast%3DMoquin%26aufirst%3DD.%26aulast%3DGenga%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DT.%2BD.%26aulast%3DGuildford%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DPhosphorylation-driven%2520assembly%2520of%2520the%2520RIP1-RIP3%2520complex%2520regulates%2520programmed%2520necrosis%2520and%2520virus-induced%2520inflammation%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D1112%26epage%3D1123%26doi%3D10.1016%2Fj.cell.2009.05.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.11.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.cell.2011.11.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22265413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=213-227&author=L.+Sunauthor=H.+Wangauthor=Z.+Wangauthor=S.+Heauthor=S.+Chenauthor=D.+Liaoauthor=L.+Wangauthor=J.+Yanauthor=W.+Liuauthor=X.+Leiauthor=X.+Wang&title=Mixed+lineage+kinase+domain-like+protein+mediates+necrosis+signaling+downstream+of+RIP3+kinase&doi=10.1016%2Fj.cell.2011.11.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase</span></div><div class="casAuthors">Sun, Liming; Wang, Huayi; Wang, Zhigao; He, Sudan; Chen, She; Liao, Daohong; Wang, Lai; Yan, Jiacong; Liu, Weilong; Lei, Xiaoguang; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">213-227</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The receptor-interacting serine-threonine kinase 3 (RIP3) is a key signaling mol. in the programmed necrosis (necroptosis) pathway.  This pathway plays important roles in a variety of physiol. and pathol. conditions, including development, tissue damage response, and antiviral immunity.  Here, we report the identification of a small mol. called (E)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide-hereafter referred to as necrosulfonamide-that specifically blocks necrosis downstream of RIP3 activation.  An affinity probe derived from necrosulfonamide and coimmunopptn. using anti-RIP3 antibodies both identified the mixed lineage kinase domain-like protein (MLKL) as the interacting target.  MLKL was phosphorylated by RIP3 at the threonine 357 and serine 358 residues, and these phosphorylation events were crit. for necrosis.  Treating cells with necrosulfonamide or knocking down MLKL expression arrested necrosis at a specific step at which RIP3 formed discrete punctae in cells.  These findings implicate MLKL as a key mediator of necrosis signaling downstream of the kinase RIP3.  MLKL connects RIP1 and RIP3 with its downstream targets.  In response to necrosis induction, activated RIP3 binds and phosphorylates MLKL, allowing downstream necrosis signaling to proceed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroTbwLFup35LVg90H21EOLACvtfcHk0ljoY4BJcIca9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKgsLY%253D&md5=c3301ecd27c6892817e18b42c56bd97e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.11.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.11.031%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520protein%2520mediates%2520necrosis%2520signaling%2520downstream%2520of%2520RIP3%2520kinase%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D213%26epage%3D227%26doi%3D10.1016%2Fj.cell.2011.11.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jitkaew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5322</span>– <span class="NLM_lpage">5327</span>, <span class="refDoi"> DOI: 10.1073/pnas.1200012109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1073%2Fpnas.1200012109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22421439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5322-5327&author=J.+Zhaoauthor=S.+Jitkaewauthor=Z.+Caiauthor=S.+Choksiauthor=Q.+Liauthor=J.+Luoauthor=Z.+G.+Liu&title=Mixed+lineage+kinase+domain-like+is+a+key+receptor+interacting+protein+3+downstream+component+of+TNF-induced+necrosis&doi=10.1073%2Fpnas.1200012109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis</span></div><div class="casAuthors">Zhao, Jie; Jitkaew, Siriporn; Cai, Zhenyu; Choksi, Swati; Li, Qiuning; Luo, Ji; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5322-5327, S5322/1-S5322/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is an important inflammatory cytokine and induces many cellular responses, including inflammation, cell proliferation, apoptosis, and necrosis.  It is known that receptor interacting protein (RIP) kinases, RIP1 and RIP3, are key effectors of TNF-induced necrosis, but little is known about how these two RIP kinases mediate this process, although reactive oxygen species (ROS) generation and JNK activation have been suggested to be two downstream events of RIP kinases.  Here we report the identification of mixed lineage kinase domain-like, MLKL, as a key RIP3 downstream component of TNF-induced necrosis.  Through screening a kinase/phosphatase shRNA library in human colon adenocarcinoma HT-29 cells, we found that knockdown of MLKL blocked TNF-induced necrosis.  Our data suggest that MLKL functions downstream of R1P1 and RIP3 and is recruited to the necrosome through its interaction with RIP3.  Finally, we found that MLKL is required for the generation of ROS and the late-phase activation of JNK during TNF-induced necrosis.  However, because these two events are not involved in TNF-induced necrosis in HT-29 cells, the target of MLKL during TNF-induced necrosis remains elusive.  Taken together, our study suggests that MLKL is a key RIP3 downstream component of TNF-induced necrotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA3gnnPnZluLVg90H21EOLACvtfcHk0ljoY4BJcIca9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOjs70%253D&md5=74fd138fd18afacf677003f41d6be280</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1200012109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1200012109%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJitkaew%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520is%2520a%2520key%2520receptor%2520interacting%2520protein%25203%2520downstream%2520component%2520of%2520TNF-induced%2520necrosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D5322%26epage%3D5327%26doi%3D10.1073%2Fpnas.1200012109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jitkaew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/ncb2883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fncb2883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24316671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=55-65&author=Z.+Caiauthor=S.+Jitkaewauthor=J.+Zhaoauthor=H.+C.+Chiangauthor=S.+Choksiauthor=J.+Liuauthor=Y.+Wardauthor=L.+G.+Wuauthor=Z.+G.+Liu&title=Plasma+membrane+translocation+of+trimerized+MLKL+protein+is+required+for+TNF-induced+necroptosis&doi=10.1038%2Fncb2883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis</span></div><div class="casAuthors">Cai, Zhenyu; Jitkaew, Siriporn; Zhao, Jie; Chiang, Hsueh-Cheng; Choksi, Swati; Liu, Jie; Ward, Yvona; Wu, Ling-gang; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-65</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mixed lineage kinase domain-like protein (MLKL) has recently been identified as a key RIP3 (receptor interacting protein 3) downstream component of tumor necrosis factor (TNF)-induced necroptosis.  MLKL is phosphorylated by RIP3 and is recruited to the necrosome through its interaction with RIP3.  However, it is still unknown how MLKL mediates TNF-induced necroptosis.  Here, we report that MLKL forms a homotrimer through its amino-terminal coiled-coil domain and locates to the cell plasma membrane during TNF-induced necroptosis.  By generating different MLKL mutants, we demonstrated that the plasma membrane localization of trimerized MLKL is crit. for mediating necroptosis.  Importantly, we found that the membrane localization of MLKL is essential for Ca2+ influx, which is an early event of TNF-induced necroptosis.  Furthermore, we identified that TRPM7 (transient receptor potential melastatin related 7) is a MLKL downstream target for the mediation of Ca2+ influx and TNF-induced necroptosis.  Hence, our study reveals a crucial mechanism of MLKL-mediated TNF-induced necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEjJZlohdKsLVg90H21EOLACvtfcHk0ljoY4BJcIca9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3E&md5=95e4468ee729b5a3bd8ab8ce49af8f25</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncb2883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2883%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DJitkaew%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DH.%2BC.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%2BG.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DPlasma%2520membrane%2520translocation%2520of%2520trimerized%2520MLKL%2520protein%2520is%2520required%2520for%2520TNF-induced%2520necroptosis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D55%26epage%3D65%26doi%3D10.1038%2Fncb2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/cr.2013.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcr.2013.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24366341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=105-121&author=X.+Chenauthor=W.+Liauthor=J.+Renauthor=D.+Huangauthor=W.+T.+Heauthor=Y.+Songauthor=C.+Yangauthor=W.+Liauthor=X.+Zhengauthor=P.+Chenauthor=J.+Han&title=Translocation+of+mixed+lineage+kinase+domain-like+protein+to+plasma+membrane+leads+to+necrotic+cell+death&doi=10.1038%2Fcr.2013.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death</span></div><div class="casAuthors">Chen, Xin; Li, Wenjuan; Ren, Junming; Huang, Deli; He, Wan-ting; Song, Yunlong; Yang, Chao; Li, Wanyun; Zheng, Xinru; Chen, Pengda; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Mixed lineage kinase domain-like protein (MLKL) was identified to function downstream of receptor interacting protein 3 (RIP3) in tumor necrosis factor-α (TNF)-induced necrosis (also called necroptosis).  However, how MLKL functions to mediate necroptosis is unknown.  By reconstitution of MLKL function in MLKL-knockout cells, we showed that the N-terminus of MLKL is required for its function in necroptosis.  The oligomerization of MLKL in TNF-treated cells is essential for necroptosis, as artificially forcing MLKL together by using the hormone-binding domain (HBD*) triggers necroptosis.  Notably, forcing together the N-terminal domain (ND) but not the C-terminal kinase domain of MLKL causes necroptosis.  Further deletion anal. showed that the four-α-helix bundle of MLKL (1-130 amino acids) is sufficient to trigger necroptosis.  Both the HBD*-mediated and TNF-induced complexes of MLKL(ND) or MLKL are tetramers, and translocation of these complexes to lipid rafts of the plasma membrane precedes cell death.  The homo-oligomerization is required for MLKL translocation and the signal sequence for plasma membrane location is located in the junction of the first and second α-helixes of MLKL.  The plasma membrane translocation of MLKL or MLKL(ND) leads to sodium influx, and depletion of sodium from the cell culture medium inhibits necroptosis.  All of the above phenomena were not seen in apoptosis.  Thus, the MLKL oligomerization leads to translocation of MLKL to lipid rafts of plasma membrane, and the plasma membrane MLKL complex acts either by itself or via other proteins to increase the sodium influx, which increases osmotic pressure, eventually leading to membrane rupture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3gKfH7oX77Vg90H21EOLACvtfcHk0liXD3rE57cXnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVyr&md5=16ac2183df16e01d3555e4a099540aae</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fcr.2013.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2013.171%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DW.%2BT.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DTranslocation%2520of%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%2520to%2520plasma%2520membrane%2520leads%2520to%2520necrotic%2520cell%2520death%26jtitle%3DCell%2520Res.%26date%3D2014%26volume%3D24%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fcr.2013.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dondelinger, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montessuit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggeman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulpiau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.celrep.2014.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24813885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=971-981&author=Y.+Dondelingerauthor=W.+Declercqauthor=S.+Montessuitauthor=R.+Roelandtauthor=A.+Goncalvesauthor=I.+Bruggemanauthor=P.+Hulpiauauthor=K.+Weberauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Goughauthor=S.+Savvidesauthor=J.+C.+Martinouauthor=M.+J.+Bertrandauthor=P.+Vandenabeele&title=MLKL+compromises+plasma+membrane+integrity+by+binding+to+phosphatidylinositol+phosphates&doi=10.1016%2Fj.celrep.2014.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates</span></div><div class="casAuthors">Dondelinger, Yves; Declercq, Wim; Montessuit, Sylvie; Roelandt, Ria; Goncalves, Amanda; Bruggeman, Inge; Hulpiau, Paco; Weber, Kathrin; Sehon, Clark A.; Marquis, Robert W.; Bertin, John; Gough, Peter J.; Savvides, Savvas; Martinou, Jean-Claude; Bertrand, Mathieu J. M.; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">971-981</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although mixed lineage kinase domain-like (MLKL) protein has emerged as a specific and crucial protein for necroptosis induction, how MLKL transduces the death signal remains poorly understood.  Here, we demonstrate that the full four-helical bundle domain (4HBD) in the N-terminal region of MLKL is required and sufficient to induce its oligomerization and trigger cell death.  Moreover, we found that a patch of pos. charged amino acids on the surface of the 4HBD binds to phosphatidylinositol phosphates (PIPs) and allows recruitment of MLKL to the plasma membrane.  Importantly, we found that recombinant MLKL, but not a mutant lacking these pos. charges, induces leakage of PIP-contg. liposomes as potently as BAX, supporting a model in which MLKL induces necroptosis by directly permeabilizing the plasma membrane.  Accordingly, we found that inhibiting the formation of PI(5)P and PI(4,5)P2 specifically inhibits tumor necrosis factor (TNF)-mediated necroptosis but not apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqRumZDmhVGLVg90H21EOLACvtfcHk0liXD3rE57cXnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGnu78%253D&md5=42d9a43216f884c12bd4288658563873</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DDondelinger%26aufirst%3DY.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DMontessuit%26aufirst%3DS.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DGoncalves%26aufirst%3DA.%26aulast%3DBruggeman%26aufirst%3DI.%26aulast%3DHulpiau%26aufirst%3DP.%26aulast%3DWeber%26aufirst%3DK.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DSavvides%26aufirst%3DS.%26aulast%3DMartinou%26aufirst%3DJ.%2BC.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DMLKL%2520compromises%2520plasma%2520membrane%2520integrity%2520by%2520binding%2520to%2520phosphatidylinositol%2520phosphates%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D7%26spage%3D971%26epage%3D981%26doi%3D10.1016%2Fj.celrep.2014.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.molcel.2014.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24703947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1emsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=133-146&author=H.+Wangauthor=L.+Sunauthor=L.+Suauthor=J.+Rizoauthor=L.+Liuauthor=L.+F.+Wangauthor=F.+S.+Wangauthor=X.+Wang&title=Mixed+lineage+kinase+domain-like+protein+MLKL+causes+necrotic+membrane+disruption+upon+phosphorylation+by+RIP3&doi=10.1016%2Fj.molcel.2014.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3</span></div><div class="casAuthors">Wang, Huayi; Sun, Liming; Su, Lijing; Rizo, Josep; Liu, Lei; Wang, Li-Feng; Wang, Fu-Sheng; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-146</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Programmed necrotic cell death induced by the tumor necrosis factor alpha (TNF-α) family of cytokines is dependent on a kinase cascade consisting of receptor-interacting kinases RIP1 and RIP3.  How these kinase activities cause cells to die by necrosis is not known.  The mixed lineage kinase domain-like protein MLKL is a functional RIP3 substrate that binds to RIP3 through its kinase-like domain but lacks kinase activity of its own.  RIP3 phosphorylates MLKL at the T357 and S358 sites.  Reported here is the development of a monoclonal antibody that specifically recognizes phosphorylated MLKL in cells dying of this pathway and in human liver biopsy samples from patients suffering from drug-induced liver injury.  The phosphorylated MLKL forms an oligomer that binds to phosphatidylinositol lipids and cardiolipin.  This property allows MLKL to move from the cytosol to the plasma and intracellular membranes, where it directly disrupts membrane integrity, resulting in necrotic death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPpE1gUpKITrVg90H21EOLACvtfcHk0liXD3rE57cXnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1emsro%253D&md5=8e4ab8e0a49933201ed49b147b6b189e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DRizo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%2BF.%26aulast%3DWang%26aufirst%3DF.%2BS.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520protein%2520MLKL%2520causes%2520necrotic%2520membrane%2520disruption%2520upon%2520phosphorylation%2520by%2520RIP3%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D54%26spage%3D133%26epage%3D146%26doi%3D10.1016%2Fj.molcel.2014.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span> <span> </span><span class="NLM_article-title">Programmed necrosis in inflammation: Toward identification of the effector molecules</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>352</i></span>, <span class="NLM_elocation-id">aaf2154</span> <span class="refDoi"> DOI: 10.1126/science.aaf2154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1126%2Fscience.aaf2154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27034377" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2016&author=D.+Wallachauthor=T.+B.+Kangauthor=C.+P.+Dillonauthor=D.+R.+Green&title=Programmed+necrosis+in+inflammation%3A+Toward+identification+of+the+effector+molecules&doi=10.1126%2Fscience.aaf2154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf2154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf2154%26sid%3Dliteratum%253Aachs%26aulast%3DWallach%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DT.%2BB.%26aulast%3DDillon%26aufirst%3DC.%2BP.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26atitle%3DProgrammed%2520necrosis%2520in%2520inflammation%253A%2520Toward%2520identification%2520of%2520the%2520effector%2520molecules%26jtitle%3DScience%26date%3D2016%26volume%3D352%26doi%3D10.1126%2Fscience.aaf2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of novel necroptosis inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5039</span>– <span class="NLM_lpage">5044</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.07.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.bmcl.2005.07.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=16153840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVynu73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5039-5044&author=X.+Tengauthor=A.+Degterevauthor=P.+Jagtapauthor=X.+Xingauthor=S.+Choiauthor=R.+Denuauthor=J.+Yuanauthor=G.+D.+Cuny&title=Structure-activity+relationship+study+of+novel+necroptosis+inhibitors&doi=10.1016%2Fj.bmcl.2005.07.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of novel necroptosis inhibitors</span></div><div class="casAuthors">Teng, Xin; Degterev, Alexei; Jagtap, Prakash; Xing, Xuechao; Choi, Sungwoon; Denu, Regine; Yuan, Junying; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5039-5044</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death mechanism that results in morphol. features resembling necrosis.  It can be induced in a FADD-deficient variant of human Jurkat T cells treated with TNF-α.  5-(1H-Indol-3-ylmethyl)-2-thiohydantoin derivs. and 5-(1H-indol-3-ylmethyl)hydantoin derivs. were found to be potent necroptosis inhibitors (called necrostatins).  A SAR study revealed that several positions of the indole were intolerant of substitution, while small substituents at the 7-position resulted in increased inhibitory activity.  The hydantoin ring was also quite sensitive to structural modifications.  A representative member of this compd. class demonstrated moderate pharmacokinetic characteristics and readily entered the central nervous system upon i.v. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRkqj1HWHSSLVg90H21EOLACvtfcHk0lgd_xT_hjOOgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVynu73O&md5=5a2b77e2d0461c24eaef8182ab7d4cdf</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.077%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DXing%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DDenu%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520novel%2520necroptosis%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5039%26epage%3D5044%26doi%3D10.1016%2Fj.bmcl.2005.07.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germscheid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ch’en, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Identification of RIP1 kinase as a specific cellular target of necrostatins</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nchembio.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fnchembio.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=18408713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=313-321&author=A.+Degterevauthor=J.+Hitomiauthor=M.+Germscheidauthor=I.+L.+Ch%E2%80%99enauthor=O.+Korkinaauthor=X.+Tengauthor=D.+Abbottauthor=G.+D.+Cunyauthor=C.+Yuanauthor=G.+Wagnerauthor=S.+M.+Hedrickauthor=S.+A.+Gerberauthor=A.+Lugovskoyauthor=J.+Yuan&title=Identification+of+RIP1+kinase+as+a+specific+cellular+target+of+necrostatins&doi=10.1038%2Fnchembio.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of RIP1 kinase as a specific cellular target of necrostatins</span></div><div class="casAuthors">Degterev, Alexei; Hitomi, Junichi; Germscheid, Megan; Ch'en, Irene L.; Korkina, Olga; Teng, Xin; Abbott, Derek; Cuny, Gregory D.; Yuan, Chengye; Wagner, Gerhard; Hedrick, Stephen M.; Gerber, Scott A.; Lugovskoy, Alexey; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis is a cellular mechanism of necrotic cell death induced by apoptotic stimuli in the form of death domain receptor engagement by their resp. ligands under conditions where apoptotic execution is prevented.  Although it occurs under regulated conditions, necroptotic cell death is characterized by the same morphol. features as unregulated necrotic death.  Here we report that necrostatin-1, a previously identified small-mol. inhibitor of necroptosis, is a selective allosteric inhibitor of the death domain receptor-assocd. adaptor kinase RIP1 in vitro.  We show that RIP1 is the primary cellular target responsible for the antinecroptosis activity of necrostatin-1.  In addn., we show that two other necrostatins, necrostatin-3 and necrostatin-5, also target the RIP1 kinase step in the necroptosis pathway, but through mechanisms distinct from that of necrostatin-1.  Overall, our data establish necrostatins as the first-in-class inhibitors of RIP1 kinase, the key upstream kinase involved in the activation of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOaKMR-RMwdLVg90H21EOLACvtfcHk0lgd_xT_hjOOgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D&md5=8ba3859c2b4c752da534441747a79bb5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.83%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DGermscheid%26aufirst%3DM.%26aulast%3DCh%25E2%2580%2599en%26aufirst%3DI.%2BL.%26aulast%3DKorkina%26aufirst%3DO.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DAbbott%26aufirst%3DD.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DHedrick%26aufirst%3DS.%2BM.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520RIP1%2520kinase%2520as%2520a%2520specific%2520cellular%2520target%2520of%2520necrostatins%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D313%26epage%3D321%26doi%3D10.1038%2Fnchembio.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duprez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootjans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwels, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nerinckx, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hauwermeiren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callewaert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e437</span> <span class="refDoi"> DOI: 10.1038/cddis.2012.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcddis.2012.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=23190609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&author=N.+Takahashiauthor=L.+Duprezauthor=S.+Grootjansauthor=A.+Cauwelsauthor=W.+Nerinckxauthor=J.+B.+DuHadawayauthor=V.+Goossensauthor=R.+Roelandtauthor=F.+Van+Hauwermeirenauthor=C.+Libertauthor=W.+Declercqauthor=N.+Callewaertauthor=G.+C.+Prendergastauthor=A.+Degterevauthor=J.+Yuanauthor=P.+Vandenabeele&title=Necrostatin-1+analogues%3A+critical+issues+on+the+specificity%2C+activity+and+in+vivo+use+in+experimental+disease+models&doi=10.1038%2Fcddis.2012.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models</span></div><div class="casAuthors">Takahashi, N.; Duprez, L.; Grootjans, S.; Cauwels, A.; Nerinckx, W.; DuHadaway, J. B.; Goossens, V.; Roelandt, R.; Van Hauwermeiren, F.; Libert, C.; Declercq, W.; Callewaert, N.; Prendergast, G. C.; Degterev, A.; Yuan, J.; Vandenabeele, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">e437, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necrostatin-1 (Nec-1) is widely used in disease models to examine the contribution of receptor-interacting protein kinase (RIPK) 1 in cell death and inflammation.  We studied three Nec-1 analogs: Nec-1, the active inhibitor of RIPK1, Nec-1 inactive (Nec-1i), its inactive variant, and Nec-1 stable (Nec-1s), its more stable variant.  We report that Nec-1 is identical to methyl-thiohydantoin-tryptophan, an inhibitor of the potent immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO).  Both Nec-1 and Nec-1i inhibited human IDO, but Nec-1s did not, as predicted by mol. modeling.  Therefore, Nec-1s is a more specific RIPK1 inhibitor lacking the IDO-targeting effect.  Next, although Nec-1i was ∼100 × less effective than Nec-1 in inhibiting human RIPK1 kinase activity in vitro, it was only 10 times less potent than Nec-1 and Nec-1s in a mouse necroptosis assay and became even equipotent at high concns.  Along the same line, in vivo, high doses of Nec-1, Nec-1i and Nec-1s prevented tumor necrosis factor (TNF)-induced mortality equally well, excluding the use of Nec-1i as an inactive control.  Paradoxically, low doses of Nec-1 or Nec-1i, but not Nec-1s, even sensitized mice to TNF-induced mortality.  Importantly, Nec-1s did not exhibit this low dose toxicity, stressing again the preferred use of Nec-1s in vivo.  Our findings have important implications for the interpretation of Nec-1-based data in exptl. disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2yIQ4UD-yb7Vg90H21EOLACvtfcHk0ljicIeg79Pfeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFSitg%253D%253D&md5=2d4f57016d88e474cbfe00dee540b8fa</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.176%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DDuprez%26aufirst%3DL.%26aulast%3DGrootjans%26aufirst%3DS.%26aulast%3DCauwels%26aufirst%3DA.%26aulast%3DNerinckx%26aufirst%3DW.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DVan%2BHauwermeiren%26aufirst%3DF.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DCallewaert%26aufirst%3DN.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DNecrostatin-1%2520analogues%253A%2520critical%2520issues%2520on%2520the%2520specificity%252C%2520activity%2520and%2520in%2520vivo%2520use%2520in%2520experimental%2520disease%2520models%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26doi%3D10.1038%2Fcddis.2012.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigi, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikatendu, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakakariya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yogo, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (RIP1) kinase inhibitors: analysis of structure-kinetic relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2384</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2384-2409&author=M.+Yoshikawaauthor=M.+Saitohauthor=T.+Katohauthor=T.+Sekiauthor=S.+V.+Bigiauthor=Y.+Shimizuauthor=T.+Ishiiauthor=T.+Okaiauthor=M.+Kunoauthor=H.+Hattoriauthor=E.+Watanabeauthor=K.+S.+Saikatenduauthor=H.+Zouauthor=M.+Nakakariyaauthor=T.+Tatamiyaauthor=Y.+Nakadaauthor=T.+Yogo&title=Discovery+of+7-Oxo-2%2C4%2C5%2C7-tetrahydro-6+H-pyrazolo%5B3%2C4-+c%5Dpyridine+derivatives+as+potent%2C+orally+available%2C+and+brain-penetrating+receptor+interacting+protein+1+%28RIP1%29+kinase+inhibitors%3A+analysis+of+structure-kinetic+relationships&doi=10.1021%2Facs.jmedchem.7b01647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships</span></div><div class="casAuthors">Yoshikawa, Masato; Saitoh, Morihisa; Katoh, Taisuke; Seki, Tomohiro; Bigi, Simone V.; Shimizu, Yuji; Ishii, Tsuyoshi; Okai, Takuro; Kuno, Masako; Hattori, Harumi; Watanabe, Etsuro; Saikatendu, Kumar S.; Zou, Hua; Nakakariya, Masanori; Tatamiya, Takayuki; Nakada, Yoshihisa; Yogo, Takatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2384-2409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the discovery of 7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine derivs. as a novel class of receptor interacting protein 1 (RIP1) kinase inhibitors.  On the basis of the overlay study between HTS hit 10 and GSK2982772 in RIP1 kinase, the authors designed and synthesized a novel class of RIP1 kinase inhibitor (11, (3S)-3-(2-Benzyl-4-oxo-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one trifluoroacetic acid) possessing moderate RIP1 kinase inhibitory activity and P-gp mediated efflux.  The optimization of the core structure and the exploration of appropriate substituents utilizing SBDD approach led to the discovery of (22, (3S)-3-(2-Benzyl-3-chloro-7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-8-carbonitrile), a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor with excellent PK profiles.  Compd. 22 significantly suppressed necroptotic cell death both in mouse and human cells.  Oral administration of 22 (10 mg/kg, bid) attenuated disease progression in the mouse exptl. autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS).  Moreover, anal. of structure-kinetic relationship (SKR) for the authors' novel chem. series was also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP8rRmbdh7w7Vg90H21EOLACvtfcHk0ljicIeg79Pfeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOku78%253D&md5=a76ab7f12af03e277ba37d7ea08274c9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01647%26sid%3Dliteratum%253Aachs%26aulast%3DYoshikawa%26aufirst%3DM.%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKatoh%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DBigi%26aufirst%3DS.%2BV.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DOkai%26aufirst%3DT.%26aulast%3DKuno%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DE.%26aulast%3DSaikatendu%26aufirst%3DK.%2BS.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DNakakariya%26aufirst%3DM.%26aulast%3DTatamiya%26aufirst%3DT.%26aulast%3DNakada%26aufirst%3DY.%26aulast%3DYogo%26aufirst%3DT.%26atitle%3DDiscovery%2520of%25207-Oxo-2%252C4%252C5%252C7-tetrahydro-6%2520H-pyrazolo%255B3%252C4-%2520c%255Dpyridine%2520derivatives%2520as%2520potent%252C%2520orally%2520available%252C%2520and%2520brain-penetrating%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520inhibitors%253A%2520analysis%2520of%2520structure-kinetic%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2384%26epage%3D2409%26doi%3D10.1021%2Facs.jmedchem.7b01647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01898</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01898" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2163-2178&author=P.+A.+Harrisauthor=B.+W.+Kingauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=J.+N.+Fingerauthor=L.+C.+Gradyauthor=S.+J.+Hoffmanauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=A.+S.+Lakdawalaauthor=R.+Lehrauthor=D.+E.+McNultyauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+R.+Rendinaauthor=M.+C.+Schaefferauthor=J.+D.+Summerfieldauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=A.+Zhangauthor=D.+Zhangauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=DNA-encoded+library+screening+identifies+benzo%5Bb%5D%5B1%2C4%5Doxazepin-4-ones+as+highly+potent+and+monoselective+receptor+interacting+protein+1+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors</span></div><div class="casAuthors">Harris, Philip A.; King, Bryan W.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Finger, Joshua N.; Grady, LaShadric C.; Hoffman, Sandra J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Lakdawala, Ami S.; Lehr, Ruth; McNulty, Dean E.; Nagilla, Rakesh; Ouellette, Michael T.; Pao, Christina S.; Rendina, Alan R.; Schaeffer, Michelle C.; Summerfield, Jennifer D.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Zhang, Aming; Zhang, Daohua; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent discovery of the role of receptor interacting protein 1 (RIP1) kinase in tumor necrosis factor (TNF)-mediated inflammation has led to its emergence as a highly promising target for the treatment of multiple inflammatory diseases.  The authors screened RIP1 against GSK's DNA-encoded small-mol. libraries and identified a novel highly potent benzoxazepinone inhibitor series.  The authors demonstrate that this template possesses complete monokinase selectivity for RIP1 plus unique species selectivity for primate vs. nonprimate RIP1.  The authors elucidate the conformation of RIP1 bound to this benzoxazepinone inhibitor driving its high kinase selectivity and design specific mutations in murine RIP1 to restore potency to levels similar to primate RIP1.  This series differentiates itself from known RIP1 inhibitors in combining high potency and kinase selectivity with good pharmacokinetic profiles in rodents.  The favorable developability profile of this benzoxazepinone template, as exemplified by compd. 14 (GSK'481), makes it an excellent starting point for further optimization into a RIP1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XvpziWGWg7Vg90H21EOLACvtfcHk0lhDu4zWueAD4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D&md5=d6325dcaed97b7c339d1830ca041298c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01898%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSummerfield%26aufirst%3DJ.%2BD.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDNA-encoded%2520library%2520screening%2520identifies%2520benzo%255Bb%255D%255B1%252C4%255Doxazepin-4-ones%2520as%2520highly%2520potent%2520and%2520monoselective%2520receptor%2520interacting%2520protein%25201%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2163%26epage%3D2178%26doi%3D10.1021%2Facs.jmedchem.5b01898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0lhDu4zWueAD4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolstenholme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards-Peterson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verticelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. L.</span></span> <span> </span><span class="NLM_article-title">Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e00365</span> <span class="refDoi"> DOI: 10.1002/prp2.365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1002%2Fprp2.365" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&author=K.+Weiselauthor=N.+E.+Scottauthor=D.+J.+Tompsonauthor=B.+J.+Vottaauthor=S.+Madhavanauthor=K.+Poveyauthor=A.+Wolstenholmeauthor=M.+Simeoniauthor=T.+Rudoauthor=L.+Richards-Petersonauthor=T.+Sahotaauthor=J.+G.+Wangauthor=J.+Lichauthor=J.+Fingerauthor=A.+Verticelliauthor=M.+Reillyauthor=P.+J.+Goughauthor=P.+A.+Harrisauthor=J.+Bertinauthor=M.+L.+Wang&title=Randomized+clinical+study+of+safety%2C+pharmacokinetics%2C+and+pharmacodynamics+of+RIPK1+inhibitor+GSK2982772+in+healthy+volunteers&doi=10.1002%2Fprp2.365"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fprp2.365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.365%26sid%3Dliteratum%253Aachs%26aulast%3DWeisel%26aufirst%3DK.%26aulast%3DScott%26aufirst%3DN.%2BE.%26aulast%3DTompson%26aufirst%3DD.%2BJ.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DMadhavan%26aufirst%3DS.%26aulast%3DPovey%26aufirst%3DK.%26aulast%3DWolstenholme%26aufirst%3DA.%26aulast%3DSimeoni%26aufirst%3DM.%26aulast%3DRudo%26aufirst%3DT.%26aulast%3DRichards-Peterson%26aufirst%3DL.%26aulast%3DSahota%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%2BG.%26aulast%3DLich%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DVerticelli%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.%2BL.%26atitle%3DRandomized%2520clinical%2520study%2520of%2520safety%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%2520of%2520RIPK1%2520inhibitor%2520GSK2982772%2520in%2520healthy%2520volunteers%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2017%26volume%3D5%26doi%3D10.1002%2Fprp2.365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Microglia-targeted candidates push the Alzheimer drug envelope</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fnrd.2018.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=29700495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=303-305&author=A.+Mullard&title=Microglia-targeted+candidates+push+the+Alzheimer+drug+envelope&doi=10.1038%2Fnrd.2018.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia-targeted candidates push the Alzheimer drug envelope</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">303-305</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Denali Therapeutics is taking a swing at neuroinflammation with a first-in-man trial of a RIPK1 inhibitor, while the company and others search for ways to target microglial biol. more precisely.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYpgRypRFIELVg90H21EOLACvtfcHk0liSrhrZ8Z3HNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgs7s%253D&md5=4a47cda8bae5e3142f21d97a0a2208af</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.65%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DMicroglia-targeted%2520candidates%2520push%2520the%2520Alzheimer%2520drug%2520envelope%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D303%26epage%3D305%26doi%3D10.1038%2Fnrd.2018.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Execution of RIPK3-regulated necrosis</span>. <i>Mol. Cell Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e960759</span> <span class="refDoi"> DOI: 10.4161/23723548.2014.960759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.4161%2F23723548.2014.960759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27308332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVart7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&author=Z.+Caiauthor=Z.+G.+Liu&title=Execution+of+RIPK3-regulated+necrosis&doi=10.4161%2F23723548.2014.960759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Execution of RIPK3-regulated necrosis</span></div><div class="casAuthors">Cai, Zhenyu; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e960759/1-e960759/7</span>CODEN:
                <span class="NLM_cas:coden">MCOOCO</span>;
        ISSN:<span class="NLM_cas:issn">2372-3556</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Necroptosis is a form of regulated necrotic cell death that is mediated by receptor-interacting protein 1 (RIP1) and RIP3 kinases.  Diverse receptors, including death receptors, Toll-like receptors, interferon receptors, and DAI DNA receptors are able to trigger necroptosis.  The newly identified MLKL protein functions downstream of RIP1/RIP3 and is essential for the execution of necroptosis.  Studies also indicate involvement of reactive oxygen species and calcium and sodium ions.  Identification of the key mediators of necroptosis is crit. for understanding the mol. mechanisms of the necroptotic process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt35ztg1n-rrVg90H21EOLACvtfcHk0liSrhrZ8Z3HNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVart7vN&md5=65d7f10e73fc3e518584c01f9ded2975</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.4161%2F23723548.2014.960759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F23723548.2014.960759%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DExecution%2520of%2520RIPK3-regulated%2520necrosis%26jtitle%3DMol.%2520Cell%2520Oncol.%26date%3D2014%26volume%3D1%26doi%3D10.4161%2F23723548.2014.960759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">Necroptosis-independent signaling by the RIP kinases in inflammation</span>. <i>Cell Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">2334</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2203-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1007%2Fs00018-016-2203-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27048814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=2325-2334&author=K.+Moriwakiauthor=F.+K.+Chan&title=Necroptosis-independent+signaling+by+the+RIP+kinases+in+inflammation&doi=10.1007%2Fs00018-016-2203-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis-independent signaling by the RIP kinases in inflammation</span></div><div class="casAuthors">Moriwaki, Kenta; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2325-2334</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Recent advances have identified a signaling cascade involving receptor interacting protein kinase 1 (RIPK1), RIPK3 and the pseudokinase mixed lineage kinase domain-like (MLKL) that is crucial for induction of necroptosis, a non-apoptotic form of cell death.  RIPK1-RIPK3-MLKL-mediated necroptosis has been attributed to cause many inflammatory diseases through the release of cellular damage-assocd. mol. patterns (DAMPs).  In addn. to necroptosis, emerging evidence suggests that these necroptosis signal adaptors can also facilitate inflammation independent of cell death.  In particular, the RIP kinases can drive NF-κB and inflammasome activation independent of cell death.  In this review, we will discuss recent discoveries that led to this realization and present arguments why cell death-independent signaling by the RIP kinases may have a more important role in inflammation than necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6wW0-uJ6xhbVg90H21EOLACvtfcHk0lgFrRnMrpITWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValurs%253D&md5=8ba1cc7565ca54604626eb5d030dce48</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2203-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2203-4%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DNecroptosis-independent%2520signaling%2520by%2520the%2520RIP%2520kinases%2520in%2520inflammation%26jtitle%3DCell%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D2325%26epage%3D2334%26doi%3D10.1007%2Fs00018-016-2203-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span> <span> </span><span class="NLM_article-title">Generation of small molecules to interfere with regulated necrosis</span>. <i>Cell Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2251</span>– <span class="NLM_lpage">2267</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2198-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1007%2Fs00018-016-2198-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27048812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=2251-2267&author=A.+Degterevauthor=A.+Linkermann&title=Generation+of+small+molecules+to+interfere+with+regulated+necrosis&doi=10.1007%2Fs00018-016-2198-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of small molecules to interfere with regulated necrosis</span></div><div class="casAuthors">Degterev, Alexei; Linkermann, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2251-2267</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Interference with regulated necrosis for clin. purposes carries broad therapeutic relevance and, if successfully achieved, has a potential to revolutionize everyday clin. routine.  Necrosis was interpreted as something that no clinician might ever be able to prevent due to the unregulated nature of this form of cell death.  However, given our growing understanding of the existence of regulated forms of necrosis and the roles of key enzymes of these pathways, e.g., kinases, peroxidases, etc., the possibility emerges to identify efficient and selective small mol. inhibitors of pathol. necrosis.  Here, we review the published literature on small mol. inhibition of regulated necrosis and provide an outlook on how combination therapy may be most effective in treatment of necrosis-assocd. clin. situations like stroke, myocardial infarction, sepsis, cancer and solid organ transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzrtP6mR8SDbVg90H21EOLACvtfcHk0lgFrRnMrpITWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValur0%253D&md5=24f31e0580cc6423dbf59063b51ae4c6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2198-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2198-x%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DLinkermann%26aufirst%3DA.%26atitle%3DGeneration%2520of%2520small%2520molecules%2520to%2520interfere%2520with%2520regulated%2520necrosis%26jtitle%3DCell%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D2251%26epage%3D2267%26doi%3D10.1007%2Fs00018-016-2198-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casillas, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley-Bauer, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roback, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carette, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocarski, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span> <span> </span><span class="NLM_article-title">RIP3 induces apoptosis independent of pronecrotic kinase activity</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.molcel.2014.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=25459880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2014&pages=481-495&author=P.+Mandalauthor=S.+B.+Bergerauthor=S.+Pillayauthor=K.+Moriwakiauthor=C.+Huangauthor=H.+Guoauthor=J.+D.+Lichauthor=J.+Fingerauthor=V.+Kasparcovaauthor=B.+Vottaauthor=M.+Ouelletteauthor=B.+W.+Kingauthor=D.+Wisnoskiauthor=A.+S.+Lakdawalaauthor=M.+P.+DeMartinoauthor=L.+N.+Casillasauthor=P.+A.+Haileauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Uptonauthor=L.+P.+Daley-Bauerauthor=L.+Robackauthor=N.+Ramiaauthor=C.+M.+Doveyauthor=J.+E.+Caretteauthor=F.+K.+Chanauthor=J.+Bertinauthor=P.+J.+Goughauthor=E.+S.+Mocarskiauthor=W.+J.+Kaiser&title=RIP3+induces+apoptosis+independent+of+pronecrotic+kinase+activity&doi=10.1016%2Fj.molcel.2014.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity</span></div><div class="casAuthors">Mandal, Pratyusha; Berger, Scott B.; Pillay, Sirika; Moriwaki, Kenta; Huang, Chunzi; Guo, Hongyan; Lich, John D.; Finger, Joshua; Kasparcova, Viera; Votta, Bart; Ouellette, Michael; King, Bryan W.; Wisnoski, David; Lakdawala, Ami S.; DeMartino, Michael P.; Casillas, Linda N.; Haile, Pamela A.; Sehon, Clark A.; Marquis, Robert W.; Upton, Jason; Daley-Bauer, Lisa P.; Roback, Linda; Ramia, Nancy; Dovey, Cole M.; Carette, Jan E.; Chan, Francis Ka-Ming; Bertin, John; Gough, Peter J.; Mocarski, Edward S.; Kaiser, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">481-495</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 3 (RIP3 or RIPK3) has emerged as a central player in necroptosis and a potential target to control inflammatory disease.  Here, three selective small-mol. compds. are shown to inhibit RIP3 kinase-dependent necroptosis, although their therapeutic value is undermined by a surprising, concn.-dependent induction of apoptosis.  These compds. interact with RIP3 to activate caspase 8 (Casp8) via RHIM-driven recruitment of RIP1 (RIPK1) to assemble a Casp8-FADD-cFLIP complex completely independent of pronecrotic kinase activities and MLKL.  RIP3 kinase-dead D161N mutant induces spontaneous apoptosis independent of compd., whereas D161G, D143N, and K51A mutants, like wild-type, only trigger apoptosis when compd. is present.  Accordingly, RIP3-K51A mutant mice (Rip3K51A/K51A) are viable and fertile, in stark contrast to the perinatal lethality of Rip3D161N/D161N mice.  RIP3 therefore holds both necroptosis and apoptosis in balance through a Ripoptosome-like platform.  This work highlights a common mechanism unveiling RHIM-driven apoptosis by therapeutic or genetic perturbation of RIP3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmaOmUttaymrVg90H21EOLACvtfcHk0lgFrRnMrpITWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsb%252FK&md5=43567ddc4cb1b78b17294118acb8a951</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DPillay%26aufirst%3DS.%26aulast%3DMoriwaki%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DOuellette%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DDeMartino%26aufirst%3DM.%2BP.%26aulast%3DCasillas%26aufirst%3DL.%2BN.%26aulast%3DHaile%26aufirst%3DP.%2BA.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DUpton%26aufirst%3DJ.%26aulast%3DDaley-Bauer%26aufirst%3DL.%2BP.%26aulast%3DRoback%26aufirst%3DL.%26aulast%3DRamia%26aufirst%3DN.%26aulast%3DDovey%26aufirst%3DC.%2BM.%26aulast%3DCarette%26aufirst%3DJ.%2BE.%26aulast%3DChan%26aufirst%3DF.%2BK.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DMocarski%26aufirst%3DE.%2BS.%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26atitle%3DRIP3%2520induces%2520apoptosis%2520independent%2520of%2520pronecrotic%2520kinase%2520activity%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D56%26spage%3D481%26epage%3D495%26doi%3D10.1016%2Fj.molcel.2014.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickliffe, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almagro, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komuves, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrando, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roose-Girma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warming, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1126/science.1249361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1126%2Fscience.1249361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24557836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=1357-1360&author=K.+Newtonauthor=D.+L.+Duggerauthor=K.+E.+Wickliffeauthor=N.+Kapoorauthor=M.+C.+de+Almagroauthor=D.+Vucicauthor=L.+Komuvesauthor=R.+E.+Ferrandoauthor=D.+M.+Frenchauthor=J.+Websterauthor=M.+Roose-Girmaauthor=S.+Warmingauthor=V.+M.+Dixit&title=Activity+of+protein+kinase+RIPK3+determines+whether+cells+die+by+necroptosis+or+apoptosis&doi=10.1126%2Fscience.1249361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis</span></div><div class="casAuthors">Newton, Kim; Dugger, Debra L.; Wickliffe, Katherine E.; Kapoor, Neeraj; de Almagro, M. Cristina; Vucic, Domagoj; Komuves, Laszlo; Ferrando, Ronald E.; French, Dorothy M.; Webster, Joshua; Roose-Girma, Merone; Warming, Soren; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6177</span>),
    <span class="NLM_cas:pages">1357-1360</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 1 (RIPK1) and RIPK3 trigger pro-inflammatory cell death termed "necroptosis.".  Studies with RIPK3-deficient mice or the RIPK1 inhibitor necrostatin-1 suggest that necroptosis exacerbates pathol. in many disease models.  We engineered mice expressing catalytically inactive RIPK3 D161N or RIPK1 D138N to det. the need for the active kinase in the whole animal.  Unexpectedly, RIPK3 D161N promoted lethal RIPK1- and caspase-8-dependent apoptosis.  In contrast, mice expressing RIPK1 D138N were viable and, like RIPK3-deficient mice, resistant to tumor necrosis factor (TNF)-induced hypothermia.  Cells expressing RIPK1 D138N were resistant to TNF-induced necroptosis, whereas TNF-induced signaling pathways promoting gene transcription were unperturbed.  Our data indicate that the kinase activity of RIPK3 is essential for necroptosis but also governs whether a cell activates caspase-8 and dies by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt_ux2V9rge7Vg90H21EOLACvtfcHk0lhjJRXO1iCoZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktl2gs7g%253D&md5=a07b82bee66bdc1fe471b15e3294792b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.1249361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1249361%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DDugger%26aufirst%3DD.%2BL.%26aulast%3DWickliffe%26aufirst%3DK.%2BE.%26aulast%3DKapoor%26aufirst%3DN.%26aulast%3Dde%2BAlmagro%26aufirst%3DM.%2BC.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DKomuves%26aufirst%3DL.%26aulast%3DFerrando%26aufirst%3DR.%2BE.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DWebster%26aufirst%3DJ.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DActivity%2520of%2520protein%2520kinase%2520RIPK3%2520determines%2520whether%2520cells%2520die%2520by%2520necroptosis%2520or%2520apoptosis%26jtitle%3DScience%26date%3D2014%26volume%3D343%26spage%3D1357%26epage%3D1360%26doi%3D10.1126%2Fscience.1249361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z. H.</span></span> <span> </span><span class="NLM_article-title">The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1278</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcddis.2014.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24901049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=J.+X.+Liauthor=J.+M.+Fengauthor=Y.+Wangauthor=X.+H.+Liauthor=X.+X.+Chenauthor=Y.+Suauthor=Y.+Y.+Shenauthor=Y.+Chenauthor=B.+Xiongauthor=C.+H.+Yangauthor=J.+Dingauthor=Z.+H.+Miao&title=The+B-Raf%28V600E%29+inhibitor+dabrafenib+selectively+inhibits+RIP3+and+alleviates+acetaminophen-induced+liver+injury&doi=10.1038%2Fcddis.2014.241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury</span></div><div class="casAuthors">Li, J.-X.; Feng, J-.M.; Wang, Y.; Li, X.-H.; Chen, X.-X.; Su, Y.; Shen, Y.-Y.; Chen, Y.; Xiong, B.; Yang, C.-H.; Ding, J.; Miao, Z.-H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1278</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Receptor-interacting protein (RIP)3 is a crit. regulator of necroptosis and has been demonstrated to be assocd. with various diseases, suggesting that its inhibitors are promising in the clinic.  However, there have been few RIP3 inhibitors reported as yet.  B-RafV600E inhibitors are an important anticancer drug class for metastatic melanoma therapy.  In this study, we found that 6 B-Raf inhibitors could inhibit RIP3 enzymic activity in vitro.  Among them, dabrafenib showed the most potent inhibition on RIP3, which was achieved by its ATP-competitive binding to the enzyme.  Dabrafenib displayed highly selective inhibition on RIP3 over RIP1, RIP2 and RIP5.  Moreover, only dabrafenib rescued cells from RIP3-mediated necroptosis induced by the necroptosis-induced combinations, i.e., tumor necrosis factor (TNF)α, TNF-related apoptosis-inducing ligand or Fas ligand plus Smac mimetic and the caspase inhibitor z-VAD.  Dabrafenib decreased the RIP3-mediated Ser358 phosphorylation of mixed lineage kinase domain-like protein (MLKL) and disrupted the interaction between RIP3 and MLKL.  Notably, RIP3 inhibition of dabrafenib appeared to be independent of its B-Raf inhibition.  Dabrafenib was further revealed to prevent acetaminophen-induced necrosis in normal human hepatocytes, which is considered to be mediated by RIP3.  In acetaminophen-overdosed mouse models, dabrafenib was found to apparently ease the acetaminophen-caused liver damage.  The results indicate that the anticancer B-RafV600E inhibitor dabrafenib is a RIP3 inhibitor, which could serve as a sharp tool for probing the RIP3 biol. and as a potential preventive or therapeutic agent for RIP3-involved necroptosis-related diseases such as acetaminophen-induced liver damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr40b524L_pOLVg90H21EOLACvtfcHk0lhjJRXO1iCoZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7o%253D&md5=a425dc91c461e5725d553428187db972</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.241%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BX.%26aulast%3DFeng%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DChen%26aufirst%3DX.%2BX.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%2BY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%2BH.%26atitle%3DThe%2520B-Raf%2528V600E%2529%2520inhibitor%2520dabrafenib%2520selectively%2520inhibits%2520RIP3%2520and%2520alleviates%2520acetaminophen-induced%2520liver%2520injury%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dwyer, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grippo, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, P. B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of mutated, activated BRAF in metastatic melanoma</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">819</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1002011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1056%2FNEJMoa1002011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=20818844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVyksb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=809-819&author=K.+T.+Flahertyauthor=I.+Puzanovauthor=K.+B.+Kimauthor=A.+Ribasauthor=G.+A.+McArthurauthor=J.+A.+Sosmanauthor=P.+J.+O%E2%80%99Dwyerauthor=R.+J.+Leeauthor=J.+F.+Grippoauthor=K.+Nolopauthor=P.+B.+Chapman&title=Inhibition+of+mutated%2C+activated+BRAF+in+metastatic+melanoma&doi=10.1056%2FNEJMoa1002011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of mutated, activated BRAF in metastatic melanoma</span></div><div class="casAuthors">Flaherty, Keith T.; Puzanov, Igor; Kim, Kevin B.; Ribas, Antoni; McArthur, Grant A.; Sosman, Jeffrey A.; O'dwyer, Peter J.; Lee, Richard J.; Grippo, Joseph F.; Nolop, Keith; Chapman, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">809-819</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: The identification of somatic mutations in the gene encoding the serine-threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to test oncogene-targeted therapy for this disease.  Methods: We conducted a multicenter, phase 1, dose-escalation trial of PLX4032 (also known as RG7204), an orally available inhibitor of mutated BRAF, followed by an extension phase involving the max. dose that could be administered without adverse effects (the recommended phase 2 dose).  Patients received PLX4032 twice daily until they had disease progression.  Pharmacokinetic anal. and tumor-response assessments were conducted in all patients.  In selected patients, tumor biopsy was performed before and during treatment to validate BRAF inhibition.  Results: A total of 55 patients (49 of whom had melanoma) were enrolled in the dose-escalation phase, and 32 addnl. patients with metastatic melanoma who had BRAF with the V600E mutation were enrolled in the extension phase.  The recommended phase 2 dose was 960 mg twice daily, with increases in the dose limited by grade 2 or 3 rash, fatigue, and arthralgia.  In the dose-escalation cohort, among the 16 patients with melanoma whose tumors carried the V600E BRAF mutation and who were receiving 240 mg or more of PLX4032 twice daily, 10 had a partial response and 1 had a complete response.  Among the 32 patients in the extension cohort, 24 had a partial response and 2 had a complete response.  The estd. median progression-free survival among all patients was more than 7 mo.  Conclusions: Treatment of metastatic melanoma with PLX4032 in patients with tumors that carry the V600E BRAF mutation resulted in complete or partial tumor regression in the majority of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwq1fkvEjfyLVg90H21EOLACvtfcHk0lhjJRXO1iCoZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVyksb3M&md5=80f70df0ac490828a42e6c7c0b40067f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1002011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1002011%26sid%3Dliteratum%253Aachs%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DO%25E2%2580%2599Dwyer%26aufirst%3DP.%2BJ.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26atitle%3DInhibition%2520of%2520mutated%252C%2520activated%2520BRAF%2520in%2520metastatic%2520melanoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D809%26epage%3D819%26doi%3D10.1056%2FNEJMoa1002011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span> <span> </span><span class="NLM_article-title">Necrosulfonamide inhibits necroptosis by selectively targeting the mixed lineage kinase domain-like protein</span>. <i>MedChemCommun</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1039/c3md00278k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1039%2Fc3md00278k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=333-337&author=D.+Liaoauthor=L.+Sunauthor=W.+Liuauthor=S.+Heauthor=X.+Wangauthor=X.+Lei&title=Necrosulfonamide+inhibits+necroptosis+by+selectively+targeting+the+mixed+lineage+kinase+domain-like+protein&doi=10.1039%2Fc3md00278k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fc3md00278k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00278k%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DX.%26atitle%3DNecrosulfonamide%2520inhibits%2520necroptosis%2520by%2520selectively%2520targeting%2520the%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%26jtitle%3DMedChemCommun%26date%3D2014%26volume%3D5%26spage%3D333%26epage%3D337%26doi%3D10.1039%2Fc3md00278k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-g.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-y.</span></span> <span> </span><span class="NLM_article-title">Identification of TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1111/bph.14653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1111%2Fbph.14653" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=X.+Chenauthor=C.+Zhuangauthor=Y.+Renauthor=H.+Zhangauthor=X.+Qinauthor=L.+Huauthor=J.+Fuauthor=Z.+Miaoauthor=Y.+Chaiauthor=Z.-g.+Liuauthor=H.+Zhangauthor=Z.+Caiauthor=H.-y.+Wang&title=Identification+of+TAK-632+and+its+analogues+as+potent+inhibitors+of+necroptosis+by+targeting+RIPK1+and+RIPK3&doi=10.1111%2Fbph.14653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fbph.14653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14653%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DChai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.-g.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.-y.%26atitle%3DIdentification%2520of%2520TAK-632%2520and%2520its%2520analogues%2520as%2520potent%2520inhibitors%2520of%2520necroptosis%2520by%2520targeting%2520RIPK1%2520and%2520RIPK3%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26doi%3D10.1111%2Fbph.14653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okaniwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tottori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a selective kinase inhibitor (TAK-632) targeting pan-RAF inhibition: design, synthesis, and biological evaluation of C-7-substituted 1,3-benzothiazole derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6478</span>– <span class="NLM_lpage">6494</span>, <span class="refDoi"> DOI: 10.1021/jm400778d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400778d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2qsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6478-6494&author=M.+Okaniwaauthor=M.+Hiroseauthor=T.+Aritaauthor=M.+Yabukiauthor=A.+Nakamuraauthor=T.+Takagiauthor=T.+Kawamotoauthor=N.+Uchiyamaauthor=A.+Sumitaauthor=S.+Tsutsumiauthor=T.+Tottoriauthor=Y.+Inuiauthor=B.+C.+Sangauthor=J.+Yanoauthor=K.+Aertgeertsauthor=S.+Yoshidaauthor=T.+Ishikawa&title=Discovery+of+a+selective+kinase+inhibitor+%28TAK-632%29+targeting+pan-RAF+inhibition%3A+design%2C+synthesis%2C+and+biological+evaluation+of+C-7-substituted+1%2C3-benzothiazole+derivatives&doi=10.1021%2Fjm400778d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives</span></div><div class="casAuthors">Okaniwa, Masanori; Hirose, Masaaki; Arita, Takeo; Yabuki, Masato; Nakamura, Akito; Takagi, Terufumi; Kawamoto, Tomohiro; Uchiyama, Noriko; Sumita, Akihiko; Tsutsumi, Shunichirou; Tottori, Tsuneaki; Inui, Yoshitaka; Sang, Bi-Ching; Yano, Jason; Aertgeerts, Kathleen; Yoshida, Sei; Ishikawa, Tomoyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6478-6494</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the aim of discovering a selective kinase inhibitor targeting pan-RAF kinase inhibition, we designed novel 1,3-benzothiazole derivs. based on our thiazolo[5,4-b]pyridine class RAF/VEGFR2 inhibitor and developed a regioselective cyclization methodol. for the C-7-substituted 1,3-benzothiazole scaffold utilizing meta-substituted anilines.  Eventually, we selected 7-cyano deriv. I (TAK-632) as a development candidate and confirmed its binding mode by cocrystal structure with BRAF.  Accommodation of the 7-cyano group into the BRAF-selectivity pocket and the 3-(trifluoromethyl)phenyl acetamide moiety into the hydrophobic back pocket of BRAF in the DFG-out conformation contributed to enhanced RAF potency and selectivity vs VEGFR2.  Reflecting its potent pan-RAF inhibition and slow off-rate profile, I demonstrated significant cellular activity against mutated BRAF or mutated NRAS cancer cell lines.  Furthermore, in both A375 (BRAFV600E) and HMVII (NRASQ61K) xenograft models in rats, I demonstrated regressive antitumor efficacy by twice daily, 14-day repetitive administration without significant body wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2jcxKx47lWLVg90H21EOLACvtfcHk0lg8z-CF_zGb7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2qsrzL&md5=60ccb75bcf7d7772cdf21468e26c141f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm400778d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400778d%26sid%3Dliteratum%253Aachs%26aulast%3DOkaniwa%26aufirst%3DM.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DArita%26aufirst%3DT.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DA.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DSumita%26aufirst%3DA.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DTottori%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DY.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520kinase%2520inhibitor%2520%2528TAK-632%2529%2520targeting%2520pan-RAF%2520inhibition%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520C-7-substituted%25201%252C3-benzothiazole%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6478%26epage%3D6494%26doi%3D10.1021%2Fjm400778d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donelan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouitar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carideo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okaniwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of the selective pan-RAF inhibitor TAK-632 in BRAF inhibitor-resistant melanoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7043</span>– <span class="NLM_lpage">7055</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1158%2F0008-5472.CAN-13-1825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24121489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=7043-7055&author=A.+Nakamuraauthor=T.+Aritaauthor=S.+Tsuchiyaauthor=J.+Donelanauthor=J.+Chouitarauthor=E.+Carideoauthor=K.+Galvinauthor=M.+Okaniwaauthor=T.+Ishikawaauthor=S.+Yoshida&title=Antitumor+activity+of+the+selective+pan-RAF+inhibitor+TAK-632+in+BRAF+inhibitor-resistant+melanoma&doi=10.1158%2F0008-5472.CAN-13-1825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma</span></div><div class="casAuthors">Nakamura, Akito; Arita, Takeo; Tsuchiya, Shuntarou; Donelan, Jill; Chouitar, Jouhara; Carideo, Elizabeth; Galvin, Katherine; Okaniwa, Masanori; Ishikawa, Tomoyasu; Yoshida, Sei</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7043-7055</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK) pathway is particularly important for the survival and proliferation of melanoma cells.  Somatic mutations in BRAF and NKAS are frequently obsd. in melanoma.  Recently, the BRAF inhibitors vemurafenib and dabrafenib have emerged as promising agents for the treatment of melanoma patients with BRAF-activating mutations.  Flowever, as BRAF inhibitors induce RAF paradoxical activation via RAF dimerization in BRAF wild-type cells, rapid emergence of acquired resistance and secondary skin tumors as well as presence of few effective treatment options for melanoma bearing wild- type BRAF (including NRAS-mutant melanoma) are clin. concerns.  Here, we demonstrate that the selective pan-RAF inhibitor TAK-632 suppresses RAF activity in BRAF wild-type cells with minimal RAF paradoxical activation.  Our anal. using RNAi and TAK-632 in preclin. models reveals that the MAPK pathway of NRAS-mutated melanoma cells is highly dependent on RAF.  We also show that TAK-632 induces RAF dimerization but inhibits the kinase activity of the RAF dimer, probably because of its slow dissocn. from RAF.  As a result, TAK-632 demonstrates potent antiproliferative effects both on NRAS-mutated melanoma cells and BRAF-mutated melanoma cells with acquired resistance to BRAF inhibitors through NRAS mutation or BRAF truncation.  Furthermore, we demonstrate that the combination of TAK-632 and the MAPK kinase (MEK) inhibitor TAK-733 exhibits synergistic antiproliferative effects on these cells.  Our findings characterize the unique features of TAK-632 as a pan-RAF inhibitor and provide rationale for its further investigation in NRAS-mutated melanoma and a subset of BRAF-mutated melanomas refractory to BRAF inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1LknpOlxiFrVg90H21EOLACvtfcHk0lg8z-CF_zGb7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77L&md5=beeec0a6c53216a97762c91af9df8c0e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1825%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DA.%26aulast%3DArita%26aufirst%3DT.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DDonelan%26aufirst%3DJ.%26aulast%3DChouitar%26aufirst%3DJ.%26aulast%3DCarideo%26aufirst%3DE.%26aulast%3DGalvin%26aufirst%3DK.%26aulast%3DOkaniwa%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DS.%26atitle%3DAntitumor%2520activity%2520of%2520the%2520selective%2520pan-RAF%2520inhibitor%2520TAK-632%2520in%2520BRAF%2520inhibitor-resistant%2520melanoma%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D7043%26epage%3D7055%26doi%3D10.1158%2F0008-5472.CAN-13-1825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Najjar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suebsuwong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thapa, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogusa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span> <span> </span><span class="NLM_article-title">Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1850</span>– <span class="NLM_lpage">1860</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.celrep.2015.02.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=25801024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1850-1860&author=M.+Najjarauthor=C.+Suebsuwongauthor=S.+S.+Rayauthor=R.+J.+Thapaauthor=J.+L.+Makiauthor=S.+Nogusaauthor=S.+Shahauthor=D.+Salehauthor=P.+J.+Goughauthor=J.+Bertinauthor=J.+Yuanauthor=S.+Balachandranauthor=G.+D.+Cunyauthor=A.+Degterev&title=Structure+guided+design+of+potent+and+selective+ponatinib-based+hybrid+inhibitors+for+RIPK1&doi=10.1016%2Fj.celrep.2015.02.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1</span></div><div class="casAuthors">Najjar, Malek; Suebsuwong, Chalada; Ray, Soumya S.; Thapa, Roshan J.; Maki, Jenny L.; Nogusa, Shoko; Shah, Saumil; Saleh, Danish; Gough, Peter J.; Bertin, John; Yuan, Junying; Balachandran, Siddharth; Cuny, Gregory D.; Degterev, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1850-1860</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIPK1 and RIPK3, two closely related RIPK family members, have emerged as important regulators of pathol. cell death and inflammation.  In the current work, we report that the Bcr-Abl inhibitor and anti-leukemia agent ponatinib is also a first-in-class dual inhibitor of RIPK1 and RIPK3.  Ponatinib potently inhibited multiple paradigms of RIPK1- and RIPK3-dependent cell death and inflammatory tumor necrosis factor alpha (TNF-α) gene transcription.  We further describe design strategies that utilize the ponatinib scaffold to develop two classes of inhibitors (CS and PN series), each with greatly improved selectivity for RIPK1.  In particular, we detail the development of PN10, a highly potent and selective "hybrid" RIPK1 inhibitor, capturing the best properties of two different allosteric RIPK1 inhibitors, ponatinib and necrostatin-1.  Finally, we show that RIPK1 inhibitors from both classes are powerful blockers of TNF-induced injury in vivo.  Altogether, these findings outline promising candidate mols. and design approaches for targeting RIPK1- and RIPK3-driven inflammatory pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUQJThkEIWBbVg90H21EOLACvtfcHk0lgqw3N74xnDZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVWktro%253D&md5=c13215958ddcca5a685a4d1e82a96560</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DNajjar%26aufirst%3DM.%26aulast%3DSuebsuwong%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DThapa%26aufirst%3DR.%2BJ.%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DNogusa%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DSaleh%26aufirst%3DD.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DBalachandran%26aufirst%3DS.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DDegterev%26aufirst%3DA.%26atitle%3DStructure%2520guided%2520design%2520of%2520potent%2520and%2520selective%2520ponatinib-based%2520hybrid%2520inhibitors%2520for%2520RIPK1%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D10%26spage%3D1850%26epage%3D1860%26doi%3D10.1016%2Fj.celrep.2015.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauster, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigenzahn, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stukalov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardeau, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gridling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parapatics, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colinge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubicek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span> <span> </span><span class="NLM_article-title">A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1767</span> <span class="refDoi"> DOI: 10.1038/cddis.2015.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcddis.2015.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=25996294" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=A.+Fausterauthor=M.+Rebsamenauthor=K.+V.+Huberauthor=J.+W.+Bigenzahnauthor=A.+Stukalovauthor=C.+H.+Lardeauauthor=S.+Scorzoniauthor=M.+Brucknerauthor=M.+Gridlingauthor=K.+Parapaticsauthor=J.+Colingeauthor=K.+L.+Bennettauthor=S.+Kubicekauthor=S.+Krautwaldauthor=A.+Linkermannauthor=G.+Superti-Furga&title=A+cellular+screen+identifies+ponatinib+and+pazopanib+as+inhibitors+of+necroptosis&doi=10.1038%2Fcddis.2015.130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2015.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2015.130%26sid%3Dliteratum%253Aachs%26aulast%3DFauster%26aufirst%3DA.%26aulast%3DRebsamen%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DK.%2BV.%26aulast%3DBigenzahn%26aufirst%3DJ.%2BW.%26aulast%3DStukalov%26aufirst%3DA.%26aulast%3DLardeau%26aufirst%3DC.%2BH.%26aulast%3DScorzoni%26aufirst%3DS.%26aulast%3DBruckner%26aufirst%3DM.%26aulast%3DGridling%26aufirst%3DM.%26aulast%3DParapatics%26aufirst%3DK.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DKubicek%26aufirst%3DS.%26aulast%3DKrautwald%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26atitle%3DA%2520cellular%2520screen%2520identifies%2520ponatinib%2520and%2520pazopanib%2520as%2520inhibitors%2520of%2520necroptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fcddis.2015.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonnus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e2904</span> <span class="refDoi"> DOI: 10.1038/cddis.2017.298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcddis.2017.298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=28661484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=S.+Martensauthor=M.+Jeongauthor=W.+Tonnusauthor=F.+Feldmannauthor=S.+Hofmansauthor=V.+Goossensauthor=N.+Takahashiauthor=J.+H.+Brasenauthor=E.+W.+Leeauthor=P.+Van+der+Vekenauthor=J.+Joossensauthor=K.+Augustynsauthor=S.+Fuldaauthor=A.+Linkermannauthor=J.+Songauthor=P.+Vandenabeele&title=Sorafenib+tosylate+inhibits+directly+necrosome+complex+formation+and+protects+in+mouse+models+of+inflammation+and+tissue+injury&doi=10.1038%2Fcddis.2017.298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury</span></div><div class="casAuthors">Martens, Sofie; Jeong, Manhyung; Tonnus, Wulf; Feldmann, Friederike; Hofmans, Sam; Goossens, Vera; Takahashi, Nozomi; Brasen, Jan Hinrich; Lee, Eun-Woo; Van der Veken, Pieter; Joossens, Jurgen; Augustyns, Koen; Fulda, Simone; Linkermann, Andreas; Song, Jaewhan; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e2904</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis contributes to the pathophysiol. of several inflammatory, infectious and degenerative disorders.  TNF-induced necroptosis involves activation of the receptor-interacting protein kinases 1 and 3 (RIPK1/3) in a necrosome complex, eventually leading to the phosphorylation and relocation of mixed lineage kinase domain like protein (MLKL).  Using a high-content screening of small compds. and FDA-approved drug libraries, we identified the anti-cancer drug Sorafenib tosylate as a potent inhibitor of TNF-dependent necroptosis.  Interestingly, Sorafenib has a dual activity spectrum depending on its concn.  In murine and human cell lines it induces cell death, while at lower concns. it inhibits necroptosis, without affecting NF-κB activation.  Pull down expts. with biotinylated Sorafenib show that it binds independently RIPK1, RIPK3 and MLKL.  Moreover, it inhibits RIPK1 and RIPK3 kinase activity.  In vivo Sorafenib protects against TNF-induced systemic inflammatory response syndrome (SIRS) and renal ischemia-reperfusion injury (IRI).  Altogether, we show that Sorafenib can, next to the reported Braf/Mek/Erk and VEGFR pathways, also target the necroptotic pathway and that it can protect in an acute inflammatory RIPK1/3-mediated pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfswPD82jd67Vg90H21EOLACvtfcHk0lgqw3N74xnDZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7nO&md5=bb4e411a5d4a9a76e2a52d84075ddb3c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.298%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DM.%26aulast%3DTonnus%26aufirst%3DW.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DE.%2BW.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DSorafenib%2520tosylate%2520inhibits%2520directly%2520necrosome%2520complex%2520formation%2520and%2520protects%2520in%2520mouse%2520models%2520of%2520inflammation%2520and%2520tissue%2520injury%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fcddis.2017.298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural insights into RIP3-mediated necroptotic signaling</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2013.08.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.celrep.2013.08.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24095729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=70-78&author=T.+Xieauthor=W.+Pengauthor=C.+Yanauthor=J.+Wuauthor=X.+Gongauthor=Y.+Shi&title=Structural+insights+into+RIP3-mediated+necroptotic+signaling&doi=10.1016%2Fj.celrep.2013.08.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights into RIP3-Mediated Necroptotic Signaling</span></div><div class="casAuthors">Xie, Tian; Peng, Wei; Yan, Chuangye; Wu, Jianping; Gong, Xinqi; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-78</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIP3 is an essential upstream kinase in necroptosis.  The pseudokinase MLKL functions as a substrate of RIP3 to mediate downstream signaling.  The mol. mechanism by which RIP3 recognizes and phosphorylates MLKL remains unknown.  Here, we report the crystal structures of the mouse RIP3 kinase domain, the MLKL kinase-like domain, and a binary complex between the two.  Both RIP3 and MLKL adopt the canonical kinase fold.  Free RIP3 exists in an active conformation, whereas MLKL-bound RIP3 is stabilized by AMP-PNP to adopt an inactive conformation.  The formation of the RIP3-MLKL complex, involving their resp. N- and C-lobes, is accompanied by pronounced conformational changes of the αC helix and activation loop in RIP3 and the corresponding structural elements in MLKL.  RIP3-mediated MLKL phosphorylation, though important for downstream signaling, is dispensable for stable complex formation between RIP3 and MLKL.  Our study serves as a framework for mechanistic understanding of RIP3-mediated necroptotic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7R60YS-0cP7Vg90H21EOLACvtfcHk0lgDXrPq-ji7Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrL&md5=53fa2aefe1223dfca855a95d28e5d478</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.08.044%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520insights%2520into%2520RIP3-mediated%2520necroptotic%2520signaling%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D5%26spage%3D70%26epage%3D78%26doi%3D10.1016%2Fj.celrep.2013.08.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savadkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunk, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaboh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diskin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundeyin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinwand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochen Rossi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aykut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glacken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevaraja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adeegbe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almonte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagdatlioglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G.</span></span> <span> </span><span class="NLM_article-title">RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">757</span>– <span class="NLM_lpage">774</span>, e757 <span class="refDoi"> DOI: 10.1016/j.ccell.2018.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.ccell.2018.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=30423296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOisLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=757-774&author=W.+Wangauthor=J.+M.+Marinisauthor=A.+M.+Bealauthor=S.+Savadkarauthor=Y.+Wuauthor=M.+Khanauthor=P.+S.+Taunkauthor=N.+Wuauthor=W.+Suauthor=J.+Wuauthor=A.+Ahsanauthor=E.+Kurzauthor=T.+Chenauthor=I.+Yabohauthor=F.+Liauthor=J.+Gutierrezauthor=B.+Diskinauthor=M.+Hundeyinauthor=M.+Reillyauthor=J.+D.+Lichauthor=P.+A.+Harrisauthor=M.+K.+Mahajanauthor=J.+H.+Thorpeauthor=P.+Nassauauthor=J.+E.+Mosleyauthor=J.+Leinwandauthor=J.+A.+Kochen+Rossiauthor=A.+Mishraauthor=B.+Aykutauthor=M.+Glackenauthor=A.+Ochiauthor=N.+Vermaauthor=J.+I.+Kimauthor=V.+Vasudevarajaauthor=D.+Adeegbeauthor=C.+Almonteauthor=E.+Bagdatliogluauthor=D.+J.+Cohenauthor=K.+K.+Wongauthor=J.+Bertinauthor=G.+Miller&title=RIP1+kinase+drives+macrophage-mediated+adaptive+immune+tolerance+in+pancreatic+cancer&doi=10.1016%2Fj.ccell.2018.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer</span></div><div class="casAuthors">Wang, Wei; Marinis, Jill M.; Beal, Allison M.; Savadkar, Shivraj; Wu, Yue; Khan, Mohammed; Taunk, Pardeep S.; Wu, Nan; Su, Wenyu; Wu, Jingjing; Ahsan, Aarif; Kurz, Emma; Chen, Ting; Yaboh, Inedouye; Li, Fei; Gutierrez, Johana; Diskin, Brian; Hundeyin, Mautin; Reilly, Michael; Lich, John D.; Harris, Philip A.; Mahajan, Mukesh K.; Thorpe, James H.; Nassau, Pamela; Mosley, Julie E.; Leinwand, Joshua; Kochen Rossi, Juan A.; Mishra, Ankita; Aykut, Berk; Glacken, Michael; Ochi, Atsuo; Verma, Narendra; Kim, Jacqueline I.; Vasudevaraja, Varshini; Adeegbe, Dennis; Almonte, Christina; Bagdatlioglu, Ece; Cohen, Deirdre J.; Wong, Kwok-Kin; Bertin, John; Miller, George</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">757-774.e7</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and immunotherapeutic resistance.  We discovered upregulation of receptor-interacting serine/threonine protein kinase 1 (RIP1) in tumor-assocd. macrophages (TAMs) in PDA.  To study its role in oncogenic progression, we developed a selective small-mol. RIP1 inhibitor with high in vivo exposure.  Targeting RIP1 reprogrammed TAMs toward an MHCIIhiTNFα+IFNγ+ immunogenic phenotype in a STAT1-dependent manner.  RIP1 inhibition in TAMs resulted in cytotoxic T cell activation and T helper cell differentiation toward a mixed Th1/Th17 phenotype, leading to tumor immunity in mice and in organotypic models of human PDA.  Targeting RIP1 synergized with PD1-and inducible co-stimulator-based immunotherapies.  Tumor-promoting effects of RIP1 were independent of its co-assocn. with RIP3.  Collectively, our work describes RIP1 as a checkpoint kinase governing tumor immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDOuua4gAvrLVg90H21EOLACvtfcHk0lgDXrPq-ji7Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOisLfO&md5=9210358fa2dbb4da0d0981e84ac696f9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMarinis%26aufirst%3DJ.%2BM.%26aulast%3DBeal%26aufirst%3DA.%2BM.%26aulast%3DSavadkar%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DTaunk%26aufirst%3DP.%2BS.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DAhsan%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYaboh%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DGutierrez%26aufirst%3DJ.%26aulast%3DDiskin%26aufirst%3DB.%26aulast%3DHundeyin%26aufirst%3DM.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DMahajan%26aufirst%3DM.%2BK.%26aulast%3DThorpe%26aufirst%3DJ.%2BH.%26aulast%3DNassau%26aufirst%3DP.%26aulast%3DMosley%26aufirst%3DJ.%2BE.%26aulast%3DLeinwand%26aufirst%3DJ.%26aulast%3DKochen%2BRossi%26aufirst%3DJ.%2BA.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DAykut%26aufirst%3DB.%26aulast%3DGlacken%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BI.%26aulast%3DVasudevaraja%26aufirst%3DV.%26aulast%3DAdeegbe%26aufirst%3DD.%26aulast%3DAlmonte%26aufirst%3DC.%26aulast%3DBagdatlioglu%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DD.%2BJ.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DG.%26atitle%3DRIP1%2520kinase%2520drives%2520macrophage-mediated%2520adaptive%2520immune%2520tolerance%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D34%26spage%3D757%26epage%3D774%26doi%3D10.1016%2Fj.ccell.2018.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breslin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kini, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1165</span>, <span class="refDoi"> DOI: 10.1038/leu.2016.287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fleu.2016.287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27748372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCjt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=1154-1165&author=J.+Xinauthor=D.+Youauthor=P.+Breslinauthor=J.+Liauthor=J.+Zhangauthor=W.+Weiauthor=J.+Cannovaauthor=A.+Volkauthor=R.+Gutierrezauthor=Y.+Xiaoauthor=A.+Niauthor=G.+Ngauthor=R.+Schmidtauthor=Z.+Xiaauthor=J.+Panauthor=H.+Chenauthor=M.+M.+Patelauthor=P.+C.+Kuoauthor=S.+Nandauthor=A.+R.+Kiniauthor=J.+Zhangauthor=J.+Chenauthor=J.+Zhuauthor=J.+Zhang&title=Sensitizing+acute+myeloid+leukemia+cells+to+induced+differentiation+by+inhibiting+the+RIP1%2FRIP3+pathway&doi=10.1038%2Fleu.2016.287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway</span></div><div class="casAuthors">Xin, J.; You, D.; Breslin, P.; Li, J.; Zhang, J.; Wei, W.; Cannova, J.; Volk, A.; Gutierrez, R.; Xiao, Y.; Ni, A.; Ng, G.; Schmidt, R.; Xia, Z.; Pan, J.; Chen, H.; Patel, M. M.; Kuo, P. C.; Nand, S.; Kini, A. R.; Zhang, J.; Chen, J.; Zhu, J.; Zhang, J.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1154-1165</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor-α (TNF-α)-induced RIP1/RIP3 (receptor-interacting protein kinase 1/receptor-interacting protein kinase 3)-mediated necroptosis has been proposed as an alternative strategy for treating apoptosis-resistant leukemia.  However, we found that most acute myeloid leukemia (AML) cells, esp. M4 and M5 subtypes, produce TNF and show basal level activation of RIP1/RIP3/MLKL signaling, yet do not undergo necroptosis.  TNF, through RIP1/RIP3 signaling, prevents degrdn. of SOCS1, a key neg. regulator of interferon-γ (IFN-γ) signaling.  Using both pharmacol. and genetic assays, we show here that inactivation of RIP1/RIP3 resulted in redn. of SOCS1 protein levels and partial differentiation of AML cells.  AML cells with inactivated RIP1/RIP3 signaling show increased sensitivity to IFN-γ-induced differentiation.  RIP1/RIP3 inactivation combined with IFN-γ treatment significantly attenuated the clonogenic capacity of both primary AML cells and AML cell lines.  This combination treatment also compromised the leukemogenic ability of murine AML cells in vivo.  Our studies suggest that inhibition of RIP1/RIP3-mediated necroptotic signaling might be a novel strategy for the treatment of AML when combined with other differentiation inducers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo12Vhh4iOPv7Vg90H21EOLACvtfcHk0ljUwJdDjHr4RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCjt7fP&md5=f7a9bd4c110a2ee97a63a83257f23a39</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fleu.2016.287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2016.287%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DD.%26aulast%3DBreslin%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DCannova%26aufirst%3DJ.%26aulast%3DVolk%26aufirst%3DA.%26aulast%3DGutierrez%26aufirst%3DR.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DM.%2BM.%26aulast%3DKuo%26aufirst%3DP.%2BC.%26aulast%3DNand%26aufirst%3DS.%26aulast%3DKini%26aufirst%3DA.%2BR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DSensitizing%2520acute%2520myeloid%2520leukemia%2520cells%2520to%2520induced%2520differentiation%2520by%2520inhibiting%2520the%2520RIP1%252FRIP3%2520pathway%26jtitle%3DLeukemia%26date%3D2017%26volume%3D31%26spage%3D1154%26epage%3D1165%26doi%3D10.1038%2Fleu.2016.287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective effect of swertiamain on cerebral ischemia/reperfusion injury by inducing the Nrf2 protective pathway</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">2276</span>– <span class="NLM_lpage">2286</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVWnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=2276-2286&author=H.+Wangauthor=W.+Weiauthor=X.+Lanauthor=N.+Liuauthor=Y.+Liauthor=H.+Maauthor=T.+Sunauthor=X.+Pengauthor=C.+Zhuangauthor=J.+Yu&title=Neuroprotective+effect+of+swertiamain+on+cerebral+ischemia%2Freperfusion+injury+by+inducing+the+Nrf2+protective+pathway&doi=10.1021%2Facschemneuro.8b00605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective Effect of Swertiamarin on Cerebral Ischemia/Reperfusion Injury by Inducing the Nrf2 Protective Pathway</span></div><div class="casAuthors">Wang, Hui; Wei, Wei; Lan, Xiaobing; Liu, Ning; Li, Yuxiang; Ma, Hanxiang; Sun, Tao; Peng, Xiaodong; Zhuang, Chunlin; Yu, Jianqiang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2276-2286</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxidative stress plays a vital role in the development of cerebral ischemic/reperfusion (I/R).  Targeting oxidative stress is proposed to be an effective strategy to treat cerebral I/R injury.  Gentiana macrophylla Pall is reported to have a potential protective effect against stroke.  Swertiamarin (Swe), an active secoiridoid glycoside compd. isolated from Gentiana macrophylla Pall, has been reported to possess antioxidative potential.  This study is to explore whether Swe could prevent brain from I/R injury, and the related mechanisms of oxidative stress are also elucidated using mice middle cerebral artery occlusion (MCAO) model and primary hippocampal neurons oxygen-glucose deprivation/reperfusion (OGD/R) model.  Swe (25, 100, or 400 mg/kg) was pretreated i.p. for 7 days until establishment of the MCAO model, while hippocampal neurons were maintained in Swe (0.1, 1, or 10μM) in the entire process of reoxygenation.  The results indicated that Swe pretreatment markedly decreased infarct vol., apoptotic neurons, and oxidative damage and promoted neurol. recovery in vivo.  It also decreased reactive oxygen species (ROS) and increased cell viability in vitro.  Western blot analyses and immunofluorescence staining demonstrated that Swe pretreatment promoted Nrf2 nuclear translocation from Keap1-Nrf2 complex and enhanced the expressions of NAD(P)H: quinone oxidoreductase-1 (NQO1) and heme oxygenase-1 (HO-1) both in vivo and in vitro, while the expressions could be reversed by a Nrf2 inhibitor.  The binding mode of Keap1 with Swe was also proposed by covalent mol. docking.  Collectively, Swe could be considered as a promising protective agent against cerebral I/R injury through suppressing oxidative stress by activation of the Nrf2 protective pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoijWw6jeubobVg90H21EOLACvtfcHk0ljUwJdDjHr4RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVWnu74%253D&md5=f705a34e402466b5c5a63cfbb87ead7d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00605%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DNeuroprotective%2520effect%2520of%2520swertiamain%2520on%2520cerebral%2520ischemia%252Freperfusion%2520injury%2520by%2520inducing%2520the%2520Nrf2%2520protective%2520pathway%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26spage%3D2276%26epage%3D2286%26doi%3D10.1021%2Facschemneuro.8b00605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanapillai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span> <span> </span><span class="NLM_article-title">Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1126</span>, <span class="refDoi"> DOI: 10.1021/jm4017174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4017174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1121-1126&author=C.+Zhuangauthor=S.+Narayanapillaiauthor=W.+Zhangauthor=Y.+Y.+Shamauthor=C.+Xing&title=Rapid+identification+of+Keap1-Nrf2+small-molecule+inhibitors+through+structure-based+virtual+screening+and+hit-based+substructure+search&doi=10.1021%2Fjm4017174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Identification of Keap1-Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search</span></div><div class="casAuthors">Zhuang, Chunlin; Narayanapillai, Sreekanth; Zhang, Wannian; Sham, Yuk Yin; Xing, Chengguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1121-1126</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, rapid structure-based virtual screening and hit-based substructure search were utilized to identify small mols. that disrupt the interaction of Keap1-Nrf2.  Special emphasis was placed toward maximizing the exploration of chem. diversity of the initial hits while economically establishing informative structure-activity relationship (SAR) of novel scaffolds.  Our most potent noncovalent inhibitor exhibits three times improved cellular activation in Nrf2 activation than the most active noncovalent Keap1 inhibitor known to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRWjo_56WOF7Vg90H21EOLACvtfcHk0ljUwJdDjHr4RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVemsA%253D%253D&md5=dcf9d53a0fb18363c6e47b8077c350b9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm4017174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4017174%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DNarayanapillai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DXing%26aufirst%3DC.%26atitle%3DRapid%2520identification%2520of%2520Keap1-Nrf2%2520small-molecule%2520inhibitors%2520through%2520structure-based%2520virtual%2520screening%2520and%2520hit-based%2520substructure%2520search%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1121%26epage%3D1126%26doi%3D10.1021%2Fjm4017174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chunlin Zhuang, <span class="NLM_string-name hlFld-ContribAuthor">Fener Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 1490-1510. <a href="https://doi.org/10.1021/acs.jmedchem.9b01317" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01317%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BNecroptosis%25253A%252BCurrent%252BStatus%252Band%252BPerspectives%26aulast%3DZhuang%26aufirst%3DChunlin%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D11082019%26date%3D31102019%26date%3D17102019%26volume%3D63%26issue%3D4%26spage%3D1490%26epage%3D1510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhuo  Qu</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Huang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Xu</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantiomeric profiling of a chiral benzothiazole necroptosis inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>43 </em>, 128084. <a href="https://doi.org/10.1016/j.bmcl.2021.128084" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128084%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEnantiomeric%252Bprofiling%252Bof%252Ba%252Bchiral%252Bbenzothiazole%252Bnecroptosis%252Binhibitor%26aulast%3DZhu%26aufirst%3DJing%26date%3D2021%26volume%3D43%26spage%3D128084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuwei  Wu</span>, <span class="hlFld-ContribAuthor ">Chen  Xu</span>, <span class="hlFld-ContribAuthor ">Kaijiang  Xia</span>, <span class="hlFld-ContribAuthor ">Yu  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Yuting  Ji</span>, <span class="hlFld-ContribAuthor ">Fang  Zhu</span>, <span class="hlFld-ContribAuthor ">Sudan  He</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Ring closure strategy leads to potent RIPK3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>217 </em>, 113327. <a href="https://doi.org/10.1016/j.ejmech.2021.113327" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113327%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRing%252Bclosure%252Bstrategy%252Bleads%252Bto%252Bpotent%252BRIPK3%252Binhibitors%26aulast%3DWu%26aufirst%3DShuwei%26date%3D2021%26volume%3D217%26spage%3D113327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhennan  Fang</span>, <span class="hlFld-ContribAuthor ">Huiqiang  Wei</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Gou</span>, <span class="hlFld-ContribAuthor ">Leyuan  Chen</span>, <span class="hlFld-ContribAuthor ">Changfen  Bi</span>, <span class="hlFld-ContribAuthor ">Wenbin  Hou</span>, <span class="hlFld-ContribAuthor ">Yiliang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in small-molecule inhibitors for critical therapeutic targets of necroptosis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (9)
                                     , 817-837. <a href="https://doi.org/10.4155/fmc-2020-0386" title="DOI URL">https://doi.org/10.4155/fmc-2020-0386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0386%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Bsmall-molecule%252Binhibitors%252Bfor%252Bcritical%252Btherapeutic%252Btargets%252Bof%252Bnecroptosis%26aulast%3DFang%26aufirst%3DZhennan%26date%3D2021%26volume%3D13%26issue%3D9%26spage%3D817%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Zhu</span>, <span class="hlFld-ContribAuthor ">Meng  Xin</span>, <span class="hlFld-ContribAuthor ">Congcong  Xu</span>, <span class="hlFld-ContribAuthor ">Yuan  He</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhibin  Wang</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>184 </em><a href="https://doi.org/10.1016/j.apsb.2021.05.017" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.05.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.05.017%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DLigand-based%252Bsubstituent-anchoring%252Bdesign%252Bof%252Bselective%252Breceptor-interacting%252Bprotein%252Bkinase%252B1%252Bnecroptosis%252Binhibitors%252Bfor%252Bulcerative%252Bcolitis%252Btherapy%26aulast%3DZhu%26aufirst%3DJing%26date%3D2021%26volume%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Ma</span>, <span class="hlFld-ContribAuthor ">Jiaxuan  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengguang  Yao</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Lichao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhibin  Wang</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113030. <a href="https://doi.org/10.1016/j.ejmech.2020.113030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbardoxolone%252Bderivatives%252Bas%252Bnovel%252Borally%252Bactive%252Bnecroptosis%252Binhibitors%26aulast%3DWang%26aufirst%3DYuanyuan%26date%3D2021%26volume%3D212%26spage%3D113030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory D.  Cuny</span>, <span class="hlFld-ContribAuthor ">Alexei  Degterev</span>. </span><span class="cited-content_cbyCitation_article-title">RIPK protein kinase family: Atypical lives of typical kinases. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cell & Developmental Biology</span><span> <strong>2021,</strong> <em>109 </em>, 96-105. <a href="https://doi.org/10.1016/j.semcdb.2020.06.014" title="DOI URL">https://doi.org/10.1016/j.semcdb.2020.06.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcdb.2020.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcdb.2020.06.014%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cell%2520%2526%2520Developmental%2520Biology%26atitle%3DRIPK%252Bprotein%252Bkinase%252Bfamily%25253A%252BAtypical%252Blives%252Bof%252Btypical%252Bkinases%26aulast%3DCuny%26aufirst%3DGregory%2BD.%26date%3D2021%26volume%3D109%26spage%3D96%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaijiang  Xia</span>, <span class="hlFld-ContribAuthor ">Fang  Zhu</span>, <span class="hlFld-ContribAuthor ">Chengkui  Yang</span>, <span class="hlFld-ContribAuthor ">Shuwei  Wu</span>, <span class="hlFld-ContribAuthor ">Yu  Lin</span>, <span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Yu</span>, <span class="hlFld-ContribAuthor ">Cong  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuting  Ji</span>, <span class="hlFld-ContribAuthor ">Wenxiang  Ge</span>, <span class="hlFld-ContribAuthor ">Jingrui  Wang</span>, <span class="hlFld-ContribAuthor ">Yayun  Du</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>, <span class="hlFld-ContribAuthor ">Sudan  He</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fcell.2020.606119" title="DOI URL">https://doi.org/10.3389/fcell.2020.606119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2020.606119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2020.606119%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BRIPK3%252BInhibitor%252Bfor%252Bthe%252BAmelioration%252Bof%252BNecroptosis-Associated%252BInflammatory%252BInjury%26aulast%3DXia%26aufirst%3DKaijiang%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Wu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting necroptosis in anticancer therapy: mechanisms and modulators. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 1601-1618. <a href="https://doi.org/10.1016/j.apsb.2020.01.007" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.01.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.01.007%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTargeting%252Bnecroptosis%252Bin%252Banticancer%252Btherapy%25253A%252Bmechanisms%252Band%252Bmodulators%26aulast%3DWu%26aufirst%3DYing%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D1601%26epage%3D1618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Qin</span>, <span class="hlFld-ContribAuthor ">Longmiao  Hu</span>, <span class="hlFld-ContribAuthor ">Shen-nan  Shi</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Chen</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Wen  Zhang</span>, <span class="hlFld-ContribAuthor ">Siriporn  Jitkaew</span>, <span class="hlFld-ContribAuthor ">Xiufeng  Pang</span>, <span class="hlFld-ContribAuthor ">Jianqiang  Yu</span>, <span class="hlFld-ContribAuthor ">Ye-xiong  Tan</span>, <span class="hlFld-ContribAuthor ">Hong-yang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenyu  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>, 113947. <a href="https://doi.org/10.1016/j.bcp.2020.113947" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.113947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.113947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.113947%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DThe%252BBcr-Abl%252Binhibitor%252BGNF-7%252Binhibits%252Bnecroptosis%252Band%252Bameliorates%252Bacute%252Bkidney%252Binjury%252Bby%252Btargeting%252BRIPK1%252Band%252BRIPK3%252Bkinases%26aulast%3DQin%26aufirst%3DXia%26date%3D2020%26volume%3D177%26spage%3D113947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative known necroptosis inhibitors targeting RIPK1, RIPK3, or MLKL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaBH<sub>4</sub>, EtOH/MeOH (20:1), 0 °C to room temperature, 3 h, 95–98%; (b) R<sup>2</sup>COOH, HATU, dry pyridine, 85 °C, 8 h, 19–71%. Details of the synthetic route and procedures for accessing intermediates <b>m11</b>–<b>16</b> are presented in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_001.pdf" class="ext-link">Supporting Information</a>.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>2</sup>SO<sub>2</sub>Cl, dry pyridine, 0 °C to room temperature, 12 h, 45%; (b) R<sup>2</sup>CHO, NaBH<sub>3</sub>CN, AcOH, room temperature, 24 h, 26–32%; (c) R<sup>4</sup>NCO, <i>N</i>,<i>N</i>-dimethylformamide (DMF), MeCN, or dimethyl sulfoxide (DMSO), room temperature, 12 h, 18–54%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Systematic summary of the SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding modes of compound <b>16</b> (carbon in green) or <b>42</b> (carbon in yellow) with RIPK1 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HHO">6HHO</a>) and RIPK3 (a homology model based on PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M66">4M66</a>). (A) Compound <b>16</b> with RIPK1; (B) compound <b>42</b> with RIPK1; (C) compound <b>16</b> with RIPK3; and (D) compound <b>42</b> with RIPK3. Superposition of the binding modes of compound <b>16</b> (carbon in green) or <b>42</b> (carbon in yellow) with RIPK1 or RIPK3. (E) Compounds <b>16</b> and <b>42</b> with RIPK1. (F) Compounds <b>16</b> and <b>42</b> with RIPK3. Residues of enzymes are depicted as gray sticks. Hydrogen bonds and halogen bonds are depicted as green and purple dash lines, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of TAK-632 analogues on necroptosis and apoptosis. (A) HT-29 cells were pretreated with DMSO, compound <b>42</b> (3 μM), or TAK-632 (3 μM) and then stimulated with TNF-α (20 ng/mL), cycloheximide (5 μg/mL), and z-VAD-fmk (20 μM) (TCZ) for 12 h. (B) HT-29 cells were pretreated with DMSO, compound <b>42</b>, or TAK-632 (3 μM) and then stimulated with TNF-α (20 ng/mL) plus cycloheximide (5 μg/mL) (TC) or TNF-α (20 ng/mL) plus Smac mimetic (10 nM) (TS) for 20 h. (C) L929 cells were pretreated with DMSO or compound <b>42</b> at the indicated concentrations and then stimulated with mouse TNF-α (20 ng/mL) and z-VAD-fmk (20 μM) (TZ) for 4 h. ** <i>p</i> < 0.005, *** <i>p</i> < 0.0005, compounds <b>42</b> or TAK-632 vs no treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>42</b> blocks necrosome formation by inhibiting the phosphorylation of RIPK3. (A) HT-29 cells were pretreated with compound <b>42</b> (1 μM) and then stimulated with TSZ at the indicated time points. The cells were lysed and immunoblotted with the indicated antibodies. (B) HT-29 cells were treated with DMSO or compound <b>42</b> (1 μM) for 4 h. The cell lysates were immunoprecipitated with an anti-RIPK1 antibody (IP: RIPK1) and analyzed by immunoblotting with the indicated antibodies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/medium/jm-2019-00611j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>42</b> protected mice from SIRS. (A) Body temperature and (B) survival curve of C57BL/6 female mice (<i>n</i> = 10 per group) injected with mTNF-α (400 μg/kg) after pretreatment with different doses of compound <b>42</b> (5, 25, and 50 mg/kg). *** <i>p</i> < 0.0005, treatment group vs vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-14/acs.jmedchem.9b00611/20190719/images/large/jm-2019-00611j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00611&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jäättelä, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschopp, J.</span></span> <span> </span><span class="NLM_article-title">Caspase-independent cell death in T lymphocytes</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1038/ni0503-416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fni0503-416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=12719731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A280%3ADC%252BD3s7pvF2qtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=416-423&author=M.+J%C3%A4%C3%A4ttel%C3%A4author=J.+Tschopp&title=Caspase-independent+cell+death+in+T+lymphocytes&doi=10.1038%2Fni0503-416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase-independent cell death in T lymphocytes</span></div><div class="casAuthors">Jaattela Marja; Tschopp Jurg</div><div class="citationInfo"><span class="NLM_cas:title">Nature immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">416-23</span>
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    </div><div class="casAbstract">T lymphocyte death is essential for proper function of the immune system.  During the decline of an immune response, most of the activated T cells die.  Cell death is also responsible for eliminating autoreactive lymphocytes.  Although recent studies have focused on caspase-dependent apoptotic signals, much evidence now shows that caspase- independent, necrotic cell death pathways are as important.  An understanding of the molecular control of these alternative pathways is beginning to emerge.  Damage of organelles including mitochondria, endoplasmic reticulum or lysozymes, leading to an increase in calcium and reactive oxygen species and the release of effector proteins, is frequently involved in caspase-independent cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQMmc36aJI4XI2y4bB4mnvYfW6udTcc2eaXnKOXAEEG1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7pvF2qtA%253D%253D&md5=890aedf63623db4cace6f4d958c8c80b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fni0503-416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni0503-416%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25A4%25C3%25A4ttel%25C3%25A4%26aufirst%3DM.%26aulast%3DTschopp%26aufirst%3DJ.%26atitle%3DCaspase-independent%2520cell%2520death%2520in%2520T%2520lymphocytes%26jtitle%3DNat.%2520Immunol.%26date%3D2003%26volume%3D4%26spage%3D416%26epage%3D423%26doi%3D10.1038%2Fni0503-416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and its role in inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>517</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1038/nature14191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fnature14191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=25592536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=517&publication_year=2015&pages=311-320&author=M.+Pasparakisauthor=P.+Vandenabeele&title=Necroptosis+and+its+role+in+inflammation&doi=10.1038%2Fnature14191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and its role in inflammation</span></div><div class="casAuthors">Pasparakis, Manolis; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">517</span>
        (<span class="NLM_cas:issue">7534</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Regulated cell death has essential functions in development and in adult tissue homeostasis.  Necroptosis is a newly discovered pathway of regulated necrosis that requires the proteins RIPK3 and MLKL and is induced by death receptors, interferons, toll-like receptors, intracellular RNA and DNA sensors, and probably other mediators.  RIPK1 has important kinase-dependent and scaffolding functions that inhibit or trigger necroptosis and apoptosis.  Mouse-model studies have revealed important functions for necroptosis in inflammation and suggested that it could be implicated in the pathogenesis of many human inflammatory diseases.  We discuss the mechanisms regulating necroptosis and its potential role in inflammation and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA9_ozm2Tq27Vg90H21EOLACvtfcHk0lhKF3C6_woSqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2mtA%253D%253D&md5=3acc43a5a345c231eb47ba079211783e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature14191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14191%26sid%3Dliteratum%253Aachs%26aulast%3DPasparakis%26aufirst%3DM.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DNecroptosis%2520and%2520its%2520role%2520in%2520inflammation%26jtitle%3DNature%26date%3D2015%26volume%3D517%26spage%3D311%26epage%3D320%26doi%3D10.1038%2Fnature14191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Zen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinlich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwendener, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span> <span> </span><span class="NLM_article-title">Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-alpha-induced shock</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.2119/molmed.2011.00423</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.2119%2Fmolmed.2011.00423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22371307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGmurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=577-586&author=A.+Linkermannauthor=J.+H.+Brasenauthor=F.+De+Zenauthor=R.+Weinlichauthor=R.+A.+Schwendenerauthor=D.+R.+Greenauthor=U.+Kunzendorfauthor=S.+Krautwald&title=Dichotomy+between+RIP1-+and+RIP3-mediated+necroptosis+in+tumor+necrosis+factor-alpha-induced+shock&doi=10.2119%2Fmolmed.2011.00423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-α-induced shock</span></div><div class="casAuthors">Linkermann, Andreas; Braesen, Jan H.; De Zen, Federica; Weinlich, Ricardo; Schwendener, Reto A.; Green, Douglas R.; Kunzendorf, Ulrich; Krautwald, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">577-586</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Tumor necrosis factor receptor (TNFR) signaling may result in survival, apoptosis or programmed necrosis.  The latter is called necroptosis if the receptor-interacting protein 1 (RIP1) inhibitor necrostatin-1 (Nec-1) or genetic knockout of RIP3 prevents it.  In the lethal mouse model of TNFα-mediated shock, addn. of the pan-caspase inhibitor zVAD-fmk (zVAD) accelerates time to death.  Here, we demonstrate that RIP3-deficient mice are protected markedly from TNFα-mediated shock in the presence and absence of caspase inhibition.  We further show that the fusion protein TAT-crmA, previously demonstrated to inhibit apoptosis, also prevents necroptosis in L929, HT29 and FADD-deficient Jurkat cells.  In contrast to RIP3-deficient mice, blocking necroptosis by Nec-1 or TAT-crmA did not protect from TNFα/zVAD-mediated shock, but further accelerated time to death.  Even in the absence of caspase inhibition, Nec-1 application led to similar kinetics.  Depletion of macrophages, natural killer (NK) cells, granulocytes or genetic deficiency for T lymphocytes did not influence this model.  Because RIP3-deficient mice are known to be protected from caerulein-induced pancreatitis (CIP), we applied Nec-1 and TAT-crmA in this model and demonstrated the deterioration of pancreatic damage upon addn. of these substances.  These data highlight the importance of sepg. genetic RIP3 deficiency from RIP1 inhibition by Nec-1 application in vivo and challenge the current definition of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp7Qyxdz0VLrVg90H21EOLACvtfcHk0lhKF3C6_woSqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGmurnL&md5=81217487911e74332e9c13cfd4b62a25</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2011.00423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2011.00423%26sid%3Dliteratum%253Aachs%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DDe%2BZen%26aufirst%3DF.%26aulast%3DWeinlich%26aufirst%3DR.%26aulast%3DSchwendener%26aufirst%3DR.%2BA.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DKunzendorf%26aufirst%3DU.%26aulast%3DKrautwald%26aufirst%3DS.%26atitle%3DDichotomy%2520between%2520RIP1-%2520and%2520RIP3-mediated%2520necroptosis%2520in%2520tumor%2520necrosis%2520factor-alpha-induced%2520shock%26jtitle%3DMol.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D577%26epage%3D586%26doi%3D10.2119%2Fmolmed.2011.00423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmerkus, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunzendorf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span> <span> </span><span class="NLM_article-title">Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1038/ki.2011.450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fki.2011.450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22237751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvV2rtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=751-761&author=A.+Linkermannauthor=J.+H.+Brasenauthor=N.+Himmerkusauthor=S.+Liuauthor=T.+B.+Huberauthor=U.+Kunzendorfauthor=S.+Krautwald&title=Rip1+%28receptor-interacting+protein+kinase+1%29+mediates+necroptosis+and+contributes+to+renal+ischemia%2Freperfusion+injury&doi=10.1038%2Fki.2011.450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury</span></div><div class="casAuthors">Linkermann, Andreas; Braesen, Jan H.; Himmerkus, Nina; Liu, Shuya; Huber, Tobias B.; Kunzendorf, Ulrich; Krautwald, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">751-761</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Loss of kidney function in renal ischemia/reperfusion injury is due to programmed cell death, but the contribution of necroptosis, a newly discovered form of programmed necrosis, has not been evaluated.  Here, we identified the presence of death receptor-mediated but caspase-independent cell death in murine tubular cells and characterized it as necroptosis by the addn. of necrostatin-1, a highly specific receptor-interacting protein kinase 1 inhibitor.  The detection of receptor-interacting protein kinase 1 and 3 in whole-kidney lysates and freshly isolated murine proximal tubules led us to investigate the contribution of necroptosis in a mouse model of renal ischemia/reperfusion injury.  Treatment with necrostatin-1 reduced organ damage and renal failure, even when administered after reperfusion, resulting in a significant survival benefit in a model of lethal renal ischemia/reperfusion injury.  Unexpectedly, specific blockade of apoptosis by zVAD, a pan-caspase inhibitor, did not prevent the organ damage or the increase in urea and creatinine in vivo in renal ischemia/reperfusion injury.  Thus, necroptosis is present and has functional relevance in the pathophysiol. course of ischemic kidney injury and shows the predominance of necroptosis over apoptosis in this setting.  Necrostatin-1 may have therapeutic potential to prevent and treat renal ischemia/reperfusion injury.  Kidney International (2012) 81, 751-761; doi:10.1038/ki.2011.450; published online 11 Jan. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKdkP2OeYjeLVg90H21EOLACvtfcHk0lhyNkvaIz7LpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvV2rtbo%253D&md5=5eea0d0e70f6a604223d5a8eb848ae5e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fki.2011.450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2011.450%26sid%3Dliteratum%253Aachs%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DHimmerkus%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DT.%2BB.%26aulast%3DKunzendorf%26aufirst%3DU.%26aulast%3DKrautwald%26aufirst%3DS.%26atitle%3DRip1%2520%2528receptor-interacting%2520protein%2520kinase%25201%2529%2520mediates%2520necroptosis%2520and%2520contributes%2520to%2520renal%2520ischemia%252Freperfusion%2520injury%26jtitle%3DKidney%2520Int.%26date%3D2012%26volume%3D81%26spage%3D751%26epage%3D761%26doi%3D10.1038%2Fki.2011.450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duprez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hauwermeiren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandendriessche, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanden Berghe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwels, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2011.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.immuni.2011.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22195746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1KrtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2011&pages=908-918&author=L.+Duprezauthor=N.+Takahashiauthor=F.+Van+Hauwermeirenauthor=B.+Vandendriesscheauthor=V.+Goossensauthor=T.+Vanden+Bergheauthor=W.+Declercqauthor=C.+Libertauthor=A.+Cauwelsauthor=P.+Vandenabeele&title=RIP+kinase-dependent+necrosis+drives+lethal+systemic+inflammatory+response+syndrome&doi=10.1016%2Fj.immuni.2011.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome</span></div><div class="casAuthors">Duprez, Linde; Takahashi, Nozomi; Van Hauwermeiren, Filip; Vandendriessche, Benjamin; Goossens, Vera; Vanden Berghe, Tom; Declercq, Wim; Libert, Claude; Cauwels, Anje; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">908-918</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Engagement of tumor necrosis factor receptor 1 signals two diametrically opposed pathways: survival-inflammation and cell death.  An addnl. switch decides, depending on the cellular context, between caspase-dependent apoptosis and RIP kinase (RIPK)-mediated necrosis, also termed necroptosis.  We explored the contribution of both cell death pathways in TNF-induced systemic inflammatory response syndrome (SIRS).  Deletion of apoptotic executioner caspases (caspase-3 or -7) or inflammatory caspase-1 had no impact on lethal SIRS.  However, deletion of RIPK3 conferred complete protection against lethal SIRS and reduced the amts. of circulating damage-assocd. mol. patterns.  Pretreatment with the RIPK1 kinase inhibitor, necrostatin-1, provided a similar effect.  These results suggest that RIPK1-RIPK3-mediated cellular damage by necrosis drives mortality during TNF-induced SIRS.  RIPK3 deficiency also protected against cecal ligation and puncture, underscoring the clin. relevance of RIPK kinase inhibition in sepsis and identifying components of the necroptotic pathway that are potential therapeutic targets for treatment of SIRS and sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiE2quF2rmSLVg90H21EOLACvtfcHk0lhyNkvaIz7LpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1KrtrfJ&md5=191d5b38562d315da4dd18e267da5246</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2011.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2011.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DDuprez%26aufirst%3DL.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DVan%2BHauwermeiren%26aufirst%3DF.%26aulast%3DVandendriessche%26aufirst%3DB.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DVanden%2BBerghe%26aufirst%3DT.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DCauwels%26aufirst%3DA.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DRIP%2520kinase-dependent%2520necrosis%2520drives%2520lethal%2520systemic%2520inflammatory%2520response%2520syndrome%26jtitle%3DImmunity%26date%3D2011%26volume%3D35%26spage%3D908%26epage%3D918%26doi%3D10.1016%2Fj.immuni.2011.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizushima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchison, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskowitz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1038/nchembio711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fnchembio711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=16408008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1OmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=112-119&author=A.+Degterevauthor=Z.+Huangauthor=M.+Boyceauthor=Y.+Liauthor=P.+Jagtapauthor=N.+Mizushimaauthor=G.+D.+Cunyauthor=T.+J.+Mitchisonauthor=M.+A.+Moskowitzauthor=J.+Yuan&title=Chemical+inhibitor+of+nonapoptotic+cell+death+with+therapeutic+potential+for+ischemic+brain+injury&doi=10.1038%2Fnchembio711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury</span></div><div class="casAuthors">Degterev, Alexei; Huang, Zhihong; Boyce, Michael; Li, Yaqiao; Jagtap, Prakash; Mizushima, Noboru; Cuny, Gregory D.; Mitchison, Timothy J.; Moskowitz, Michael A.; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-119</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death.  Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, the authors demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which the authors term necroptosis.  The authors showed that necroptosis is characterized by necrotic cell death morphol. and activation of autophagy.  The authors identified a specific and potent small-mol. inhibitor of necroptosis, necrostatin-1, which blocks a crit. step in necroptosis.  The authors demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection.  Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiiBDVRJkdUbVg90H21EOLACvtfcHk0lhyNkvaIz7LpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1OmsLg%253D&md5=83f8c363ffb73ccc14bf11ec02577336</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnchembio711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio711%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DBoyce%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DMizushima%26aufirst%3DN.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DMitchison%26aufirst%3DT.%2BJ.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DChemical%2520inhibitor%2520of%2520nonapoptotic%2520cell%2520death%2520with%2520therapeutic%2520potential%2520for%2520ischemic%2520brain%2520injury%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2005%26volume%3D1%26spage%3D112%26epage%3D119%26doi%3D10.1038%2Fnchembio711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">A role of RIP3-mediated macrophage necrosis in atherosclerosis development</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2012.12.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.celrep.2012.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=23333278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Gjtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=200-210&author=J.+Linauthor=H.+Liauthor=M.+Yangauthor=J.+Renauthor=Z.+Huangauthor=F.+Hanauthor=J.+Huangauthor=J.+Maauthor=D.+Zhangauthor=Z.+Zhangauthor=J.+Wuauthor=D.+Huangauthor=M.+Qiaoauthor=G.+Jinauthor=Q.+Wuauthor=Y.+Huangauthor=J.+Duauthor=J.+Han&title=A+role+of+RIP3-mediated+macrophage+necrosis+in+atherosclerosis+development&doi=10.1016%2Fj.celrep.2012.12.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A Role of RIP3-Mediated Macrophage Necrosis in Atherosclerosis Development</span></div><div class="casAuthors">Lin, Juan; Li, Hanjie; Yang, Min; Ren, Junming; Huang, Zhe; Han, Felicia; Huang, Jian; Ma, Jianhui; Zhang, Duanwu; Zhang, Zhirong; Wu, Jianfeng; Huang, Deli; Qiao, Muzhen; Jin, Guanghui; Wu, Qiao; Huang, Yinghui; Du, Jie; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">200-210</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Necrotic death of macrophages has long been known to be present in atherosclerotic lesions but has not been studied.  We examd. the role of receptor interacting protein (RIP) 3, a mediator of necrotic cell death, in atherosclerosis and found that RIP3-/-;Ldlr-/- mice were no different from RIP3+/+;Ldlr-/- mice in early atherosclerosis but had significant redn. in advanced atherosclerotic lesions.  Similar results were obsd. in Apoe-/- background mice.  Bone marrow transplantation revealed that loss of RIP3 expression from bone-marrow-derived cells is responsible for the reduced disease progression.  While no difference was found in apoptosis between RIP3-/-;Ldlr-/- and RIP3+/+;Ldlr-/- mice, electron microscopy revealed a significant redn. of macrophage primary necrosis in the advanced lesions of RIP3-/- mice.  In vitro cellular studies showed that RIP3 deletion had no effect on oxidized low-d. lipoprotein (LDL)-induced macrophage apoptosis, but prevented macrophage primary necrosis occurring in response to oxidized LDL under caspase inhibition or RIP3 overexpression conditions.  RIP3-dependent necrosis is not postapoptotic, and the increased primary necrosis in advanced atherosclerotic lesions most likely resulted from the increase of RIP3 expression.  Our data demonstrate that primary necrosis of macrophages is proatherogenic during advanced atherosclerosis development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdqCpSUOrMbVg90H21EOLACvtfcHk0lhwwoiDTOYFVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Gjtr8%253D&md5=9209a0f4999a29c821a9b732ce7a17f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DQiao%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DA%2520role%2520of%2520RIP3-mediated%2520macrophage%2520necrosis%2520in%2520atherosclerosis%2520development%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D3%26spage%3D200%26epage%3D210%26doi%3D10.1016%2Fj.celrep.2012.12.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlic, M.</span></span> <span> </span><span class="NLM_article-title">The diverse role of RIP kinases in necroptosis and inflammation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1038/ni.3206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fni.3206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=26086143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OmtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=689-697&author=J.+Silkeauthor=J.+A.+Rickardauthor=M.+Gerlic&title=The+diverse+role+of+RIP+kinases+in+necroptosis+and+inflammation&doi=10.1038%2Fni.3206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse role of RIP kinases in necroptosis and inflammation</span></div><div class="casAuthors">Silke, John; Rickard, James A.; Gerlic, Motti</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">689-697</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammation is a healthy response to infection or danger and should be rapid, specific and terminated once the threat has passed.  Inflammatory diseases, where this regulation fails, cause considerable human suffering.  Treatments have successfully targeted pro-inflammatory cytokines, such as tumor-necrosis factor (TNF), that directly induce genes encoding inflammatory products.  Inflammatory signals, including TNF, may also directly induce caspase-independent cell death (necroptosis), which can also elicit inflammation.  Necroptosis was originally defined as being dependent on the kinase RIPK1 but is now known to be dependent on RIPK3 and the pseudo-kinase MLKL.  Therefore, RIPK1, RIPK3 and MLKL are potential therapeutic targets.  RIPK1 and RIPK3 also directly regulate inflammatory signaling, which complicates interpretation of their function but might alter their therapeutic utility.  This Review examines the role of cell death, particularly necroptosis, in inflammation, in the context of recent insights into the roles of the key necroptosis effector mols. RIPK1, RIPK3 and MLKL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQwQIKren3X7Vg90H21EOLACvtfcHk0lhwwoiDTOYFVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OmtL3E&md5=124026d3c7caa25e1d416c6cb2bd8d87</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fni.3206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.3206%26sid%3Dliteratum%253Aachs%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DRickard%26aufirst%3DJ.%2BA.%26aulast%3DGerlic%26aufirst%3DM.%26atitle%3DThe%2520diverse%2520role%2520of%2520RIP%2520kinases%2520in%2520necroptosis%2520and%2520inflammation%26jtitle%3DNat.%2520Immunol.%26date%3D2015%26volume%3D16%26spage%3D689%26epage%3D697%26doi%3D10.1038%2Fni.3206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofengeim, D.</span></span> <span> </span><span class="NLM_article-title">Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1038/s41583-018-0093-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fs41583-018-0093-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=30467385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFegtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=19-33&author=J.+Yuanauthor=P.+Aminauthor=D.+Ofengeim&title=Necroptosis+and+RIPK1-mediated+neuroinflammation+in+CNS+diseases&doi=10.1038%2Fs41583-018-0093-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases</span></div><div class="casAuthors">Yuan, Junying; Amin, Palak; Ofengeim, Dimitry</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-33</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Apoptosis is crucial for the normal development of the nervous system, whereas neurons in the adult CNS are relatively resistant to this form of cell death.  However, under pathol. conditions, upregulation of death receptor family ligands, such as tumor necrosis factor (TNF), can sensitize cells in the CNS to apoptosis and a form of regulated necrotic cell death known as necroptosis that is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL).  Necroptosis promotes further cell death and neuroinflammation in the pathogenesis of several neurodegenerative diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease and Alzheimer disease.  In this Review, we outline the evidence implicating necroptosis in these neurol. diseases and suggest that targeting RIPK1 might help to inhibit multiple cell death pathways and ameliorate neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5SkNdlkg47rVg90H21EOLACvtfcHk0lhwwoiDTOYFVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFegtL7O&md5=935fd7ac622d04317a9f7c2c21f40717</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fs41583-018-0093-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41583-018-0093-1%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DP.%26aulast%3DOfengeim%26aufirst%3DD.%26atitle%3DNecroptosis%2520and%2520RIPK1-mediated%2520neuroinflammation%2520in%2520CNS%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2019%26volume%3D20%26spage%3D19%26epage%3D33%26doi%3D10.1038%2Fs41583-018-0093-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grootjans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghe, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Initiation and execution mechanisms of necroptosis: an overview</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1184</span>– <span class="NLM_lpage">1195</span>, <span class="refDoi"> DOI: 10.1038/cdd.2017.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcdd.2017.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=28498367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1184-1195&author=S.+Grootjansauthor=T.+V.+Bergheauthor=P.+Vandenabeele&title=Initiation+and+execution+mechanisms+of+necroptosis%3A+an+overview&doi=10.1038%2Fcdd.2017.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation and execution mechanisms of necroptosis: an overview</span></div><div class="casAuthors">Grootjans, Sasker; Vanden Berghe, Tom; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1184-1195</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis is a form of regulated cell death, which is induced by ligand binding to TNF family death domain receptors, pattern recognizing receptors and virus sensors.  The common feature of these receptor systems is the implication of proteins, which contain a receptor interaction protein kinase (RIPK) homol. interaction motif (RHIM) mediating recruitment and activation of receptor-interacting protein kinase 3 (RIPK3), which ultimately activates the necroptosis executioner mixed lineage kinase domain-like (MLKL).  In case of the TNF family members, the initiator is the survival- and cell death-regulating RIPK1 kinase, in the case of Toll-like receptor 3/4 (TLR3/4), a RHIM-contg. adaptor, called TRIF, while in the case of Z-DNA-binding protein ZBP1/DAI, the cytosolic viral sensor itself contains a RHIM domain.  In this review, we discuss the different protein complexes that serve as nucleation platforms for necroptosis and the mechanism of execution of necroptosis.  Transgenic models (knockout, kinase-dead knock-in) and pharmacol. inhibition indicate that RIPK1, RIPK3 or MLKL are implicated in many inflammatory, degenerative and infectious diseases.  However, the conclusion of necroptosis being solely involved in the etiol. of diseases is blurred by the pleiotropic roles of RIPK1 and RIPK3 in other cellular processes such as apoptosis and inflammasome activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraHklySa3j_rVg90H21EOLACvtfcHk0lhwwoiDTOYFVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjsLjL&md5=9128fd271b67c02c9ca5d40fba222318</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2017.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2017.65%26sid%3Dliteratum%253Aachs%26aulast%3DGrootjans%26aufirst%3DS.%26aulast%3DBerghe%26aufirst%3DT.%2BV.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DInitiation%2520and%2520execution%2520mechanisms%2520of%2520necroptosis%253A%2520an%2520overview%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2017%26volume%3D24%26spage%3D1184%26epage%3D1195%26doi%3D10.1038%2Fcdd.2017.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1111</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.cell.2009.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=19524512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1100-1111&author=S.+Heauthor=L.+Wangauthor=L.+Miaoauthor=T.+Wangauthor=F.+Duauthor=L.+Zhaoauthor=X.+Wang&title=Receptor+interacting+protein+kinase-3+determines+cellular+necrotic+response+to+TNF-alpha&doi=10.1016%2Fj.cell.2009.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α</span></div><div class="casAuthors">He, Sudan; Wang, Lai; Miao, Lin; Wang, Tao; Du, Fenghe; Zhao, Liping; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1100-1111</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Smac mimetics induce apoptosis synergistically with TNF-α by triggering the formation of a caspase-8-activating complex contg. receptor interacting protein kinase-1 (RIPK1).  Caspase inhibitors block this form of apoptosis in many types of cells.  However, in several other cell lines, caspase inhibitors switch the apoptotic response to necrosis.  A genome wide siRNA screen revealed another member of the RIP kinase family, RIP3, to be required for necrosis.  The expression of RIP3 in different cell lines correlates with their responsiveness to necrosis induction.  The kinase activity of RIP3 is essential for necrosis execution.  Upon induction of necrosis, RIP3 is recruited to RIPK1 to form a necrosis-inducing complex.  Embryonic fibroblasts from RIP3 knockout mice are resistant to necrosis and RIP3 knockout animals are devoid of inflammation inflicted tissue damage in an acute pancreatitis model.  These data indicate RIP3 as the determinant for cellular necrosis in response to TNF-α family of death-inducing cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoymGY6l3d1LbVg90H21EOLACvtfcHk0lh0Hd5c4QRFnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiu70%253D&md5=6397b34b896f8fe36c726f6d2ab39933</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DReceptor%2520interacting%2520protein%2520kinase-3%2520determines%2520cellular%2520necrotic%2520response%2520to%2520TNF-alpha%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D1100%26epage%3D1111%26doi%3D10.1016%2Fj.cell.2009.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Challa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moquin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genga, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guildford, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2009.05.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.cell.2009.05.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=19524513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1eiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2009&pages=1112-1123&author=Y.+S.+Choauthor=S.+Challaauthor=D.+Moquinauthor=R.+Gengaauthor=T.+D.+Rayauthor=M.+Guildfordauthor=F.+K.+Chan&title=Phosphorylation-driven+assembly+of+the+RIP1-RIP3+complex+regulates+programmed+necrosis+and+virus-induced+inflammation&doi=10.1016%2Fj.cell.2009.05.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation</span></div><div class="casAuthors">Cho, YoungSik; Challa, Sreerupa; Moquin, David; Genga, Ryan; Dutta Ray, Tathagat; Guildford, Melissa; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1112-1123</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Programmed necrosis is a form of caspase-independent cell death whose mol. regulation is poorly understood.  The kinase RIP1 is crucial for programmed necrosis, but also mediates activation of the prosurvival transcription factor NF-κB.  The authors postulated that addnl. mols. are required to specifically activate programmed necrosis.  Using a RNA interference screen, the authors identified the kinase RIP3 as a crucial activator for programmed necrosis induced by TNF and during virus infection.  RIP3 regulates necrosis-specific RIP1 phosphorylation.  The phosphorylation of RIP1 and RIP3 stabilizes their assocn. within the pronecrotic complex, activates the pronecrotic kinase activity, and triggers downstream reactive oxygen species prodn.  The pronecrotic RIP1-RIP3 complex is induced during vaccinia virus infection.  Consequently, RIP3-/- mice exhibited severely impaired virus-induced tissue necrosis, inflammation, and control of viral replication.  The authors' findings suggest that RIP3 controls programmed necrosis by initiating the pronecrotic kinase cascade, and that this is necessary for the inflammatory response against virus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmgsGJGayANrVg90H21EOLACvtfcHk0lh0Hd5c4QRFnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1eiu7o%253D&md5=6c158081daa49222becf864ac4a23885</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2009.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2009.05.037%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DChalla%26aufirst%3DS.%26aulast%3DMoquin%26aufirst%3DD.%26aulast%3DGenga%26aufirst%3DR.%26aulast%3DRay%26aufirst%3DT.%2BD.%26aulast%3DGuildford%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DPhosphorylation-driven%2520assembly%2520of%2520the%2520RIP1-RIP3%2520complex%2520regulates%2520programmed%2520necrosis%2520and%2520virus-induced%2520inflammation%26jtitle%3DCell%26date%3D2009%26volume%3D137%26spage%3D1112%26epage%3D1123%26doi%3D10.1016%2Fj.cell.2009.05.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.11.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.cell.2011.11.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22265413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=213-227&author=L.+Sunauthor=H.+Wangauthor=Z.+Wangauthor=S.+Heauthor=S.+Chenauthor=D.+Liaoauthor=L.+Wangauthor=J.+Yanauthor=W.+Liuauthor=X.+Leiauthor=X.+Wang&title=Mixed+lineage+kinase+domain-like+protein+mediates+necrosis+signaling+downstream+of+RIP3+kinase&doi=10.1016%2Fj.cell.2011.11.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase</span></div><div class="casAuthors">Sun, Liming; Wang, Huayi; Wang, Zhigao; He, Sudan; Chen, She; Liao, Daohong; Wang, Lai; Yan, Jiacong; Liu, Weilong; Lei, Xiaoguang; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">213-227</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The receptor-interacting serine-threonine kinase 3 (RIP3) is a key signaling mol. in the programmed necrosis (necroptosis) pathway.  This pathway plays important roles in a variety of physiol. and pathol. conditions, including development, tissue damage response, and antiviral immunity.  Here, we report the identification of a small mol. called (E)-N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide-hereafter referred to as necrosulfonamide-that specifically blocks necrosis downstream of RIP3 activation.  An affinity probe derived from necrosulfonamide and coimmunopptn. using anti-RIP3 antibodies both identified the mixed lineage kinase domain-like protein (MLKL) as the interacting target.  MLKL was phosphorylated by RIP3 at the threonine 357 and serine 358 residues, and these phosphorylation events were crit. for necrosis.  Treating cells with necrosulfonamide or knocking down MLKL expression arrested necrosis at a specific step at which RIP3 formed discrete punctae in cells.  These findings implicate MLKL as a key mediator of necrosis signaling downstream of the kinase RIP3.  MLKL connects RIP1 and RIP3 with its downstream targets.  In response to necrosis induction, activated RIP3 binds and phosphorylates MLKL, allowing downstream necrosis signaling to proceed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroTbwLFup35LVg90H21EOLACvtfcHk0lh0Hd5c4QRFnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFKgsLY%253D&md5=c3301ecd27c6892817e18b42c56bd97e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.11.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.11.031%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLei%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520protein%2520mediates%2520necrosis%2520signaling%2520downstream%2520of%2520RIP3%2520kinase%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D213%26epage%3D227%26doi%3D10.1016%2Fj.cell.2011.11.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jitkaew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5322</span>– <span class="NLM_lpage">5327</span>, <span class="refDoi"> DOI: 10.1073/pnas.1200012109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1073%2Fpnas.1200012109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=22421439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5322-5327&author=J.+Zhaoauthor=S.+Jitkaewauthor=Z.+Caiauthor=S.+Choksiauthor=Q.+Liauthor=J.+Luoauthor=Z.+G.+Liu&title=Mixed+lineage+kinase+domain-like+is+a+key+receptor+interacting+protein+3+downstream+component+of+TNF-induced+necrosis&doi=10.1073%2Fpnas.1200012109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis</span></div><div class="casAuthors">Zhao, Jie; Jitkaew, Siriporn; Cai, Zhenyu; Choksi, Swati; Li, Qiuning; Luo, Ji; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5322-5327, S5322/1-S5322/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumor necrosis factor (TNF) is an important inflammatory cytokine and induces many cellular responses, including inflammation, cell proliferation, apoptosis, and necrosis.  It is known that receptor interacting protein (RIP) kinases, RIP1 and RIP3, are key effectors of TNF-induced necrosis, but little is known about how these two RIP kinases mediate this process, although reactive oxygen species (ROS) generation and JNK activation have been suggested to be two downstream events of RIP kinases.  Here we report the identification of mixed lineage kinase domain-like, MLKL, as a key RIP3 downstream component of TNF-induced necrosis.  Through screening a kinase/phosphatase shRNA library in human colon adenocarcinoma HT-29 cells, we found that knockdown of MLKL blocked TNF-induced necrosis.  Our data suggest that MLKL functions downstream of R1P1 and RIP3 and is recruited to the necrosome through its interaction with RIP3.  Finally, we found that MLKL is required for the generation of ROS and the late-phase activation of JNK during TNF-induced necrosis.  However, because these two events are not involved in TNF-induced necrosis in HT-29 cells, the target of MLKL during TNF-induced necrosis remains elusive.  Taken together, our study suggests that MLKL is a key RIP3 downstream component of TNF-induced necrotic cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA3gnnPnZluLVg90H21EOLACvtfcHk0lgcN3Sn5986Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOjs70%253D&md5=74fd138fd18afacf677003f41d6be280</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1200012109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1200012109%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJitkaew%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520is%2520a%2520key%2520receptor%2520interacting%2520protein%25203%2520downstream%2520component%2520of%2520TNF-induced%2520necrosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D5322%26epage%3D5327%26doi%3D10.1073%2Fpnas.1200012109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jitkaew, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choksi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1038/ncb2883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fncb2883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24316671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=55-65&author=Z.+Caiauthor=S.+Jitkaewauthor=J.+Zhaoauthor=H.+C.+Chiangauthor=S.+Choksiauthor=J.+Liuauthor=Y.+Wardauthor=L.+G.+Wuauthor=Z.+G.+Liu&title=Plasma+membrane+translocation+of+trimerized+MLKL+protein+is+required+for+TNF-induced+necroptosis&doi=10.1038%2Fncb2883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis</span></div><div class="casAuthors">Cai, Zhenyu; Jitkaew, Siriporn; Zhao, Jie; Chiang, Hsueh-Cheng; Choksi, Swati; Liu, Jie; Ward, Yvona; Wu, Ling-gang; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-65</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mixed lineage kinase domain-like protein (MLKL) has recently been identified as a key RIP3 (receptor interacting protein 3) downstream component of tumor necrosis factor (TNF)-induced necroptosis.  MLKL is phosphorylated by RIP3 and is recruited to the necrosome through its interaction with RIP3.  However, it is still unknown how MLKL mediates TNF-induced necroptosis.  Here, we report that MLKL forms a homotrimer through its amino-terminal coiled-coil domain and locates to the cell plasma membrane during TNF-induced necroptosis.  By generating different MLKL mutants, we demonstrated that the plasma membrane localization of trimerized MLKL is crit. for mediating necroptosis.  Importantly, we found that the membrane localization of MLKL is essential for Ca2+ influx, which is an early event of TNF-induced necroptosis.  Furthermore, we identified that TRPM7 (transient receptor potential melastatin related 7) is a MLKL downstream target for the mediation of Ca2+ influx and TNF-induced necroptosis.  Hence, our study reveals a crucial mechanism of MLKL-mediated TNF-induced necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEjJZlohdKsLVg90H21EOLACvtfcHk0lgcN3Sn5986Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsb3E&md5=95e4468ee729b5a3bd8ab8ce49af8f25</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fncb2883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2883%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DJitkaew%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DH.%2BC.%26aulast%3DChoksi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%2BG.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DPlasma%2520membrane%2520translocation%2520of%2520trimerized%2520MLKL%2520protein%2520is%2520required%2520for%2520TNF-induced%2520necroptosis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D55%26epage%3D65%26doi%3D10.1038%2Fncb2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span> <span> </span><span class="NLM_article-title">Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/cr.2013.171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcr.2013.171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24366341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=105-121&author=X.+Chenauthor=W.+Liauthor=J.+Renauthor=D.+Huangauthor=W.+T.+Heauthor=Y.+Songauthor=C.+Yangauthor=W.+Liauthor=X.+Zhengauthor=P.+Chenauthor=J.+Han&title=Translocation+of+mixed+lineage+kinase+domain-like+protein+to+plasma+membrane+leads+to+necrotic+cell+death&doi=10.1038%2Fcr.2013.171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death</span></div><div class="casAuthors">Chen, Xin; Li, Wenjuan; Ren, Junming; Huang, Deli; He, Wan-ting; Song, Yunlong; Yang, Chao; Li, Wanyun; Zheng, Xinru; Chen, Pengda; Han, Jiahuai</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">Mixed lineage kinase domain-like protein (MLKL) was identified to function downstream of receptor interacting protein 3 (RIP3) in tumor necrosis factor-α (TNF)-induced necrosis (also called necroptosis).  However, how MLKL functions to mediate necroptosis is unknown.  By reconstitution of MLKL function in MLKL-knockout cells, we showed that the N-terminus of MLKL is required for its function in necroptosis.  The oligomerization of MLKL in TNF-treated cells is essential for necroptosis, as artificially forcing MLKL together by using the hormone-binding domain (HBD*) triggers necroptosis.  Notably, forcing together the N-terminal domain (ND) but not the C-terminal kinase domain of MLKL causes necroptosis.  Further deletion anal. showed that the four-α-helix bundle of MLKL (1-130 amino acids) is sufficient to trigger necroptosis.  Both the HBD*-mediated and TNF-induced complexes of MLKL(ND) or MLKL are tetramers, and translocation of these complexes to lipid rafts of the plasma membrane precedes cell death.  The homo-oligomerization is required for MLKL translocation and the signal sequence for plasma membrane location is located in the junction of the first and second α-helixes of MLKL.  The plasma membrane translocation of MLKL or MLKL(ND) leads to sodium influx, and depletion of sodium from the cell culture medium inhibits necroptosis.  All of the above phenomena were not seen in apoptosis.  Thus, the MLKL oligomerization leads to translocation of MLKL to lipid rafts of plasma membrane, and the plasma membrane MLKL complex acts either by itself or via other proteins to increase the sodium influx, which increases osmotic pressure, eventually leading to membrane rupture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3gKfH7oX77Vg90H21EOLACvtfcHk0lijnH09R8fQ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVyr&md5=16ac2183df16e01d3555e4a099540aae</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fcr.2013.171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2013.171%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DHe%26aufirst%3DW.%2BT.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DHan%26aufirst%3DJ.%26atitle%3DTranslocation%2520of%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%2520to%2520plasma%2520membrane%2520leads%2520to%2520necrotic%2520cell%2520death%26jtitle%3DCell%2520Res.%26date%3D2014%26volume%3D24%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fcr.2013.171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dondelinger, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montessuit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruggeman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulpiau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinou, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.celrep.2014.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24813885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=971-981&author=Y.+Dondelingerauthor=W.+Declercqauthor=S.+Montessuitauthor=R.+Roelandtauthor=A.+Goncalvesauthor=I.+Bruggemanauthor=P.+Hulpiauauthor=K.+Weberauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Goughauthor=S.+Savvidesauthor=J.+C.+Martinouauthor=M.+J.+Bertrandauthor=P.+Vandenabeele&title=MLKL+compromises+plasma+membrane+integrity+by+binding+to+phosphatidylinositol+phosphates&doi=10.1016%2Fj.celrep.2014.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates</span></div><div class="casAuthors">Dondelinger, Yves; Declercq, Wim; Montessuit, Sylvie; Roelandt, Ria; Goncalves, Amanda; Bruggeman, Inge; Hulpiau, Paco; Weber, Kathrin; Sehon, Clark A.; Marquis, Robert W.; Bertin, John; Gough, Peter J.; Savvides, Savvas; Martinou, Jean-Claude; Bertrand, Mathieu J. M.; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">971-981</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although mixed lineage kinase domain-like (MLKL) protein has emerged as a specific and crucial protein for necroptosis induction, how MLKL transduces the death signal remains poorly understood.  Here, we demonstrate that the full four-helical bundle domain (4HBD) in the N-terminal region of MLKL is required and sufficient to induce its oligomerization and trigger cell death.  Moreover, we found that a patch of pos. charged amino acids on the surface of the 4HBD binds to phosphatidylinositol phosphates (PIPs) and allows recruitment of MLKL to the plasma membrane.  Importantly, we found that recombinant MLKL, but not a mutant lacking these pos. charges, induces leakage of PIP-contg. liposomes as potently as BAX, supporting a model in which MLKL induces necroptosis by directly permeabilizing the plasma membrane.  Accordingly, we found that inhibiting the formation of PI(5)P and PI(4,5)P2 specifically inhibits tumor necrosis factor (TNF)-mediated necroptosis but not apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqRumZDmhVGLVg90H21EOLACvtfcHk0lgW9erT3_kpEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGnu78%253D&md5=42d9a43216f884c12bd4288658563873</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DDondelinger%26aufirst%3DY.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DMontessuit%26aufirst%3DS.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DGoncalves%26aufirst%3DA.%26aulast%3DBruggeman%26aufirst%3DI.%26aulast%3DHulpiau%26aufirst%3DP.%26aulast%3DWeber%26aufirst%3DK.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DSavvides%26aufirst%3DS.%26aulast%3DMartinou%26aufirst%3DJ.%2BC.%26aulast%3DBertrand%26aufirst%3DM.%2BJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DMLKL%2520compromises%2520plasma%2520membrane%2520integrity%2520by%2520binding%2520to%2520phosphatidylinositol%2520phosphates%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D7%26spage%3D971%26epage%3D981%26doi%3D10.1016%2Fj.celrep.2014.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.molcel.2014.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24703947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1emsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=133-146&author=H.+Wangauthor=L.+Sunauthor=L.+Suauthor=J.+Rizoauthor=L.+Liuauthor=L.+F.+Wangauthor=F.+S.+Wangauthor=X.+Wang&title=Mixed+lineage+kinase+domain-like+protein+MLKL+causes+necrotic+membrane+disruption+upon+phosphorylation+by+RIP3&doi=10.1016%2Fj.molcel.2014.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3</span></div><div class="casAuthors">Wang, Huayi; Sun, Liming; Su, Lijing; Rizo, Josep; Liu, Lei; Wang, Li-Feng; Wang, Fu-Sheng; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-146</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Programmed necrotic cell death induced by the tumor necrosis factor alpha (TNF-α) family of cytokines is dependent on a kinase cascade consisting of receptor-interacting kinases RIP1 and RIP3.  How these kinase activities cause cells to die by necrosis is not known.  The mixed lineage kinase domain-like protein MLKL is a functional RIP3 substrate that binds to RIP3 through its kinase-like domain but lacks kinase activity of its own.  RIP3 phosphorylates MLKL at the T357 and S358 sites.  Reported here is the development of a monoclonal antibody that specifically recognizes phosphorylated MLKL in cells dying of this pathway and in human liver biopsy samples from patients suffering from drug-induced liver injury.  The phosphorylated MLKL forms an oligomer that binds to phosphatidylinositol lipids and cardiolipin.  This property allows MLKL to move from the cytosol to the plasma and intracellular membranes, where it directly disrupts membrane integrity, resulting in necrotic death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPpE1gUpKITrVg90H21EOLACvtfcHk0lgW9erT3_kpEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1emsro%253D&md5=8e4ab8e0a49933201ed49b147b6b189e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DL.%26aulast%3DRizo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%2BF.%26aulast%3DWang%26aufirst%3DF.%2BS.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DMixed%2520lineage%2520kinase%2520domain-like%2520protein%2520MLKL%2520causes%2520necrotic%2520membrane%2520disruption%2520upon%2520phosphorylation%2520by%2520RIP3%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D54%26spage%3D133%26epage%3D146%26doi%3D10.1016%2Fj.molcel.2014.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wallach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillon, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span> <span> </span><span class="NLM_article-title">Programmed necrosis in inflammation: Toward identification of the effector molecules</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>352</i></span>, <span class="NLM_elocation-id">aaf2154</span> <span class="refDoi"> DOI: 10.1126/science.aaf2154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1126%2Fscience.aaf2154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27034377" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2016&author=D.+Wallachauthor=T.+B.+Kangauthor=C.+P.+Dillonauthor=D.+R.+Green&title=Programmed+necrosis+in+inflammation%3A+Toward+identification+of+the+effector+molecules&doi=10.1126%2Fscience.aaf2154"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaf2154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaf2154%26sid%3Dliteratum%253Aachs%26aulast%3DWallach%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DT.%2BB.%26aulast%3DDillon%26aufirst%3DC.%2BP.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26atitle%3DProgrammed%2520necrosis%2520in%2520inflammation%253A%2520Toward%2520identification%2520of%2520the%2520effector%2520molecules%26jtitle%3DScience%26date%3D2016%26volume%3D352%26doi%3D10.1126%2Fscience.aaf2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagtap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study of novel necroptosis inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">5039</span>– <span class="NLM_lpage">5044</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2005.07.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.bmcl.2005.07.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=16153840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVynu73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5039-5044&author=X.+Tengauthor=A.+Degterevauthor=P.+Jagtapauthor=X.+Xingauthor=S.+Choiauthor=R.+Denuauthor=J.+Yuanauthor=G.+D.+Cuny&title=Structure-activity+relationship+study+of+novel+necroptosis+inhibitors&doi=10.1016%2Fj.bmcl.2005.07.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study of novel necroptosis inhibitors</span></div><div class="casAuthors">Teng, Xin; Degterev, Alexei; Jagtap, Prakash; Xing, Xuechao; Choi, Sungwoon; Denu, Regine; Yuan, Junying; Cuny, Gregory D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5039-5044</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Necroptosis is a regulated caspase-independent cell death mechanism that results in morphol. features resembling necrosis.  It can be induced in a FADD-deficient variant of human Jurkat T cells treated with TNF-α.  5-(1H-Indol-3-ylmethyl)-2-thiohydantoin derivs. and 5-(1H-indol-3-ylmethyl)hydantoin derivs. were found to be potent necroptosis inhibitors (called necrostatins).  A SAR study revealed that several positions of the indole were intolerant of substitution, while small substituents at the 7-position resulted in increased inhibitory activity.  The hydantoin ring was also quite sensitive to structural modifications.  A representative member of this compd. class demonstrated moderate pharmacokinetic characteristics and readily entered the central nervous system upon i.v. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRkqj1HWHSSLVg90H21EOLACvtfcHk0lgpKVcHI2nlbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVynu73O&md5=5a2b77e2d0461c24eaef8182ab7d4cdf</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.077%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DJagtap%26aufirst%3DP.%26aulast%3DXing%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DDenu%26aufirst%3DR.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure-activity%2520relationship%2520study%2520of%2520novel%2520necroptosis%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5039%26epage%3D5044%26doi%3D10.1016%2Fj.bmcl.2005.07.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitomi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Germscheid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ch’en, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korkina, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugovskoy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span> <span> </span><span class="NLM_article-title">Identification of RIP1 kinase as a specific cellular target of necrostatins</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nchembio.83</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fnchembio.83" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=18408713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=313-321&author=A.+Degterevauthor=J.+Hitomiauthor=M.+Germscheidauthor=I.+L.+Ch%E2%80%99enauthor=O.+Korkinaauthor=X.+Tengauthor=D.+Abbottauthor=G.+D.+Cunyauthor=C.+Yuanauthor=G.+Wagnerauthor=S.+M.+Hedrickauthor=S.+A.+Gerberauthor=A.+Lugovskoyauthor=J.+Yuan&title=Identification+of+RIP1+kinase+as+a+specific+cellular+target+of+necrostatins&doi=10.1038%2Fnchembio.83"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of RIP1 kinase as a specific cellular target of necrostatins</span></div><div class="casAuthors">Degterev, Alexei; Hitomi, Junichi; Germscheid, Megan; Ch'en, Irene L.; Korkina, Olga; Teng, Xin; Abbott, Derek; Cuny, Gregory D.; Yuan, Chengye; Wagner, Gerhard; Hedrick, Stephen M.; Gerber, Scott A.; Lugovskoy, Alexey; Yuan, Junying</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis is a cellular mechanism of necrotic cell death induced by apoptotic stimuli in the form of death domain receptor engagement by their resp. ligands under conditions where apoptotic execution is prevented.  Although it occurs under regulated conditions, necroptotic cell death is characterized by the same morphol. features as unregulated necrotic death.  Here we report that necrostatin-1, a previously identified small-mol. inhibitor of necroptosis, is a selective allosteric inhibitor of the death domain receptor-assocd. adaptor kinase RIP1 in vitro.  We show that RIP1 is the primary cellular target responsible for the antinecroptosis activity of necrostatin-1.  In addn., we show that two other necrostatins, necrostatin-3 and necrostatin-5, also target the RIP1 kinase step in the necroptosis pathway, but through mechanisms distinct from that of necrostatin-1.  Overall, our data establish necrostatins as the first-in-class inhibitors of RIP1 kinase, the key upstream kinase involved in the activation of necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOaKMR-RMwdLVg90H21EOLACvtfcHk0lgpKVcHI2nlbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVSmtL0%253D&md5=8ba3859c2b4c752da534441747a79bb5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.83&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.83%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DHitomi%26aufirst%3DJ.%26aulast%3DGermscheid%26aufirst%3DM.%26aulast%3DCh%25E2%2580%2599en%26aufirst%3DI.%2BL.%26aulast%3DKorkina%26aufirst%3DO.%26aulast%3DTeng%26aufirst%3DX.%26aulast%3DAbbott%26aufirst%3DD.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DHedrick%26aufirst%3DS.%2BM.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DLugovskoy%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520RIP1%2520kinase%2520as%2520a%2520specific%2520cellular%2520target%2520of%2520necrostatins%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D313%26epage%3D321%26doi%3D10.1038%2Fnchembio.83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duprez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grootjans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwels, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nerinckx, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DuHadaway, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roelandt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hauwermeiren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Declercq, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callewaert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e437</span> <span class="refDoi"> DOI: 10.1038/cddis.2012.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcddis.2012.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=23190609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&author=N.+Takahashiauthor=L.+Duprezauthor=S.+Grootjansauthor=A.+Cauwelsauthor=W.+Nerinckxauthor=J.+B.+DuHadawayauthor=V.+Goossensauthor=R.+Roelandtauthor=F.+Van+Hauwermeirenauthor=C.+Libertauthor=W.+Declercqauthor=N.+Callewaertauthor=G.+C.+Prendergastauthor=A.+Degterevauthor=J.+Yuanauthor=P.+Vandenabeele&title=Necrostatin-1+analogues%3A+critical+issues+on+the+specificity%2C+activity+and+in+vivo+use+in+experimental+disease+models&doi=10.1038%2Fcddis.2012.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models</span></div><div class="casAuthors">Takahashi, N.; Duprez, L.; Grootjans, S.; Cauwels, A.; Nerinckx, W.; DuHadaway, J. B.; Goossens, V.; Roelandt, R.; Van Hauwermeiren, F.; Libert, C.; Declercq, W.; Callewaert, N.; Prendergast, G. C.; Degterev, A.; Yuan, J.; Vandenabeele, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">e437, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necrostatin-1 (Nec-1) is widely used in disease models to examine the contribution of receptor-interacting protein kinase (RIPK) 1 in cell death and inflammation.  We studied three Nec-1 analogs: Nec-1, the active inhibitor of RIPK1, Nec-1 inactive (Nec-1i), its inactive variant, and Nec-1 stable (Nec-1s), its more stable variant.  We report that Nec-1 is identical to methyl-thiohydantoin-tryptophan, an inhibitor of the potent immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO).  Both Nec-1 and Nec-1i inhibited human IDO, but Nec-1s did not, as predicted by mol. modeling.  Therefore, Nec-1s is a more specific RIPK1 inhibitor lacking the IDO-targeting effect.  Next, although Nec-1i was ∼100 × less effective than Nec-1 in inhibiting human RIPK1 kinase activity in vitro, it was only 10 times less potent than Nec-1 and Nec-1s in a mouse necroptosis assay and became even equipotent at high concns.  Along the same line, in vivo, high doses of Nec-1, Nec-1i and Nec-1s prevented tumor necrosis factor (TNF)-induced mortality equally well, excluding the use of Nec-1i as an inactive control.  Paradoxically, low doses of Nec-1 or Nec-1i, but not Nec-1s, even sensitized mice to TNF-induced mortality.  Importantly, Nec-1s did not exhibit this low dose toxicity, stressing again the preferred use of Nec-1s in vivo.  Our findings have important implications for the interpretation of Nec-1-based data in exptl. disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2yIQ4UD-yb7Vg90H21EOLACvtfcHk0lgvwO_MbOWMRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFSitg%253D%253D&md5=2d4f57016d88e474cbfe00dee540b8fa</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2012.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2012.176%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DDuprez%26aufirst%3DL.%26aulast%3DGrootjans%26aufirst%3DS.%26aulast%3DCauwels%26aufirst%3DA.%26aulast%3DNerinckx%26aufirst%3DW.%26aulast%3DDuHadaway%26aufirst%3DJ.%2BB.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DRoelandt%26aufirst%3DR.%26aulast%3DVan%2BHauwermeiren%26aufirst%3DF.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DDeclercq%26aufirst%3DW.%26aulast%3DCallewaert%26aufirst%3DN.%26aulast%3DPrendergast%26aufirst%3DG.%2BC.%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DNecrostatin-1%2520analogues%253A%2520critical%2520issues%2520on%2520the%2520specificity%252C%2520activity%2520and%2520in%2520vivo%2520use%2520in%2520experimental%2520disease%2520models%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2012%26volume%3D3%26doi%3D10.1038%2Fcddis.2012.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshikawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saitoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigi, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikatendu, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakakariya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yogo, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine derivatives as potent, orally available, and brain-penetrating receptor interacting protein 1 (RIP1) kinase inhibitors: analysis of structure-kinetic relationships</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2384</span>– <span class="NLM_lpage">2409</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjtlOku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2384-2409&author=M.+Yoshikawaauthor=M.+Saitohauthor=T.+Katohauthor=T.+Sekiauthor=S.+V.+Bigiauthor=Y.+Shimizuauthor=T.+Ishiiauthor=T.+Okaiauthor=M.+Kunoauthor=H.+Hattoriauthor=E.+Watanabeauthor=K.+S.+Saikatenduauthor=H.+Zouauthor=M.+Nakakariyaauthor=T.+Tatamiyaauthor=Y.+Nakadaauthor=T.+Yogo&title=Discovery+of+7-Oxo-2%2C4%2C5%2C7-tetrahydro-6+H-pyrazolo%5B3%2C4-+c%5Dpyridine+derivatives+as+potent%2C+orally+available%2C+and+brain-penetrating+receptor+interacting+protein+1+%28RIP1%29+kinase+inhibitors%3A+analysis+of+structure-kinetic+relationships&doi=10.1021%2Facs.jmedchem.7b01647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships</span></div><div class="casAuthors">Yoshikawa, Masato; Saitoh, Morihisa; Katoh, Taisuke; Seki, Tomohiro; Bigi, Simone V.; Shimizu, Yuji; Ishii, Tsuyoshi; Okai, Takuro; Kuno, Masako; Hattori, Harumi; Watanabe, Etsuro; Saikatendu, Kumar S.; Zou, Hua; Nakakariya, Masanori; Tatamiya, Takayuki; Nakada, Yoshihisa; Yogo, Takatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2384-2409</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the discovery of 7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine derivs. as a novel class of receptor interacting protein 1 (RIP1) kinase inhibitors.  On the basis of the overlay study between HTS hit 10 and GSK2982772 in RIP1 kinase, the authors designed and synthesized a novel class of RIP1 kinase inhibitor (11, (3S)-3-(2-Benzyl-4-oxo-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one trifluoroacetic acid) possessing moderate RIP1 kinase inhibitory activity and P-gp mediated efflux.  The optimization of the core structure and the exploration of appropriate substituents utilizing SBDD approach led to the discovery of (22, (3S)-3-(2-Benzyl-3-chloro-7-oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine-8-carbonitrile), a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor with excellent PK profiles.  Compd. 22 significantly suppressed necroptotic cell death both in mouse and human cells.  Oral administration of 22 (10 mg/kg, bid) attenuated disease progression in the mouse exptl. autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS).  Moreover, anal. of structure-kinetic relationship (SKR) for the authors' novel chem. series was also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP8rRmbdh7w7Vg90H21EOLACvtfcHk0lgvwO_MbOWMRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjtlOku78%253D&md5=a76ab7f12af03e277ba37d7ea08274c9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01647%26sid%3Dliteratum%253Aachs%26aulast%3DYoshikawa%26aufirst%3DM.%26aulast%3DSaitoh%26aufirst%3DM.%26aulast%3DKatoh%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DBigi%26aufirst%3DS.%2BV.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DOkai%26aufirst%3DT.%26aulast%3DKuno%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DE.%26aulast%3DSaikatendu%26aufirst%3DK.%2BS.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DNakakariya%26aufirst%3DM.%26aulast%3DTatamiya%26aufirst%3DT.%26aulast%3DNakada%26aufirst%3DY.%26aulast%3DYogo%26aufirst%3DT.%26atitle%3DDiscovery%2520of%25207-Oxo-2%252C4%252C5%252C7-tetrahydro-6%2520H-pyrazolo%255B3%252C4-%2520c%255Dpyridine%2520derivatives%2520as%2520potent%252C%2520orally%2520available%252C%2520and%2520brain-penetrating%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520inhibitors%253A%2520analysis%2520of%2520structure-kinetic%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2384%26epage%3D2409%26doi%3D10.1021%2Facs.jmedchem.7b01647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01898</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01898" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2163-2178&author=P.+A.+Harrisauthor=B.+W.+Kingauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=J.+N.+Fingerauthor=L.+C.+Gradyauthor=S.+J.+Hoffmanauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=A.+S.+Lakdawalaauthor=R.+Lehrauthor=D.+E.+McNultyauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+R.+Rendinaauthor=M.+C.+Schaefferauthor=J.+D.+Summerfieldauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=A.+Zhangauthor=D.+Zhangauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=DNA-encoded+library+screening+identifies+benzo%5Bb%5D%5B1%2C4%5Doxazepin-4-ones+as+highly+potent+and+monoselective+receptor+interacting+protein+1+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors</span></div><div class="casAuthors">Harris, Philip A.; King, Bryan W.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Finger, Joshua N.; Grady, LaShadric C.; Hoffman, Sandra J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Lakdawala, Ami S.; Lehr, Ruth; McNulty, Dean E.; Nagilla, Rakesh; Ouellette, Michael T.; Pao, Christina S.; Rendina, Alan R.; Schaeffer, Michelle C.; Summerfield, Jennifer D.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Zhang, Aming; Zhang, Daohua; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent discovery of the role of receptor interacting protein 1 (RIP1) kinase in tumor necrosis factor (TNF)-mediated inflammation has led to its emergence as a highly promising target for the treatment of multiple inflammatory diseases.  The authors screened RIP1 against GSK's DNA-encoded small-mol. libraries and identified a novel highly potent benzoxazepinone inhibitor series.  The authors demonstrate that this template possesses complete monokinase selectivity for RIP1 plus unique species selectivity for primate vs. nonprimate RIP1.  The authors elucidate the conformation of RIP1 bound to this benzoxazepinone inhibitor driving its high kinase selectivity and design specific mutations in murine RIP1 to restore potency to levels similar to primate RIP1.  This series differentiates itself from known RIP1 inhibitors in combining high potency and kinase selectivity with good pharmacokinetic profiles in rodents.  The favorable developability profile of this benzoxazepinone template, as exemplified by compd. 14 (GSK'481), makes it an excellent starting point for further optimization into a RIP1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XvpziWGWg7Vg90H21EOLACvtfcHk0lgxZFdWMFYkVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D&md5=d6325dcaed97b7c339d1830ca041298c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01898%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSummerfield%26aufirst%3DJ.%2BD.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDNA-encoded%2520library%2520screening%2520identifies%2520benzo%255Bb%255D%255B1%252C4%255Doxazepin-4-ones%2520as%2520highly%2520potent%2520and%2520monoselective%2520receptor%2520interacting%2520protein%25201%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2163%26epage%3D2178%26doi%3D10.1021%2Facs.jmedchem.5b01898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0lgxZFdWMFYkVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weisel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tompson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolstenholme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards-Peterson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verticelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. L.</span></span> <span> </span><span class="NLM_article-title">Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e00365</span> <span class="refDoi"> DOI: 10.1002/prp2.365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1002%2Fprp2.365" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&author=K.+Weiselauthor=N.+E.+Scottauthor=D.+J.+Tompsonauthor=B.+J.+Vottaauthor=S.+Madhavanauthor=K.+Poveyauthor=A.+Wolstenholmeauthor=M.+Simeoniauthor=T.+Rudoauthor=L.+Richards-Petersonauthor=T.+Sahotaauthor=J.+G.+Wangauthor=J.+Lichauthor=J.+Fingerauthor=A.+Verticelliauthor=M.+Reillyauthor=P.+J.+Goughauthor=P.+A.+Harrisauthor=J.+Bertinauthor=M.+L.+Wang&title=Randomized+clinical+study+of+safety%2C+pharmacokinetics%2C+and+pharmacodynamics+of+RIPK1+inhibitor+GSK2982772+in+healthy+volunteers&doi=10.1002%2Fprp2.365"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fprp2.365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.365%26sid%3Dliteratum%253Aachs%26aulast%3DWeisel%26aufirst%3DK.%26aulast%3DScott%26aufirst%3DN.%2BE.%26aulast%3DTompson%26aufirst%3DD.%2BJ.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DMadhavan%26aufirst%3DS.%26aulast%3DPovey%26aufirst%3DK.%26aulast%3DWolstenholme%26aufirst%3DA.%26aulast%3DSimeoni%26aufirst%3DM.%26aulast%3DRudo%26aufirst%3DT.%26aulast%3DRichards-Peterson%26aufirst%3DL.%26aulast%3DSahota%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DJ.%2BG.%26aulast%3DLich%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DVerticelli%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.%2BL.%26atitle%3DRandomized%2520clinical%2520study%2520of%2520safety%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%2520of%2520RIPK1%2520inhibitor%2520GSK2982772%2520in%2520healthy%2520volunteers%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2017%26volume%3D5%26doi%3D10.1002%2Fprp2.365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">Microglia-targeted candidates push the Alzheimer drug envelope</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fnrd.2018.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=29700495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=303-305&author=A.+Mullard&title=Microglia-targeted+candidates+push+the+Alzheimer+drug+envelope&doi=10.1038%2Fnrd.2018.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia-targeted candidates push the Alzheimer drug envelope</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">303-305</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Denali Therapeutics is taking a swing at neuroinflammation with a first-in-man trial of a RIPK1 inhibitor, while the company and others search for ways to target microglial biol. more precisely.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYpgRypRFIELVg90H21EOLACvtfcHk0ljZO3g4mpv2-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgs7s%253D&md5=4a47cda8bae5e3142f21d97a0a2208af</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.65%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DMicroglia-targeted%2520candidates%2520push%2520the%2520Alzheimer%2520drug%2520envelope%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D303%26epage%3D305%26doi%3D10.1038%2Fnrd.2018.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. G.</span></span> <span> </span><span class="NLM_article-title">Execution of RIPK3-regulated necrosis</span>. <i>Mol. Cell Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1</i></span>, <span class="NLM_elocation-id">e960759</span> <span class="refDoi"> DOI: 10.4161/23723548.2014.960759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.4161%2F23723548.2014.960759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27308332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVart7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&author=Z.+Caiauthor=Z.+G.+Liu&title=Execution+of+RIPK3-regulated+necrosis&doi=10.4161%2F23723548.2014.960759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Execution of RIPK3-regulated necrosis</span></div><div class="casAuthors">Cai, Zhenyu; Liu, Zheng-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Cellular Oncology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e960759/1-e960759/7</span>CODEN:
                <span class="NLM_cas:coden">MCOOCO</span>;
        ISSN:<span class="NLM_cas:issn">2372-3556</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Necroptosis is a form of regulated necrotic cell death that is mediated by receptor-interacting protein 1 (RIP1) and RIP3 kinases.  Diverse receptors, including death receptors, Toll-like receptors, interferon receptors, and DAI DNA receptors are able to trigger necroptosis.  The newly identified MLKL protein functions downstream of RIP1/RIP3 and is essential for the execution of necroptosis.  Studies also indicate involvement of reactive oxygen species and calcium and sodium ions.  Identification of the key mediators of necroptosis is crit. for understanding the mol. mechanisms of the necroptotic process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt35ztg1n-rrVg90H21EOLACvtfcHk0ljZO3g4mpv2-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVart7vN&md5=65d7f10e73fc3e518584c01f9ded2975</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.4161%2F23723548.2014.960759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252F23723548.2014.960759%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%2BG.%26atitle%3DExecution%2520of%2520RIPK3-regulated%2520necrosis%26jtitle%3DMol.%2520Cell%2520Oncol.%26date%3D2014%26volume%3D1%26doi%3D10.4161%2F23723548.2014.960759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span> <span> </span><span class="NLM_article-title">Necroptosis-independent signaling by the RIP kinases in inflammation</span>. <i>Cell Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">2334</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2203-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1007%2Fs00018-016-2203-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27048814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=2325-2334&author=K.+Moriwakiauthor=F.+K.+Chan&title=Necroptosis-independent+signaling+by+the+RIP+kinases+in+inflammation&doi=10.1007%2Fs00018-016-2203-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Necroptosis-independent signaling by the RIP kinases in inflammation</span></div><div class="casAuthors">Moriwaki, Kenta; Chan, Francis Ka-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2325-2334</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Recent advances have identified a signaling cascade involving receptor interacting protein kinase 1 (RIPK1), RIPK3 and the pseudokinase mixed lineage kinase domain-like (MLKL) that is crucial for induction of necroptosis, a non-apoptotic form of cell death.  RIPK1-RIPK3-MLKL-mediated necroptosis has been attributed to cause many inflammatory diseases through the release of cellular damage-assocd. mol. patterns (DAMPs).  In addn. to necroptosis, emerging evidence suggests that these necroptosis signal adaptors can also facilitate inflammation independent of cell death.  In particular, the RIP kinases can drive NF-κB and inflammasome activation independent of cell death.  In this review, we will discuss recent discoveries that led to this realization and present arguments why cell death-independent signaling by the RIP kinases may have a more important role in inflammation than necroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6wW0-uJ6xhbVg90H21EOLACvtfcHk0lhKmIvyVog7cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValurs%253D&md5=8ba1cc7565ca54604626eb5d030dce48</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2203-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2203-4%26sid%3Dliteratum%253Aachs%26aulast%3DMoriwaki%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DF.%2BK.%26atitle%3DNecroptosis-independent%2520signaling%2520by%2520the%2520RIP%2520kinases%2520in%2520inflammation%26jtitle%3DCell%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D2325%26epage%3D2334%26doi%3D10.1007%2Fs00018-016-2203-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span> <span> </span><span class="NLM_article-title">Generation of small molecules to interfere with regulated necrosis</span>. <i>Cell Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">2251</span>– <span class="NLM_lpage">2267</span>, <span class="refDoi"> DOI: 10.1007/s00018-016-2198-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1007%2Fs00018-016-2198-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27048812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsValur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=2251-2267&author=A.+Degterevauthor=A.+Linkermann&title=Generation+of+small+molecules+to+interfere+with+regulated+necrosis&doi=10.1007%2Fs00018-016-2198-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of small molecules to interfere with regulated necrosis</span></div><div class="casAuthors">Degterev, Alexei; Linkermann, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">2251-2267</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Interference with regulated necrosis for clin. purposes carries broad therapeutic relevance and, if successfully achieved, has a potential to revolutionize everyday clin. routine.  Necrosis was interpreted as something that no clinician might ever be able to prevent due to the unregulated nature of this form of cell death.  However, given our growing understanding of the existence of regulated forms of necrosis and the roles of key enzymes of these pathways, e.g., kinases, peroxidases, etc., the possibility emerges to identify efficient and selective small mol. inhibitors of pathol. necrosis.  Here, we review the published literature on small mol. inhibition of regulated necrosis and provide an outlook on how combination therapy may be most effective in treatment of necrosis-assocd. clin. situations like stroke, myocardial infarction, sepsis, cancer and solid organ transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzrtP6mR8SDbVg90H21EOLACvtfcHk0lhKmIvyVog7cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsValur0%253D&md5=24f31e0580cc6423dbf59063b51ae4c6</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00018-016-2198-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-016-2198-x%26sid%3Dliteratum%253Aachs%26aulast%3DDegterev%26aufirst%3DA.%26aulast%3DLinkermann%26aufirst%3DA.%26atitle%3DGeneration%2520of%2520small%2520molecules%2520to%2520interfere%2520with%2520regulated%2520necrosis%26jtitle%3DCell%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D2251%26epage%3D2267%26doi%3D10.1007%2Fs00018-016-2198-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriwaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votta, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casillas, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley-Bauer, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roback, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dovey, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carette, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mocarski, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, W. J.</span></span> <span> </span><span class="NLM_article-title">RIP3 induces apoptosis independent of pronecrotic kinase activity</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">495</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2014.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.molcel.2014.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=25459880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2014&pages=481-495&author=P.+Mandalauthor=S.+B.+Bergerauthor=S.+Pillayauthor=K.+Moriwakiauthor=C.+Huangauthor=H.+Guoauthor=J.+D.+Lichauthor=J.+Fingerauthor=V.+Kasparcovaauthor=B.+Vottaauthor=M.+Ouelletteauthor=B.+W.+Kingauthor=D.+Wisnoskiauthor=A.+S.+Lakdawalaauthor=M.+P.+DeMartinoauthor=L.+N.+Casillasauthor=P.+A.+Haileauthor=C.+A.+Sehonauthor=R.+W.+Marquisauthor=J.+Uptonauthor=L.+P.+Daley-Bauerauthor=L.+Robackauthor=N.+Ramiaauthor=C.+M.+Doveyauthor=J.+E.+Caretteauthor=F.+K.+Chanauthor=J.+Bertinauthor=P.+J.+Goughauthor=E.+S.+Mocarskiauthor=W.+J.+Kaiser&title=RIP3+induces+apoptosis+independent+of+pronecrotic+kinase+activity&doi=10.1016%2Fj.molcel.2014.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity</span></div><div class="casAuthors">Mandal, Pratyusha; Berger, Scott B.; Pillay, Sirika; Moriwaki, Kenta; Huang, Chunzi; Guo, Hongyan; Lich, John D.; Finger, Joshua; Kasparcova, Viera; Votta, Bart; Ouellette, Michael; King, Bryan W.; Wisnoski, David; Lakdawala, Ami S.; DeMartino, Michael P.; Casillas, Linda N.; Haile, Pamela A.; Sehon, Clark A.; Marquis, Robert W.; Upton, Jason; Daley-Bauer, Lisa P.; Roback, Linda; Ramia, Nancy; Dovey, Cole M.; Carette, Jan E.; Chan, Francis Ka-Ming; Bertin, John; Gough, Peter J.; Mocarski, Edward S.; Kaiser, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">481-495</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 3 (RIP3 or RIPK3) has emerged as a central player in necroptosis and a potential target to control inflammatory disease.  Here, three selective small-mol. compds. are shown to inhibit RIP3 kinase-dependent necroptosis, although their therapeutic value is undermined by a surprising, concn.-dependent induction of apoptosis.  These compds. interact with RIP3 to activate caspase 8 (Casp8) via RHIM-driven recruitment of RIP1 (RIPK1) to assemble a Casp8-FADD-cFLIP complex completely independent of pronecrotic kinase activities and MLKL.  RIP3 kinase-dead D161N mutant induces spontaneous apoptosis independent of compd., whereas D161G, D143N, and K51A mutants, like wild-type, only trigger apoptosis when compd. is present.  Accordingly, RIP3-K51A mutant mice (Rip3K51A/K51A) are viable and fertile, in stark contrast to the perinatal lethality of Rip3D161N/D161N mice.  RIP3 therefore holds both necroptosis and apoptosis in balance through a Ripoptosome-like platform.  This work highlights a common mechanism unveiling RHIM-driven apoptosis by therapeutic or genetic perturbation of RIP3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmaOmUttaymrVg90H21EOLACvtfcHk0lhRShGO4Y5y3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyjsb%252FK&md5=43567ddc4cb1b78b17294118acb8a951</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DP.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DPillay%26aufirst%3DS.%26aulast%3DMoriwaki%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DOuellette%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DDeMartino%26aufirst%3DM.%2BP.%26aulast%3DCasillas%26aufirst%3DL.%2BN.%26aulast%3DHaile%26aufirst%3DP.%2BA.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DUpton%26aufirst%3DJ.%26aulast%3DDaley-Bauer%26aufirst%3DL.%2BP.%26aulast%3DRoback%26aufirst%3DL.%26aulast%3DRamia%26aufirst%3DN.%26aulast%3DDovey%26aufirst%3DC.%2BM.%26aulast%3DCarette%26aufirst%3DJ.%2BE.%26aulast%3DChan%26aufirst%3DF.%2BK.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DMocarski%26aufirst%3DE.%2BS.%26aulast%3DKaiser%26aufirst%3DW.%2BJ.%26atitle%3DRIP3%2520induces%2520apoptosis%2520independent%2520of%2520pronecrotic%2520kinase%2520activity%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D56%26spage%3D481%26epage%3D495%26doi%3D10.1016%2Fj.molcel.2014.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickliffe, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Almagro, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vucic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komuves, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrando, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roose-Girma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warming, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span> <span> </span><span class="NLM_article-title">Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>343</i></span>,  <span class="NLM_fpage">1357</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1126/science.1249361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1126%2Fscience.1249361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24557836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2014&pages=1357-1360&author=K.+Newtonauthor=D.+L.+Duggerauthor=K.+E.+Wickliffeauthor=N.+Kapoorauthor=M.+C.+de+Almagroauthor=D.+Vucicauthor=L.+Komuvesauthor=R.+E.+Ferrandoauthor=D.+M.+Frenchauthor=J.+Websterauthor=M.+Roose-Girmaauthor=S.+Warmingauthor=V.+M.+Dixit&title=Activity+of+protein+kinase+RIPK3+determines+whether+cells+die+by+necroptosis+or+apoptosis&doi=10.1126%2Fscience.1249361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis</span></div><div class="casAuthors">Newton, Kim; Dugger, Debra L.; Wickliffe, Katherine E.; Kapoor, Neeraj; de Almagro, M. Cristina; Vucic, Domagoj; Komuves, Laszlo; Ferrando, Ronald E.; French, Dorothy M.; Webster, Joshua; Roose-Girma, Merone; Warming, Soren; Dixit, Vishva M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">6177</span>),
    <span class="NLM_cas:pages">1357-1360</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Receptor-interacting protein kinase 1 (RIPK1) and RIPK3 trigger pro-inflammatory cell death termed "necroptosis.".  Studies with RIPK3-deficient mice or the RIPK1 inhibitor necrostatin-1 suggest that necroptosis exacerbates pathol. in many disease models.  We engineered mice expressing catalytically inactive RIPK3 D161N or RIPK1 D138N to det. the need for the active kinase in the whole animal.  Unexpectedly, RIPK3 D161N promoted lethal RIPK1- and caspase-8-dependent apoptosis.  In contrast, mice expressing RIPK1 D138N were viable and, like RIPK3-deficient mice, resistant to tumor necrosis factor (TNF)-induced hypothermia.  Cells expressing RIPK1 D138N were resistant to TNF-induced necroptosis, whereas TNF-induced signaling pathways promoting gene transcription were unperturbed.  Our data indicate that the kinase activity of RIPK3 is essential for necroptosis but also governs whether a cell activates caspase-8 and dies by apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt_ux2V9rge7Vg90H21EOLACvtfcHk0lhRShGO4Y5y3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktl2gs7g%253D&md5=a07b82bee66bdc1fe471b15e3294792b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.1249361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1249361%26sid%3Dliteratum%253Aachs%26aulast%3DNewton%26aufirst%3DK.%26aulast%3DDugger%26aufirst%3DD.%2BL.%26aulast%3DWickliffe%26aufirst%3DK.%2BE.%26aulast%3DKapoor%26aufirst%3DN.%26aulast%3Dde%2BAlmagro%26aufirst%3DM.%2BC.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DKomuves%26aufirst%3DL.%26aulast%3DFerrando%26aufirst%3DR.%2BE.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DWebster%26aufirst%3DJ.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26atitle%3DActivity%2520of%2520protein%2520kinase%2520RIPK3%2520determines%2520whether%2520cells%2520die%2520by%2520necroptosis%2520or%2520apoptosis%26jtitle%3DScience%26date%3D2014%26volume%3D343%26spage%3D1357%26epage%3D1360%26doi%3D10.1126%2Fscience.1249361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z. H.</span></span> <span> </span><span class="NLM_article-title">The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e1278</span> <span class="refDoi"> DOI: 10.1038/cddis.2014.241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcddis.2014.241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24901049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&author=J.+X.+Liauthor=J.+M.+Fengauthor=Y.+Wangauthor=X.+H.+Liauthor=X.+X.+Chenauthor=Y.+Suauthor=Y.+Y.+Shenauthor=Y.+Chenauthor=B.+Xiongauthor=C.+H.+Yangauthor=J.+Dingauthor=Z.+H.+Miao&title=The+B-Raf%28V600E%29+inhibitor+dabrafenib+selectively+inhibits+RIP3+and+alleviates+acetaminophen-induced+liver+injury&doi=10.1038%2Fcddis.2014.241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The B-RafV600E inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury</span></div><div class="casAuthors">Li, J.-X.; Feng, J-.M.; Wang, Y.; Li, X.-H.; Chen, X.-X.; Su, Y.; Shen, Y.-Y.; Chen, Y.; Xiong, B.; Yang, C.-H.; Ding, J.; Miao, Z.-H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1278</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Receptor-interacting protein (RIP)3 is a crit. regulator of necroptosis and has been demonstrated to be assocd. with various diseases, suggesting that its inhibitors are promising in the clinic.  However, there have been few RIP3 inhibitors reported as yet.  B-RafV600E inhibitors are an important anticancer drug class for metastatic melanoma therapy.  In this study, we found that 6 B-Raf inhibitors could inhibit RIP3 enzymic activity in vitro.  Among them, dabrafenib showed the most potent inhibition on RIP3, which was achieved by its ATP-competitive binding to the enzyme.  Dabrafenib displayed highly selective inhibition on RIP3 over RIP1, RIP2 and RIP5.  Moreover, only dabrafenib rescued cells from RIP3-mediated necroptosis induced by the necroptosis-induced combinations, i.e., tumor necrosis factor (TNF)α, TNF-related apoptosis-inducing ligand or Fas ligand plus Smac mimetic and the caspase inhibitor z-VAD.  Dabrafenib decreased the RIP3-mediated Ser358 phosphorylation of mixed lineage kinase domain-like protein (MLKL) and disrupted the interaction between RIP3 and MLKL.  Notably, RIP3 inhibition of dabrafenib appeared to be independent of its B-Raf inhibition.  Dabrafenib was further revealed to prevent acetaminophen-induced necrosis in normal human hepatocytes, which is considered to be mediated by RIP3.  In acetaminophen-overdosed mouse models, dabrafenib was found to apparently ease the acetaminophen-caused liver damage.  The results indicate that the anticancer B-RafV600E inhibitor dabrafenib is a RIP3 inhibitor, which could serve as a sharp tool for probing the RIP3 biol. and as a potential preventive or therapeutic agent for RIP3-involved necroptosis-related diseases such as acetaminophen-induced liver damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr40b524L_pOLVg90H21EOLACvtfcHk0lje6swdN3nEvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGqt7o%253D&md5=a425dc91c461e5725d553428187db972</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.241%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BX.%26aulast%3DFeng%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%2BH.%26aulast%3DChen%26aufirst%3DX.%2BX.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%2BY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%2BH.%26atitle%3DThe%2520B-Raf%2528V600E%2529%2520inhibitor%2520dabrafenib%2520selectively%2520inhibits%2520RIP3%2520and%2520alleviates%2520acetaminophen-induced%2520liver%2520injury%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26doi%3D10.1038%2Fcddis.2014.241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dwyer, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grippo, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, P. B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of mutated, activated BRAF in metastatic melanoma</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">819</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1002011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1056%2FNEJMoa1002011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=20818844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVyksb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=809-819&author=K.+T.+Flahertyauthor=I.+Puzanovauthor=K.+B.+Kimauthor=A.+Ribasauthor=G.+A.+McArthurauthor=J.+A.+Sosmanauthor=P.+J.+O%E2%80%99Dwyerauthor=R.+J.+Leeauthor=J.+F.+Grippoauthor=K.+Nolopauthor=P.+B.+Chapman&title=Inhibition+of+mutated%2C+activated+BRAF+in+metastatic+melanoma&doi=10.1056%2FNEJMoa1002011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of mutated, activated BRAF in metastatic melanoma</span></div><div class="casAuthors">Flaherty, Keith T.; Puzanov, Igor; Kim, Kevin B.; Ribas, Antoni; McArthur, Grant A.; Sosman, Jeffrey A.; O'dwyer, Peter J.; Lee, Richard J.; Grippo, Joseph F.; Nolop, Keith; Chapman, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">809-819</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: The identification of somatic mutations in the gene encoding the serine-threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to test oncogene-targeted therapy for this disease.  Methods: We conducted a multicenter, phase 1, dose-escalation trial of PLX4032 (also known as RG7204), an orally available inhibitor of mutated BRAF, followed by an extension phase involving the max. dose that could be administered without adverse effects (the recommended phase 2 dose).  Patients received PLX4032 twice daily until they had disease progression.  Pharmacokinetic anal. and tumor-response assessments were conducted in all patients.  In selected patients, tumor biopsy was performed before and during treatment to validate BRAF inhibition.  Results: A total of 55 patients (49 of whom had melanoma) were enrolled in the dose-escalation phase, and 32 addnl. patients with metastatic melanoma who had BRAF with the V600E mutation were enrolled in the extension phase.  The recommended phase 2 dose was 960 mg twice daily, with increases in the dose limited by grade 2 or 3 rash, fatigue, and arthralgia.  In the dose-escalation cohort, among the 16 patients with melanoma whose tumors carried the V600E BRAF mutation and who were receiving 240 mg or more of PLX4032 twice daily, 10 had a partial response and 1 had a complete response.  Among the 32 patients in the extension cohort, 24 had a partial response and 2 had a complete response.  The estd. median progression-free survival among all patients was more than 7 mo.  Conclusions: Treatment of metastatic melanoma with PLX4032 in patients with tumors that carry the V600E BRAF mutation resulted in complete or partial tumor regression in the majority of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwq1fkvEjfyLVg90H21EOLACvtfcHk0lje6swdN3nEvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVyksb3M&md5=80f70df0ac490828a42e6c7c0b40067f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1002011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1002011%26sid%3Dliteratum%253Aachs%26aulast%3DFlaherty%26aufirst%3DK.%2BT.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DK.%2BB.%26aulast%3DRibas%26aufirst%3DA.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DO%25E2%2580%2599Dwyer%26aufirst%3DP.%2BJ.%26aulast%3DLee%26aufirst%3DR.%2BJ.%26aulast%3DGrippo%26aufirst%3DJ.%2BF.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DChapman%26aufirst%3DP.%2BB.%26atitle%3DInhibition%2520of%2520mutated%252C%2520activated%2520BRAF%2520in%2520metastatic%2520melanoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D809%26epage%3D819%26doi%3D10.1056%2FNEJMoa1002011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, X.</span></span> <span> </span><span class="NLM_article-title">Necrosulfonamide inhibits necroptosis by selectively targeting the mixed lineage kinase domain-like protein</span>. <i>MedChemCommun</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1039/c3md00278k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1039%2Fc3md00278k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=333-337&author=D.+Liaoauthor=L.+Sunauthor=W.+Liuauthor=S.+Heauthor=X.+Wangauthor=X.+Lei&title=Necrosulfonamide+inhibits+necroptosis+by+selectively+targeting+the+mixed+lineage+kinase+domain-like+protein&doi=10.1039%2Fc3md00278k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fc3md00278k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00278k%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLei%26aufirst%3DX.%26atitle%3DNecrosulfonamide%2520inhibits%2520necroptosis%2520by%2520selectively%2520targeting%2520the%2520mixed%2520lineage%2520kinase%2520domain-like%2520protein%26jtitle%3DMedChemCommun%26date%3D2014%26volume%3D5%26spage%3D333%26epage%3D337%26doi%3D10.1039%2Fc3md00278k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-g.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-y.</span></span> <span> </span><span class="NLM_article-title">Identification of TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.1111/bph.14653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1111%2Fbph.14653" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=X.+Chenauthor=C.+Zhuangauthor=Y.+Renauthor=H.+Zhangauthor=X.+Qinauthor=L.+Huauthor=J.+Fuauthor=Z.+Miaoauthor=Y.+Chaiauthor=Z.-g.+Liuauthor=H.+Zhangauthor=Z.+Caiauthor=H.-y.+Wang&title=Identification+of+TAK-632+and+its+analogues+as+potent+inhibitors+of+necroptosis+by+targeting+RIPK1+and+RIPK3&doi=10.1111%2Fbph.14653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fbph.14653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14653%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DChai%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.-g.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.-y.%26atitle%3DIdentification%2520of%2520TAK-632%2520and%2520its%2520analogues%2520as%2520potent%2520inhibitors%2520of%2520necroptosis%2520by%2520targeting%2520RIPK1%2520and%2520RIPK3%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26doi%3D10.1111%2Fbph.14653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okaniwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsutsumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tottori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a selective kinase inhibitor (TAK-632) targeting pan-RAF inhibition: design, synthesis, and biological evaluation of C-7-substituted 1,3-benzothiazole derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6478</span>– <span class="NLM_lpage">6494</span>, <span class="refDoi"> DOI: 10.1021/jm400778d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400778d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2qsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6478-6494&author=M.+Okaniwaauthor=M.+Hiroseauthor=T.+Aritaauthor=M.+Yabukiauthor=A.+Nakamuraauthor=T.+Takagiauthor=T.+Kawamotoauthor=N.+Uchiyamaauthor=A.+Sumitaauthor=S.+Tsutsumiauthor=T.+Tottoriauthor=Y.+Inuiauthor=B.+C.+Sangauthor=J.+Yanoauthor=K.+Aertgeertsauthor=S.+Yoshidaauthor=T.+Ishikawa&title=Discovery+of+a+selective+kinase+inhibitor+%28TAK-632%29+targeting+pan-RAF+inhibition%3A+design%2C+synthesis%2C+and+biological+evaluation+of+C-7-substituted+1%2C3-benzothiazole+derivatives&doi=10.1021%2Fjm400778d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Selective Kinase Inhibitor (TAK-632) Targeting Pan-RAF Inhibition: Design, Synthesis, and Biological Evaluation of C-7-Substituted 1,3-Benzothiazole Derivatives</span></div><div class="casAuthors">Okaniwa, Masanori; Hirose, Masaaki; Arita, Takeo; Yabuki, Masato; Nakamura, Akito; Takagi, Terufumi; Kawamoto, Tomohiro; Uchiyama, Noriko; Sumita, Akihiko; Tsutsumi, Shunichirou; Tottori, Tsuneaki; Inui, Yoshitaka; Sang, Bi-Ching; Yano, Jason; Aertgeerts, Kathleen; Yoshida, Sei; Ishikawa, Tomoyasu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6478-6494</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the aim of discovering a selective kinase inhibitor targeting pan-RAF kinase inhibition, we designed novel 1,3-benzothiazole derivs. based on our thiazolo[5,4-b]pyridine class RAF/VEGFR2 inhibitor and developed a regioselective cyclization methodol. for the C-7-substituted 1,3-benzothiazole scaffold utilizing meta-substituted anilines.  Eventually, we selected 7-cyano deriv. I (TAK-632) as a development candidate and confirmed its binding mode by cocrystal structure with BRAF.  Accommodation of the 7-cyano group into the BRAF-selectivity pocket and the 3-(trifluoromethyl)phenyl acetamide moiety into the hydrophobic back pocket of BRAF in the DFG-out conformation contributed to enhanced RAF potency and selectivity vs VEGFR2.  Reflecting its potent pan-RAF inhibition and slow off-rate profile, I demonstrated significant cellular activity against mutated BRAF or mutated NRAS cancer cell lines.  Furthermore, in both A375 (BRAFV600E) and HMVII (NRASQ61K) xenograft models in rats, I demonstrated regressive antitumor efficacy by twice daily, 14-day repetitive administration without significant body wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2jcxKx47lWLVg90H21EOLACvtfcHk0lgzGJnMN9pCMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2qsrzL&md5=60ccb75bcf7d7772cdf21468e26c141f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm400778d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400778d%26sid%3Dliteratum%253Aachs%26aulast%3DOkaniwa%26aufirst%3DM.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DArita%26aufirst%3DT.%26aulast%3DYabuki%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DA.%26aulast%3DTakagi%26aufirst%3DT.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DSumita%26aufirst%3DA.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DTottori%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DY.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520selective%2520kinase%2520inhibitor%2520%2528TAK-632%2529%2520targeting%2520pan-RAF%2520inhibition%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520C-7-substituted%25201%252C3-benzothiazole%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6478%26epage%3D6494%26doi%3D10.1021%2Fjm400778d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donelan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouitar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carideo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okaniwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of the selective pan-RAF inhibitor TAK-632 in BRAF inhibitor-resistant melanoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7043</span>– <span class="NLM_lpage">7055</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-13-1825</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1158%2F0008-5472.CAN-13-1825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24121489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=7043-7055&author=A.+Nakamuraauthor=T.+Aritaauthor=S.+Tsuchiyaauthor=J.+Donelanauthor=J.+Chouitarauthor=E.+Carideoauthor=K.+Galvinauthor=M.+Okaniwaauthor=T.+Ishikawaauthor=S.+Yoshida&title=Antitumor+activity+of+the+selective+pan-RAF+inhibitor+TAK-632+in+BRAF+inhibitor-resistant+melanoma&doi=10.1158%2F0008-5472.CAN-13-1825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma</span></div><div class="casAuthors">Nakamura, Akito; Arita, Takeo; Tsuchiya, Shuntarou; Donelan, Jill; Chouitar, Jouhara; Carideo, Elizabeth; Galvin, Katherine; Okaniwa, Masanori; Ishikawa, Tomoyasu; Yoshida, Sei</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7043-7055</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The mitogen-activated protein kinase (MAPK) pathway is particularly important for the survival and proliferation of melanoma cells.  Somatic mutations in BRAF and NKAS are frequently obsd. in melanoma.  Recently, the BRAF inhibitors vemurafenib and dabrafenib have emerged as promising agents for the treatment of melanoma patients with BRAF-activating mutations.  Flowever, as BRAF inhibitors induce RAF paradoxical activation via RAF dimerization in BRAF wild-type cells, rapid emergence of acquired resistance and secondary skin tumors as well as presence of few effective treatment options for melanoma bearing wild- type BRAF (including NRAS-mutant melanoma) are clin. concerns.  Here, we demonstrate that the selective pan-RAF inhibitor TAK-632 suppresses RAF activity in BRAF wild-type cells with minimal RAF paradoxical activation.  Our anal. using RNAi and TAK-632 in preclin. models reveals that the MAPK pathway of NRAS-mutated melanoma cells is highly dependent on RAF.  We also show that TAK-632 induces RAF dimerization but inhibits the kinase activity of the RAF dimer, probably because of its slow dissocn. from RAF.  As a result, TAK-632 demonstrates potent antiproliferative effects both on NRAS-mutated melanoma cells and BRAF-mutated melanoma cells with acquired resistance to BRAF inhibitors through NRAS mutation or BRAF truncation.  Furthermore, we demonstrate that the combination of TAK-632 and the MAPK kinase (MEK) inhibitor TAK-733 exhibits synergistic antiproliferative effects on these cells.  Our findings characterize the unique features of TAK-632 as a pan-RAF inhibitor and provide rationale for its further investigation in NRAS-mutated melanoma and a subset of BRAF-mutated melanomas refractory to BRAF inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1LknpOlxiFrVg90H21EOLACvtfcHk0lhjRC_-pJjVEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKhu77L&md5=beeec0a6c53216a97762c91af9df8c0e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-13-1825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-13-1825%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DA.%26aulast%3DArita%26aufirst%3DT.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DDonelan%26aufirst%3DJ.%26aulast%3DChouitar%26aufirst%3DJ.%26aulast%3DCarideo%26aufirst%3DE.%26aulast%3DGalvin%26aufirst%3DK.%26aulast%3DOkaniwa%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DS.%26atitle%3DAntitumor%2520activity%2520of%2520the%2520selective%2520pan-RAF%2520inhibitor%2520TAK-632%2520in%2520BRAF%2520inhibitor-resistant%2520melanoma%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D7043%26epage%3D7055%26doi%3D10.1158%2F0008-5472.CAN-13-1825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Najjar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suebsuwong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thapa, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogusa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saleh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balachandran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuny, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degterev, A.</span></span> <span> </span><span class="NLM_article-title">Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1850</span>– <span class="NLM_lpage">1860</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.celrep.2015.02.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=25801024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1850-1860&author=M.+Najjarauthor=C.+Suebsuwongauthor=S.+S.+Rayauthor=R.+J.+Thapaauthor=J.+L.+Makiauthor=S.+Nogusaauthor=S.+Shahauthor=D.+Salehauthor=P.+J.+Goughauthor=J.+Bertinauthor=J.+Yuanauthor=S.+Balachandranauthor=G.+D.+Cunyauthor=A.+Degterev&title=Structure+guided+design+of+potent+and+selective+ponatinib-based+hybrid+inhibitors+for+RIPK1&doi=10.1016%2Fj.celrep.2015.02.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1</span></div><div class="casAuthors">Najjar, Malek; Suebsuwong, Chalada; Ray, Soumya S.; Thapa, Roshan J.; Maki, Jenny L.; Nogusa, Shoko; Shah, Saumil; Saleh, Danish; Gough, Peter J.; Bertin, John; Yuan, Junying; Balachandran, Siddharth; Cuny, Gregory D.; Degterev, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1850-1860</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIPK1 and RIPK3, two closely related RIPK family members, have emerged as important regulators of pathol. cell death and inflammation.  In the current work, we report that the Bcr-Abl inhibitor and anti-leukemia agent ponatinib is also a first-in-class dual inhibitor of RIPK1 and RIPK3.  Ponatinib potently inhibited multiple paradigms of RIPK1- and RIPK3-dependent cell death and inflammatory tumor necrosis factor alpha (TNF-α) gene transcription.  We further describe design strategies that utilize the ponatinib scaffold to develop two classes of inhibitors (CS and PN series), each with greatly improved selectivity for RIPK1.  In particular, we detail the development of PN10, a highly potent and selective "hybrid" RIPK1 inhibitor, capturing the best properties of two different allosteric RIPK1 inhibitors, ponatinib and necrostatin-1.  Finally, we show that RIPK1 inhibitors from both classes are powerful blockers of TNF-induced injury in vivo.  Altogether, these findings outline promising candidate mols. and design approaches for targeting RIPK1- and RIPK3-driven inflammatory pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUQJThkEIWBbVg90H21EOLACvtfcHk0lhjRC_-pJjVEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVWktro%253D&md5=c13215958ddcca5a685a4d1e82a96560</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DNajjar%26aufirst%3DM.%26aulast%3DSuebsuwong%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DThapa%26aufirst%3DR.%2BJ.%26aulast%3DMaki%26aufirst%3DJ.%2BL.%26aulast%3DNogusa%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%26aulast%3DSaleh%26aufirst%3DD.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DBalachandran%26aufirst%3DS.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DDegterev%26aufirst%3DA.%26atitle%3DStructure%2520guided%2520design%2520of%2520potent%2520and%2520selective%2520ponatinib-based%2520hybrid%2520inhibitors%2520for%2520RIPK1%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D10%26spage%3D1850%26epage%3D1860%26doi%3D10.1016%2Fj.celrep.2015.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauster, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigenzahn, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stukalov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lardeau, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scorzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gridling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parapatics, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colinge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubicek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krautwald, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span> <span> </span><span class="NLM_article-title">A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1767</span> <span class="refDoi"> DOI: 10.1038/cddis.2015.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcddis.2015.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=25996294" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=A.+Fausterauthor=M.+Rebsamenauthor=K.+V.+Huberauthor=J.+W.+Bigenzahnauthor=A.+Stukalovauthor=C.+H.+Lardeauauthor=S.+Scorzoniauthor=M.+Brucknerauthor=M.+Gridlingauthor=K.+Parapaticsauthor=J.+Colingeauthor=K.+L.+Bennettauthor=S.+Kubicekauthor=S.+Krautwaldauthor=A.+Linkermannauthor=G.+Superti-Furga&title=A+cellular+screen+identifies+ponatinib+and+pazopanib+as+inhibitors+of+necroptosis&doi=10.1038%2Fcddis.2015.130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2015.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2015.130%26sid%3Dliteratum%253Aachs%26aulast%3DFauster%26aufirst%3DA.%26aulast%3DRebsamen%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DK.%2BV.%26aulast%3DBigenzahn%26aufirst%3DJ.%2BW.%26aulast%3DStukalov%26aufirst%3DA.%26aulast%3DLardeau%26aufirst%3DC.%2BH.%26aulast%3DScorzoni%26aufirst%3DS.%26aulast%3DBruckner%26aufirst%3DM.%26aulast%3DGridling%26aufirst%3DM.%26aulast%3DParapatics%26aufirst%3DK.%26aulast%3DColinge%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DK.%2BL.%26aulast%3DKubicek%26aufirst%3DS.%26aulast%3DKrautwald%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26atitle%3DA%2520cellular%2520screen%2520identifies%2520ponatinib%2520and%2520pazopanib%2520as%2520inhibitors%2520of%2520necroptosis%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fcddis.2015.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonnus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goossens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linkermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenabeele, P.</span></span> <span> </span><span class="NLM_article-title">Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e2904</span> <span class="refDoi"> DOI: 10.1038/cddis.2017.298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fcddis.2017.298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=28661484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=S.+Martensauthor=M.+Jeongauthor=W.+Tonnusauthor=F.+Feldmannauthor=S.+Hofmansauthor=V.+Goossensauthor=N.+Takahashiauthor=J.+H.+Brasenauthor=E.+W.+Leeauthor=P.+Van+der+Vekenauthor=J.+Joossensauthor=K.+Augustynsauthor=S.+Fuldaauthor=A.+Linkermannauthor=J.+Songauthor=P.+Vandenabeele&title=Sorafenib+tosylate+inhibits+directly+necrosome+complex+formation+and+protects+in+mouse+models+of+inflammation+and+tissue+injury&doi=10.1038%2Fcddis.2017.298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury</span></div><div class="casAuthors">Martens, Sofie; Jeong, Manhyung; Tonnus, Wulf; Feldmann, Friederike; Hofmans, Sam; Goossens, Vera; Takahashi, Nozomi; Brasen, Jan Hinrich; Lee, Eun-Woo; Van der Veken, Pieter; Joossens, Jurgen; Augustyns, Koen; Fulda, Simone; Linkermann, Andreas; Song, Jaewhan; Vandenabeele, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e2904</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Necroptosis contributes to the pathophysiol. of several inflammatory, infectious and degenerative disorders.  TNF-induced necroptosis involves activation of the receptor-interacting protein kinases 1 and 3 (RIPK1/3) in a necrosome complex, eventually leading to the phosphorylation and relocation of mixed lineage kinase domain like protein (MLKL).  Using a high-content screening of small compds. and FDA-approved drug libraries, we identified the anti-cancer drug Sorafenib tosylate as a potent inhibitor of TNF-dependent necroptosis.  Interestingly, Sorafenib has a dual activity spectrum depending on its concn.  In murine and human cell lines it induces cell death, while at lower concns. it inhibits necroptosis, without affecting NF-κB activation.  Pull down expts. with biotinylated Sorafenib show that it binds independently RIPK1, RIPK3 and MLKL.  Moreover, it inhibits RIPK1 and RIPK3 kinase activity.  In vivo Sorafenib protects against TNF-induced systemic inflammatory response syndrome (SIRS) and renal ischemia-reperfusion injury (IRI).  Altogether, we show that Sorafenib can, next to the reported Braf/Mek/Erk and VEGFR pathways, also target the necroptotic pathway and that it can protect in an acute inflammatory RIPK1/3-mediated pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfswPD82jd67Vg90H21EOLACvtfcHk0ljYKAJeVOl6Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCht7nO&md5=bb4e411a5d4a9a76e2a52d84075ddb3c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2017.298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2017.298%26sid%3Dliteratum%253Aachs%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DJeong%26aufirst%3DM.%26aulast%3DTonnus%26aufirst%3DW.%26aulast%3DFeldmann%26aufirst%3DF.%26aulast%3DHofmans%26aufirst%3DS.%26aulast%3DGoossens%26aufirst%3DV.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DBrasen%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DE.%2BW.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DLinkermann%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DVandenabeele%26aufirst%3DP.%26atitle%3DSorafenib%2520tosylate%2520inhibits%2520directly%2520necrosome%2520complex%2520formation%2520and%2520protects%2520in%2520mouse%2520models%2520of%2520inflammation%2520and%2520tissue%2520injury%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2017%26volume%3D8%26doi%3D10.1038%2Fcddis.2017.298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span> <span> </span><span class="NLM_article-title">Structural insights into RIP3-mediated necroptotic signaling</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2013.08.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.celrep.2013.08.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=24095729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=70-78&author=T.+Xieauthor=W.+Pengauthor=C.+Yanauthor=J.+Wuauthor=X.+Gongauthor=Y.+Shi&title=Structural+insights+into+RIP3-mediated+necroptotic+signaling&doi=10.1016%2Fj.celrep.2013.08.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights into RIP3-Mediated Necroptotic Signaling</span></div><div class="casAuthors">Xie, Tian; Peng, Wei; Yan, Chuangye; Wu, Jianping; Gong, Xinqi; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-78</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">RIP3 is an essential upstream kinase in necroptosis.  The pseudokinase MLKL functions as a substrate of RIP3 to mediate downstream signaling.  The mol. mechanism by which RIP3 recognizes and phosphorylates MLKL remains unknown.  Here, we report the crystal structures of the mouse RIP3 kinase domain, the MLKL kinase-like domain, and a binary complex between the two.  Both RIP3 and MLKL adopt the canonical kinase fold.  Free RIP3 exists in an active conformation, whereas MLKL-bound RIP3 is stabilized by AMP-PNP to adopt an inactive conformation.  The formation of the RIP3-MLKL complex, involving their resp. N- and C-lobes, is accompanied by pronounced conformational changes of the αC helix and activation loop in RIP3 and the corresponding structural elements in MLKL.  RIP3-mediated MLKL phosphorylation, though important for downstream signaling, is dispensable for stable complex formation between RIP3 and MLKL.  Our study serves as a framework for mechanistic understanding of RIP3-mediated necroptotic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7R60YS-0cP7Vg90H21EOLACvtfcHk0ljYKAJeVOl6Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOltLrL&md5=53fa2aefe1223dfca855a95d28e5d478</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.08.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.08.044%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520insights%2520into%2520RIP3-mediated%2520necroptotic%2520signaling%26jtitle%3DCell%2520Rep.%26date%3D2013%26volume%3D5%26spage%3D70%26epage%3D78%26doi%3D10.1016%2Fj.celrep.2013.08.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savadkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunk, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaboh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diskin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundeyin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahajan, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nassau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leinwand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochen Rossi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aykut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glacken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevaraja, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adeegbe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almonte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagdatlioglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, G.</span></span> <span> </span><span class="NLM_article-title">RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">757</span>– <span class="NLM_lpage">774</span>, e757 <span class="refDoi"> DOI: 10.1016/j.ccell.2018.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1016%2Fj.ccell.2018.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=30423296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOisLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2018&pages=757-774&author=W.+Wangauthor=J.+M.+Marinisauthor=A.+M.+Bealauthor=S.+Savadkarauthor=Y.+Wuauthor=M.+Khanauthor=P.+S.+Taunkauthor=N.+Wuauthor=W.+Suauthor=J.+Wuauthor=A.+Ahsanauthor=E.+Kurzauthor=T.+Chenauthor=I.+Yabohauthor=F.+Liauthor=J.+Gutierrezauthor=B.+Diskinauthor=M.+Hundeyinauthor=M.+Reillyauthor=J.+D.+Lichauthor=P.+A.+Harrisauthor=M.+K.+Mahajanauthor=J.+H.+Thorpeauthor=P.+Nassauauthor=J.+E.+Mosleyauthor=J.+Leinwandauthor=J.+A.+Kochen+Rossiauthor=A.+Mishraauthor=B.+Aykutauthor=M.+Glackenauthor=A.+Ochiauthor=N.+Vermaauthor=J.+I.+Kimauthor=V.+Vasudevarajaauthor=D.+Adeegbeauthor=C.+Almonteauthor=E.+Bagdatliogluauthor=D.+J.+Cohenauthor=K.+K.+Wongauthor=J.+Bertinauthor=G.+Miller&title=RIP1+kinase+drives+macrophage-mediated+adaptive+immune+tolerance+in+pancreatic+cancer&doi=10.1016%2Fj.ccell.2018.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer</span></div><div class="casAuthors">Wang, Wei; Marinis, Jill M.; Beal, Allison M.; Savadkar, Shivraj; Wu, Yue; Khan, Mohammed; Taunk, Pardeep S.; Wu, Nan; Su, Wenyu; Wu, Jingjing; Ahsan, Aarif; Kurz, Emma; Chen, Ting; Yaboh, Inedouye; Li, Fei; Gutierrez, Johana; Diskin, Brian; Hundeyin, Mautin; Reilly, Michael; Lich, John D.; Harris, Philip A.; Mahajan, Mukesh K.; Thorpe, James H.; Nassau, Pamela; Mosley, Julie E.; Leinwand, Joshua; Kochen Rossi, Juan A.; Mishra, Ankita; Aykut, Berk; Glacken, Michael; Ochi, Atsuo; Verma, Narendra; Kim, Jacqueline I.; Vasudevaraja, Varshini; Adeegbe, Dennis; Almonte, Christina; Bagdatlioglu, Ece; Cohen, Deirdre J.; Wong, Kwok-Kin; Bertin, John; Miller, George</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">757-774.e7</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDA) is characterized by immune tolerance and immunotherapeutic resistance.  We discovered upregulation of receptor-interacting serine/threonine protein kinase 1 (RIP1) in tumor-assocd. macrophages (TAMs) in PDA.  To study its role in oncogenic progression, we developed a selective small-mol. RIP1 inhibitor with high in vivo exposure.  Targeting RIP1 reprogrammed TAMs toward an MHCIIhiTNFα+IFNγ+ immunogenic phenotype in a STAT1-dependent manner.  RIP1 inhibition in TAMs resulted in cytotoxic T cell activation and T helper cell differentiation toward a mixed Th1/Th17 phenotype, leading to tumor immunity in mice and in organotypic models of human PDA.  Targeting RIP1 synergized with PD1-and inducible co-stimulator-based immunotherapies.  Tumor-promoting effects of RIP1 were independent of its co-assocn. with RIP3.  Collectively, our work describes RIP1 as a checkpoint kinase governing tumor immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDOuua4gAvrLVg90H21EOLACvtfcHk0ljYKAJeVOl6Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOisLfO&md5=9210358fa2dbb4da0d0981e84ac696f9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2018.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMarinis%26aufirst%3DJ.%2BM.%26aulast%3DBeal%26aufirst%3DA.%2BM.%26aulast%3DSavadkar%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DM.%26aulast%3DTaunk%26aufirst%3DP.%2BS.%26aulast%3DWu%26aufirst%3DN.%26aulast%3DSu%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DAhsan%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYaboh%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DGutierrez%26aufirst%3DJ.%26aulast%3DDiskin%26aufirst%3DB.%26aulast%3DHundeyin%26aufirst%3DM.%26aulast%3DReilly%26aufirst%3DM.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DMahajan%26aufirst%3DM.%2BK.%26aulast%3DThorpe%26aufirst%3DJ.%2BH.%26aulast%3DNassau%26aufirst%3DP.%26aulast%3DMosley%26aufirst%3DJ.%2BE.%26aulast%3DLeinwand%26aufirst%3DJ.%26aulast%3DKochen%2BRossi%26aufirst%3DJ.%2BA.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DAykut%26aufirst%3DB.%26aulast%3DGlacken%26aufirst%3DM.%26aulast%3DOchi%26aufirst%3DA.%26aulast%3DVerma%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BI.%26aulast%3DVasudevaraja%26aufirst%3DV.%26aulast%3DAdeegbe%26aufirst%3DD.%26aulast%3DAlmonte%26aufirst%3DC.%26aulast%3DBagdatlioglu%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DD.%2BJ.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DG.%26atitle%3DRIP1%2520kinase%2520drives%2520macrophage-mediated%2520adaptive%2520immune%2520tolerance%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2018%26volume%3D34%26spage%3D757%26epage%3D774%26doi%3D10.1016%2Fj.ccell.2018.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breslin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kini, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span> <span> </span><span class="NLM_article-title">Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1154</span>– <span class="NLM_lpage">1165</span>, <span class="refDoi"> DOI: 10.1038/leu.2016.287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=10.1038%2Fleu.2016.287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=27748372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCjt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=1154-1165&author=J.+Xinauthor=D.+Youauthor=P.+Breslinauthor=J.+Liauthor=J.+Zhangauthor=W.+Weiauthor=J.+Cannovaauthor=A.+Volkauthor=R.+Gutierrezauthor=Y.+Xiaoauthor=A.+Niauthor=G.+Ngauthor=R.+Schmidtauthor=Z.+Xiaauthor=J.+Panauthor=H.+Chenauthor=M.+M.+Patelauthor=P.+C.+Kuoauthor=S.+Nandauthor=A.+R.+Kiniauthor=J.+Zhangauthor=J.+Chenauthor=J.+Zhuauthor=J.+Zhang&title=Sensitizing+acute+myeloid+leukemia+cells+to+induced+differentiation+by+inhibiting+the+RIP1%2FRIP3+pathway&doi=10.1038%2Fleu.2016.287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway</span></div><div class="casAuthors">Xin, J.; You, D.; Breslin, P.; Li, J.; Zhang, J.; Wei, W.; Cannova, J.; Volk, A.; Gutierrez, R.; Xiao, Y.; Ni, A.; Ng, G.; Schmidt, R.; Xia, Z.; Pan, J.; Chen, H.; Patel, M. M.; Kuo, P. C.; Nand, S.; Kini, A. R.; Zhang, J.; Chen, J.; Zhu, J.; Zhang, J.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1154-1165</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor necrosis factor-α (TNF-α)-induced RIP1/RIP3 (receptor-interacting protein kinase 1/receptor-interacting protein kinase 3)-mediated necroptosis has been proposed as an alternative strategy for treating apoptosis-resistant leukemia.  However, we found that most acute myeloid leukemia (AML) cells, esp. M4 and M5 subtypes, produce TNF and show basal level activation of RIP1/RIP3/MLKL signaling, yet do not undergo necroptosis.  TNF, through RIP1/RIP3 signaling, prevents degrdn. of SOCS1, a key neg. regulator of interferon-γ (IFN-γ) signaling.  Using both pharmacol. and genetic assays, we show here that inactivation of RIP1/RIP3 resulted in redn. of SOCS1 protein levels and partial differentiation of AML cells.  AML cells with inactivated RIP1/RIP3 signaling show increased sensitivity to IFN-γ-induced differentiation.  RIP1/RIP3 inactivation combined with IFN-γ treatment significantly attenuated the clonogenic capacity of both primary AML cells and AML cell lines.  This combination treatment also compromised the leukemogenic ability of murine AML cells in vivo.  Our studies suggest that inhibition of RIP1/RIP3-mediated necroptotic signaling might be a novel strategy for the treatment of AML when combined with other differentiation inducers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo12Vhh4iOPv7Vg90H21EOLACvtfcHk0lh9e-DAx2fRJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCjt7fP&md5=f7a9bd4c110a2ee97a63a83257f23a39</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fleu.2016.287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2016.287%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DD.%26aulast%3DBreslin%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DCannova%26aufirst%3DJ.%26aulast%3DVolk%26aufirst%3DA.%26aulast%3DGutierrez%26aufirst%3DR.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DA.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DXia%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DM.%2BM.%26aulast%3DKuo%26aufirst%3DP.%2BC.%26aulast%3DNand%26aufirst%3DS.%26aulast%3DKini%26aufirst%3DA.%2BR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DSensitizing%2520acute%2520myeloid%2520leukemia%2520cells%2520to%2520induced%2520differentiation%2520by%2520inhibiting%2520the%2520RIP1%252FRIP3%2520pathway%26jtitle%3DLeukemia%26date%3D2017%26volume%3D31%26spage%3D1154%26epage%3D1165%26doi%3D10.1038%2Fleu.2016.287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective effect of swertiamain on cerebral ischemia/reperfusion injury by inducing the Nrf2 protective pathway</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">2276</span>– <span class="NLM_lpage">2286</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVWnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=2276-2286&author=H.+Wangauthor=W.+Weiauthor=X.+Lanauthor=N.+Liuauthor=Y.+Liauthor=H.+Maauthor=T.+Sunauthor=X.+Pengauthor=C.+Zhuangauthor=J.+Yu&title=Neuroprotective+effect+of+swertiamain+on+cerebral+ischemia%2Freperfusion+injury+by+inducing+the+Nrf2+protective+pathway&doi=10.1021%2Facschemneuro.8b00605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective Effect of Swertiamarin on Cerebral Ischemia/Reperfusion Injury by Inducing the Nrf2 Protective Pathway</span></div><div class="casAuthors">Wang, Hui; Wei, Wei; Lan, Xiaobing; Liu, Ning; Li, Yuxiang; Ma, Hanxiang; Sun, Tao; Peng, Xiaodong; Zhuang, Chunlin; Yu, Jianqiang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2276-2286</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxidative stress plays a vital role in the development of cerebral ischemic/reperfusion (I/R).  Targeting oxidative stress is proposed to be an effective strategy to treat cerebral I/R injury.  Gentiana macrophylla Pall is reported to have a potential protective effect against stroke.  Swertiamarin (Swe), an active secoiridoid glycoside compd. isolated from Gentiana macrophylla Pall, has been reported to possess antioxidative potential.  This study is to explore whether Swe could prevent brain from I/R injury, and the related mechanisms of oxidative stress are also elucidated using mice middle cerebral artery occlusion (MCAO) model and primary hippocampal neurons oxygen-glucose deprivation/reperfusion (OGD/R) model.  Swe (25, 100, or 400 mg/kg) was pretreated i.p. for 7 days until establishment of the MCAO model, while hippocampal neurons were maintained in Swe (0.1, 1, or 10μM) in the entire process of reoxygenation.  The results indicated that Swe pretreatment markedly decreased infarct vol., apoptotic neurons, and oxidative damage and promoted neurol. recovery in vivo.  It also decreased reactive oxygen species (ROS) and increased cell viability in vitro.  Western blot analyses and immunofluorescence staining demonstrated that Swe pretreatment promoted Nrf2 nuclear translocation from Keap1-Nrf2 complex and enhanced the expressions of NAD(P)H: quinone oxidoreductase-1 (NQO1) and heme oxygenase-1 (HO-1) both in vivo and in vitro, while the expressions could be reversed by a Nrf2 inhibitor.  The binding mode of Keap1 with Swe was also proposed by covalent mol. docking.  Collectively, Swe could be considered as a promising protective agent against cerebral I/R injury through suppressing oxidative stress by activation of the Nrf2 protective pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoijWw6jeubobVg90H21EOLACvtfcHk0lh9e-DAx2fRJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVWnu74%253D&md5=f705a34e402466b5c5a63cfbb87ead7d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00605%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DNeuroprotective%2520effect%2520of%2520swertiamain%2520on%2520cerebral%2520ischemia%252Freperfusion%2520injury%2520by%2520inducing%2520the%2520Nrf2%2520protective%2520pathway%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26spage%3D2276%26epage%3D2286%26doi%3D10.1021%2Facschemneuro.8b00605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanapillai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span> <span> </span><span class="NLM_article-title">Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1126</span>, <span class="refDoi"> DOI: 10.1021/jm4017174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4017174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1121-1126&author=C.+Zhuangauthor=S.+Narayanapillaiauthor=W.+Zhangauthor=Y.+Y.+Shamauthor=C.+Xing&title=Rapid+identification+of+Keap1-Nrf2+small-molecule+inhibitors+through+structure-based+virtual+screening+and+hit-based+substructure+search&doi=10.1021%2Fjm4017174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid Identification of Keap1-Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search</span></div><div class="casAuthors">Zhuang, Chunlin; Narayanapillai, Sreekanth; Zhang, Wannian; Sham, Yuk Yin; Xing, Chengguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1121-1126</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, rapid structure-based virtual screening and hit-based substructure search were utilized to identify small mols. that disrupt the interaction of Keap1-Nrf2.  Special emphasis was placed toward maximizing the exploration of chem. diversity of the initial hits while economically establishing informative structure-activity relationship (SAR) of novel scaffolds.  Our most potent noncovalent inhibitor exhibits three times improved cellular activation in Nrf2 activation than the most active noncovalent Keap1 inhibitor known to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRWjo_56WOF7Vg90H21EOLACvtfcHk0lh9e-DAx2fRJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVemsA%253D%253D&md5=dcf9d53a0fb18363c6e47b8077c350b9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm4017174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4017174%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DNarayanapillai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSham%26aufirst%3DY.%2BY.%26aulast%3DXing%26aufirst%3DC.%26atitle%3DRapid%2520identification%2520of%2520Keap1-Nrf2%2520small-molecule%2520inhibitors%2520through%2520structure-based%2520virtual%2520screening%2520and%2520hit-based%2520substructure%2520search%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1121%26epage%3D1126%26doi%3D10.1021%2Fjm4017174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M69" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M69','PDB','4M69'); return false;">PDB: 4M69</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HHO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HHO','PDB','6HHO'); return false;">PDB: 6HHO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M66" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4M66','PDB','4M66'); return false;">PDB: 4M66</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KSP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KSP','PDB','4KSP'); return false;">PDB: 4KSP</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i68"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00611">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34326"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00611">10.1021/acs.jmedchem.9b00611</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic protocols, detailed experimental procedures, <sup>1</sup>H and <sup>13</sup>C NMR spectra, HRMS spectra, and HPLC chromatograms showing the purity of the target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_001.pdf">jm9b00611_si_001.pdf (18.72 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00611/suppl_file/jm9b00611_si_002.csv">jm9b00611_si_002.csv (2.89 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00611&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00611%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-14%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00611" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677af899e8ce3ce2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
